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Zusammenfassung 
Die vorliegende Doktorarbeit untersuchte grundlegende kognitive Fähigkeiten, den Einfluss des 
endocannabinoiden Systems (ECS) und Entwicklungsaspekte während der Adoleszenz 
männlicher Wistarratten. Zunächst wurden mögliche Verhaltensunterschiede zwischen drei 
verschiedenen Wistar Han Rattenlinien analysiert und die W[rcc] Linie für weitere Experimente 
auf Grund ihrer besten Leistung im Wiedererkennungstest für Objekte und ihrer guten Leistung 
der Präpulsinhibition (PPI) der akustischen Schreckreaktion (ASR) ausgewählt. 
Im zweiten Projekt wurde die basale Ontogenese verschiedener kognitiver Fähigkeiten untersucht 
und die Ergebnisse zeigten unterschiedliche Entwicklungsmuster während der Adoleszenz und 
des jungen Erwachsenenalters. Die Erinnerungsleistung für das Wiedererkennen von Objekten 
zeigte eine nicht-lineare Entwicklung mit einem Leistungsabfall am postnatalen Tag (pd) 40, am 
ungefähren Beginn der Pubertät. Dieser Abfall konnte durch die Verabreichung des 
Cannabinoidrezeptor 1 (CB1R) Antagonisten/inversen Agonisten SR141716 verbessert werden, 
was auf eine Beteiligung des sich entwickelnden ECS zu diesem Zeitpunkt hindeutet. Das 
Unterscheidungsvermögen für kürzlich und weiter in der Vergangenheit zurückliegend erkundete 
Objekte entwickelte sich später als für das Wiedererkennen von Objekten, zeigte aber keine 
Unterschiede während der Adoleszenz. Im Gegensatz hierzu entwickelte sich die PPI der ASR 
sukzessive und zeigte einen stetigen Anstieg der Startleamplitude und sensomotorischer 
Filterfähigkeiten bis hinein ins frühe Erwachsenenalter (pd 100). Molekulare Analysen zeigten 
einen erhöhten CB1R Gehalt im Hippocampus (Hip) in der frühen Adoleszenz, was auf ein 
erhöhtes ECS um dieses Alter hinweist. Die Myelinisierung, welche mit der Verbesserung 
kognitiver Fähigkeiten in Zusammenhang steht, scheint sukzessive im Hip und Caudauten 
Putamen (CPu) anzusteigen. Zusammengefasst zeigen verschiedene kognitive Fähigkeiten 
unterschiedliche Entwicklungszeitverläufe und Änderungen des sich entwickelnden ECS scheinen 
einigen dieser Entwicklungsverläufe zu Grunde zu liegen. 
Langzeiteffekte einer chronischen pubertären WIN 55,212-2 Behandlung auf kognitive 
Fähigkeiten im Erwachsenenalter beinhalteten eine verringerte Wiedererkennungsleistung von 
Objekten in der W[rcc] Rattenlinie, was dieses Tiermodell der Schizophrenie für diese Rattenlinie 
bestätigte. Darüber hinaus wurden komplexe kognitive Leistungen in einem sog. 
„Aufmerksamkeits Set Shift Test“ (ASST) untersucht, in welchem eine Beeinträchtigung der 
Fähigkeit beobachtet wurde, eine zuvor gelernte Regel umzudrehen, während andere 
Befähigungen Regeln zu lernen sich nicht von Vehikel behandelten Tieren unterschieden. Dies 
deutet eine spezielle Beeinträchtigung der Fähigkeit Regeln umzudrehen nach der chronischen 
Beeinflussung des sich entwickelnden ECS an. Außerdem zeigten molekulare Analysen einen 
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erhöhten CB1R Gehalt im medialen präfrontalen Cortex (mPFC), was auf einen möglichen 
kompensatorischen Entwicklungsmechanismus in dieser Hirnregion nach der Störung in diesem 
speziellen Zeitfenster hindeutet. 
Im vierten Projekt wurden keine Langzeiteffekte einer chronischen pubertären Methylphenidat 
(MPH) Behandlung auf verschiedene Verhaltenstests, inklusive der lokomotorischen Aktivität, 
dem Angst-ähnlichem Verhalten, der Aufnahme verschieden schmackhafter Flüssigkeiten oder 
kognitiver Fähigkeiten im Erwachsenenalter festgestellt. Daher schien das hier benutzte MPH 
Behandlungsschema keine Langzeiteffekte zu verursachen, jedoch könnten weitere 
Untersuchungen andere für eine MPH Behandlung anfällige Entwicklungszeitfenster aufzeigen. 
Zusammenfassend zeigte die vorliegende Doktorarbeit unterschiedliche Entwicklungsmuster 
kognitiver Fähigkeiten während der Adoleszenz männlicher Wistarratten, die scheinbar mit der 
Entwicklung des ECS gekoppelt sind und die Beeinflussung dieses Systems während dieses 
anfälligen Zeitraums kann die kognitiven Fähigkeiten im Erwachsenenalter beeinträchtigen. 
 
 
Summary 
 V 
 
Summary 
The present thesis investigated the basal cognitive abilities, the influence of the endocannabinoid 
system (ECS), and developmental aspects throughout the adolescence in male Wistar rats. First, 
possible behavioral differences in three different lines of Wistar Han rats were analyzed and the 
W[rcc] line was selected for the subsequent experiments based on its best performance in the 
object recognition test and good performance in the prepulse inhibition (PPI) of the acoustic 
startle reflex (ASR).  
In the second project the basic ontogeny of various cognitive abilities was analyzed and the results 
revealed differential patterns of development across adolescence and early adulthood. Object 
recognition memory showed a non-linear development with a decrease in performance on 
postnatal (pd) 40, at the approx. onset of puberty. This decrease was ameliorated by the 
administration of the cannabinoid receptor 1 (CB1R) antagonist/inverse agonist SR141716 
indicating an involvement of the developing ECS at this time point. Recency discrimination 
developed later than recognition memory but did not display variations across adolescence. In 
contrast, PPI of the ASR developed gradually revealing a continuing increase of startle amplitude 
and sensorimotor gating abilities until early adulthood (pd 100). Molecular analysis showed 
increased CB1R levels in the hippocampus (Hip) in early adolescence indicating an increased 
ECS around that age. Myelination, which is linked to improved cognitive skills, appeared to 
increase gradually in the Hip and in the caudate putamen (CPu). Altogether, different cognitive 
abilities displayed differential time-courses of development and alterations of the developing ECS 
are implicated underlying some of these behavioral patterns. 
Long-term effects of a chronic pubertal WIN 55,212-2 treatment on cognitive abilities in 
adulthood included a decreased object recognition memory in the W[rcc] line, which confirmed 
this animal model of schizophrenia for this rat line. Moreover, complex cognitive skills were 
investigated in an attentional set shift test (ASST) and an impaired reversal learning ability was 
found while other learning abilities did not differ from vehicle treated animals. This indicates 
specific deficits in reversal learning upon chronic interference with the developing ECS. 
Furthermore, molecular analysis showed increased CB1R levels in the medial prefrontal cortex 
(mPFC) indicating a possible developmental compensatory mechanism in this brain region after 
disturbances in this particular developmental time-window.  
In the fourth project no long-term effects of a chronic pubertal methylphenidate (MPH) treatment 
on various behavioral tests were observed in adulthood for locomotor activity, anxiety-related 
behavior, intake of liquids of variable palatability or cognitive processing. Thus, the presently 
employed MPH administration paradigm did not appear to cause long-term effects but further 
Summary 
 VI 
investigations may reveal other time-windows of vulnerability to MPH administration during 
development. 
Altogether, the present thesis revealed differential developmental patterns of cognitive abilities 
during adolescence of male Wistar rats which appear to be linked to the developing ECS and 
interference with this system at this vulnerable time period may impair cognitive skills in 
adulthood. 
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1. Introduction 
1.1 Cognition 
Cognition is an umbrella term for various mental processes. Shettleworth (2009) refers to 
cognition as “mechanisms by which animals acquire, process, store and act on information from 
their environment”. So at first an organism perceives sensory stimuli from its surroundings and 
then associations about the relevant information are made. These associations are then encoded 
and stored in the brain (D'Mello and Steckler, 1996). The successful integration of information is 
called binding (Treisman, 1996) and it is closely related to the formation of mnemonic 
representations (Sander et al., 2012). Cognitive processes therefore include perception, learning, 
memory, attention, planning, and decision making but also pre-attentional sensory gating (e.g. 
prepulse inhibition of the acoustic startle reflex; PPI) and meta-cognition (thinking and knowledge 
about cognition; (reviewed by Millan et al., 2012; see Figure 1)). Cognitive abilities can be 
conscious or unconscious processes and depend on motivation, attention, and prior experience 
(D'Mello and Steckler, 1996).  
Learning and memory processes can be either perceived as psychological processes or as changes 
in synaptic neural connectivity (Vanderwolf and Cain, 1994). Learning can be described as an 
adaptation to the environment which is based on information transfer and subsequent changes in 
interneural communication (Wotjak, 2005). Memory can be referred to as the relative persistence 
of these changes. Learning and memory cannot be measured per se but can only be inferred from 
behavior (Cahill et al., 2001). 
Usually three stages are considered when learning and the creation of memory occurs: Encoding 
happens during the presentation of learning material. As a result information is stored during a 
consolidation stage and the recall of learned information can be accessed during retrieval 
(Eyseneck, 2000, Straube, 2012). Memory can be divided according to type (declarative (or 
explicit) memory like facts and episodic events or procedural (or implicit) memory like motor 
skills and habits), or according to temporal categories (like short-term memory (STM) and long-
term memory (LTM) (Purves, 2004)). From the concept of STM the term working memory (WM) 
evolved (Baddeley, 2012). STM is often referred to as the storage of information for seconds to 
minutes whereas WM implies the possible mental manipulation of this information. Miller (1960) 
employed the term WM for memory used to plan and carry out behavior. Olton (1979) later 
adopted this term for the behavior of rats in a radial arm maze but his use of WM is now often 
seen as LTM.  
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Various models of memory were established and need to be constantly revised. Atkinson and 
Shiffrin’s multi-store model (1986) comprised three types of memory: sensory stores, which hold 
information briefly and are modality-specific, a short-term store, and a long-term store (Eyseneck, 
2000). Information from the environment is received via the sensory stores and transferred into 
the short-term store. This process depends on attention. Then some of this information is 
transferred into the long-term store often requiring rehearsal. However, the multi-store model was 
gradually regarded as oversimplified and needed to be improved.  
In Baddeley and Hitch’s multicomponent model (Baddeley, 2010) an attentional control system 
(the central executive) is supported by two STM storage systems (the visuo-spatial sketch-pad and 
reception
environmental stimuli
perception
discrimination
associative learning
covert
processes
attention
non-associative
learning
encoding
modification of 
associative
strength
response selection
comparator
retrieval
action environmental stimuli
storage Recognition / Recall
STM WM LTM (including declarative & procedural memory)
motivation
real-time clock
impulse control
Figure 1: Schematic diagram of processes implicated in learning and memory (Adapted from 
D'Mello and Steckler, 1996). Arrows represent possible interactions and direction of information 
flow. Abbreviations: STM: short-term memory; LTM: long-term memory; WM: working memory. 
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the phonological loop for verbal and acoustic material; see Figure 2A). The episodic buffer, as a 
further component, was added later on and is supposed to combine information of various sensory 
inputs as a temporary store. The other components are able to interact through this buffer which 
also contains links to LTM (Baddeley, 2010). It is supposed to have a limited capacity (of 
approximately four so called “chunks”) and to be consciously accessible (Baddeley, 2010). 
However, because of the importance of language in this model, it is only partially applicable when 
studying memory in animals.  
In Cowan’s embedded processes model (2008), STM is a part of a temporarily activated LTM 
(see Figure 2B). A further subset of this is the focus of attention, which has a limited chunk or 
item capacity. WM is defined as cognitive processes that keep information in a very accessible 
state and comprises therefore both the focus of attention and the central executive (attention 
control) processes (Cowan, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.1 Neuronal Structures 
Various brain regions are involved in different cognitive processes among which are the striatum, 
the prefrontal cortex (PFC), and the hippocampus (Hip). The striatum is involved in motivation 
and habit formation (White, 1997). The PFC is particularly involved in higher order executive 
functions like WM, planning, attentional set shifting, inhibitory response control, temporal 
integration of voluntary behavior, and goal directed behavior (Dalley et al., 2004, Pattij et al., 
2008). The Hip is involved in spatial learning, episodic memory, consolidation, and in forming 
multi-modal representations of environmental cues (Sweatt, 2004, Fanselow and Dong, 2010). In 
addition, the PFC-Hip pathway appears to be very important in cognition related to executive 
Figure 2: Baddeley and Hitch’s multicomponent model (A; Figure from Baddeley, 2010) and Cowan’s embedded 
process model (B; Figure from Cowan, 2008, Baddeley, 2010). A: The multicomponent model includes links to 
LTM. The visuo-spatial sketch pad, the episodic buffer and the phonological loop as three STM components interact 
with the central executive (attentional control system). B: In the embedded process model STM is a part of the 
activated LTM. 
A B
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functions and emotional regulation (Vertes, 2006, Euston et al., 2012, Godsil et al., 2013). 
Furthermore, structural anomalies as well as irregular functional coupling have been observed in 
psychiatric disorders like schizophrenia (Godsil et al., 2013).  
 
Striatum 
The striatum belongs to a group of subcortical nuclei called the basal ganglia. It consists of a 
dorsal part (comprising the nucleus caudatus and the putamen; CPu) and a ventral part (consisting 
of the nucleus accumbens (NAc); reviewed by Grahn et al., 2009). The NAc is implicated in 
reward processing and motivational behavior (Salamone and Correa, 2002, O'Doherty, 2004) and 
the dorsal striatum is involved in stimulus-response (habit) and egocentric learning (Packard and 
McGaugh, 1996, White, 1997). The striatum is also considerably connected to the PFC, receiving 
afferents from various cortical areas and projecting back to the PFC via the substantia nigra or 
globus pallidus and the thalamus (Wise et al., 1996, White, 1997). Therefore, the striatum can 
integrate sensory information (received from the PFC) with previously learned responses and 
appropriate behavior in a particular context or situation. In turn, output from the striatum to the 
frontal cortex may influence the latter to execute rules in the presence of a particular context 
(White, 1997). 
 
Prefrontal Cortex  
The PFC is the association cortex of the frontal lobe and one of the latest cortices to develop 
phylogenetically (Fuster, 2001). It also undergoes late development during ontogeny 
(Huttenlocher, 1990) and imaging studies suggest that full maturity is not reached until end of 
adolescence (Paus et al., 1999, Sowell et al., 1999). Early definitions of the PFC were based on 
the cytoarchitectonic criterion of having a granular layer IV and a location rostral to the agranular 
motor areas (Uylings et al., 2003). But when comparing different species these criteria could no 
longer be used exclusively. Rose and Woolsey defined it as the cortex with reciprocal connections 
of the mediodorsal nucleus of the thalamus (Rose and Woolsey, 1948). Today other criteria are 
additionally used for defining the PFC, e.g. functional properties, presence and distribution of 
neurotransmitters and receptors, embryological development, and for closely related species, 
cytoarchitectonic characteristics (Uylings et al., 2003).  
The primate PFC can be divided into a dorsolateral, a medial, and an orbital part (Uylings et al., 
2003). The rodent PFC is divided into a medial, a ventral, and a lateral part with further 
subdivisions as follows (see Figure 3): the medial part consists of a dorsal region including the 
precentral and the anterior cingulate cortices as well as a ventral region comprising the prelimbic 
(PL), the infralimbic (IL) and the medial orbital coritces. The ventral region comprises the ventral 
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orbital and the ventral lateral orbital cortices. The lateral part includes the dorsal and ventral 
agranular insulas and the lateral orbital cortices (Dalley et al., 2004). 
Connections of the PFC to other subcortical structures include the brainstem, the thalamus, the 
basal ganglia, and the limbic system (Fuster, 2001). Additionally, there are many internal 
connections within the PFC which are often reciprocally and topologically well organized (Fuster, 
2001). Hence, the PFC is provided with information about the internal environment (e.g. arousal, 
drives, and motives) by afferent connections from the brainstem, the diencephalon, and the limbic 
system, while information about the motivational relevance of sensory stimuli is conveyed from 
the ventral tegmental area (VTA), the amygdala and the hypothalamus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on anatomy and function there appears to be a dorsal-ventral gradient of the medial part of 
the PFC (mPFC). The dorsal regions appear to be specialized in the control of actions while the 
ventral regions seem to be specialized in autonomic and emotional control (Heidbreder and 
Groenewegen, 2003).  
When environmental demands shift, the PFC is essential in planning, controlling, and directing 
behavior accordingly and in helping to select and process information (Miller and Cohen, 2001, 
Holmes and Wellman, 2009). Thus, the PFC takes the inputs of current contexts and events and 
predicts the most adaptive responses based on previous experiences (Euston et al., 2012). 
Furthermore, the rapidly acquired input-output mappings in the PFC are most likely initially 
supported by the Hip but later become independent of it (Euston et al., 2012).  
Figure 3: Coronal (A) and sagital (B) sections of the rat PFC (Figures from Dalley et al., 2004). 
Abbreviations: PrC: precentral cortex, ACg: anterior cingulate cortex, PrL: prelimbic cortex, IL: 
infralimbic cortex, MO: medial orbital cortex, VO: ventral orbital cortex, VLO: ventrolateral orbital cortex, 
LO: lateral orbital cortex, AIV: ventral agranular insular cortex, AID: dorsal agranular insular cotex, M1: 
primary motor area, OB: olfactory bulb, cc: corpus callosum, Cg2: cinglate cortex area 2, gcc: genu of cc. 
BA
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Due to its manyfold connections with other structures and within itself it is argued that the 
functions of the PFC cannot be taken out of this broad connectionist context (Fuster, 2001). A 
particular function could not be localized within a discrete portion of the PFC. However, lesion 
studies are showing that the mPFC is important in attentional set shifting (Birrell and Brown, 
2000) whereas the orbifrontal cortex (OFC) is important in reversal learning (see also 1.4.5; 
McAlonan and Brown, 2003).  
 
Hippocampus 
The Hip is part of the limbic system and situated in the temporal lobe. It comprises the subiculum, 
the Hip proper (also termed cornu ammonis (CA1-4)), and the dentate gyrus (DG). The Hip 
receives information from the entorhinal and perirhinal cortex via the perforant path to the DG 
(see Figure 4; Sweatt, 2004, Dokter and von Bohlen und Halbach, 2012). From the DG mossy 
fibers relay information to the CA3 field and from here to CA1 via the Schaffer collaterals. The 
major output neurons in the CA1 field are glutamatergic pyramidal cells. These neurons project 
mainly to the ipsi- and contralateral entorhinal cortices but also to the contralateral Hip via the 
fornix (Sweatt, 2004). There are also direct projections from the CA1 and the subiculum to the 
mPFC (IL/PL) but there are no direct connections back from the mPFC to the Hip (Warburton and 
Brown, 2010). Connections from the mPFC reach the Hip indirectly via the entorhinal cortex and 
via the nucleus reuniens of the thalamus (Vertes, 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Schematic pathway of sensory signals through the Hip. A: (1) Fibers from the entorhinal cortex project to 
the DG via the perforant path. (2) Mossy fibers relay from DG to CA3. (3) CA 3 and CA 1 are connected via the 
Schaffer collaterals. (4) CA 1 projects back to the entorhinal cortex. B: Schematic overview over Hip pathways. 
Abbreviations: CA 1 – 3: cornu ammonis; DG: dentate gyrus. Figure A from Doktor and von Bohlen und Halbach 
(2012); Figure B adapted from Sweatt (2004). 
A B
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The importance of the Hip in memory became evident by the well-known case of the 
hippocampectomy in the patient H.M. (Scoville and Milner, 1957). In order to help treating his 
severe epilepsy he underwent experimental surgery and had both hippocampi removed. 
Consequently he suffered from anterograde amnesia and had selective deficits in certain types of 
memory (i.e. declarative) whereas other types (i.e. procedural memory) were spared (Milner et al., 
1998). The formation of declarative memory is critically dependent on the Hip and the medial 
temporal lobe (Sweatt, 2004). But there is also evidence that the Hip contributes to WM and 
planning together with the PFC (Godsil et al., 2013). The connection between PFC and Hip is 
mainly ipsilateral (Godsil et al., 2013). Investigated in asymmetric pathway disconnection 
analysis (“crossed lesions”), the PFC is compromised in one hemisphere and the Hip in the other 
hemisphere. One can study the influence of these lesions in comparison to unilateral control 
lesions in a variety of behavioral tests. Floresco (1997) revealed that this connection is needed in a 
delayed condition in a win-shift radial arm maze task in rats. Involvement in cognitive flexibility 
of goal-directed behavior was also shown in a reward-discounting choice task (Gruber et al., 
2010). In this test animals with neonatal lesions of the ventral Hip displayed neuronal 
hyperactivity in the PFC in adulthood and deficits in cognitive flexibility when reward 
contingencies were changed. The Hip-PFC pathway is thought to be critically involved in 
information transfer when acquiring new rules in goal-oriented reward learning (Godsil et al., 
2013). Asymmetric disconnection analysis also indicated an involvement of the Hip-PFC pathway 
in object recognition (OBJR) memory, particularly in tests for contextual and temporal 
recognition of objects (see also 1.4.3; Barker and Warburton, 2011).  
Altogether, the integrated activity of various brain regions appears to be involved in distinct types 
of memory processes. Inactivation or lesion of a particular brain region might interfere with one 
particular aspect of memory. However, compensation by other intact regions might help to 
maintain mnemonic functioning to a certain degree and, hence, cannot be excluded in behavioral 
performance.  
1.1.2 Neurotransmitter Systems 
The involvement of distinct neurotransmitter systems in cognition appears to be rather complex. 
Similar as to the hypothesis that multiple brain regions act in a coordinated manner in various 
cognitive processes, various neurotransmitters seem to be differently involved in them. A meta-
analysis for the involvement of several neurotransmitters in four established behavioral paradigms 
for cognitive abilities (Morris water maze, radial maze, passive avoidance, and spontaneous 
alternation) revealed that glutamate, γ-aminobutyric acid (GABA), dopamine (DA), and 
acetylcholine (ACh) seemed to have a powerful impact on cognitive processes but no 
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relationships between a specific transmitter system and a particular task was found (Myhrer, 
2003). Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) 
whereas GABA is considered the major inhibitory neurotransmitter (McEntee and Crook, 1993, 
Krnjevic, 2004). Glutamate and GABA are important in long-term potentiation (LTP) which is 
considered the neurophysiological model of learning and memory (Brown et al., 1988, McEntee 
and Crook, 1993, Myhrer, 2003). In LTP repetitive high frequency stimulation (e.g. in the Hip) 
induces the potentiation of synaptic transmission (Bliss and Lomo, 1973, McEntee and Crook, 
1993). Two major glutamate receptors, NMDA (N-Methyl-D-Aspartate) and AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid), are required for induction and expression of LTP, 
respectively (see Myhrer, 2003). Furthermore, GABA antagonists facilitate the induction of LTP 
and additionally, changes in the DAergic, cholinergic, noradrenergic, and serotonergic systems 
influence LTP.  
In addition to amino acids like glutamate and GABA, monamines are also important 
neurotransmitters in learning and memory. DA is considered to be involved in motivational 
behavior but also in response selection and habit formation (Romanides et al., 1999, Myhrer, 
2003). Serotonin is connected to emotional behavior but its influence in learning and memory 
seems to be less strong (Hashimoto et al., 1999). Although ACh has often been considered as 
essential in learning and memory processes, it is now rather considered to have an important role 
in attention processes (Blokland, 1995). Furthermore, interactions between neurotransmitter 
systems are widely observed in various cognitive tests, e.g between ACh and glutamate (Levin et 
al., 1998), between ACh and DA (McGurk et al., 1988), and between ACh and serotonin (Steckler 
and Sahgal, 1995).  
A very important modulatory neurotransmitter system involved in cognition is the 
endocannabinoid system (ECS, see 1.3.4). The ECS is also known to interact with various 
neurotransmitter systems, e.g. with DA (reviewed by El Khoury et al., 2012), ACh (Bura et al., 
2007), glutamate and GABA (reviewed by Lopez-Moreno et al., 2008). Thus, as Myhrer (2003) 
mentioned: “the multiple memory systems in the rat brain can hardly be related to specific 
transmitter systems because of the great extent of interactions between the systems”. Optimal 
performance in a behavioral task most likely depends on plural memory systems and 
monaminergic projections exert modulatory functions like attention, emotion, and motivation 
(Myhrer, 2003). In addition, interactions of various neurotransmitters with the ECS have an 
important influence in cognition. 
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1.1.3 Neuropsychiatric Disorders 
Cognitive dysfunctions are very common in a range of neurpsychiatric disorders including 
schizophrenia, attention deficit hyperactivity disorder (ADHD), Alzheimers’s disease, bipolar 
disorder, and many more (reviewed by Millan et al., 2012). Traditionally, emotional symptoms 
like anxiety, hallucinations, and depression have been primarily investigated in these disorders but 
the cognitive deficits are now also considered a core deficit and a major component decreasing the 
quality of life in affected individuals (Millan et al., 2012). In schizophrenia a broad pattern of 
cognitive deficits can be observed, e.g. deficits in WM, executive functions, PPI, and attention. 
Impairments in bipolar disorder are similar but less severe. Interestingly, bipolar disorder shares 
certain genetic risk factors with schizophrenia (Millan et al., 2012). In addition, schizophrenia 
patients often display co-morbidity for anther disorder like obsessive-compulsive or anxiety 
disorders (see Braga et al., 2013, Lepage et al., 2014). Observations like these led to a novel 
approach of integrating the research on pathophysiology of mental disorders into a new 
classification scheme to provide a better match between research findings and clinical decision 
making (Insel et al., 2010). This RDoC (Research Domain Criteria) project is designed to 
complement the current DSM 5 (Diagnostic and Statistical Manual of Mental Disorders) for 
characterizing mental disorders. The goal is to eventually identify new targets for treatment 
developments and detect subgroups for treatment selection by incorporating data obtained from 
genetics, imaging, and cognitive science. Regarding schizophrenia, a recent study found an 
association between a higher genetic risk for the disorder and treatment outcome (Frank et al., 
2014). In this study the patients with a higher genetic load also displayed a higher risk for 
treatment resistance. The authors suggest that early treatment with clozapine (which is usually 
prescribed only if positive response to two other antipsychotics has failed due to unwanted side 
effects) might be useful to be considered in this subgroup.  
Similarly, the endophenotype-based approach seeks to establish biological underpinnings for 
diagnosis and classification of psychiatric disorders in order to improve understanding of their 
neurobiology and genetics (Gottesman and Gould, 2003). An endophenotype is considered a 
heritable vulnerability trait mediating between genes and phenotype, thus forming a causal 
connection between genes and observable symptoms (Rommelse et al., 2011). Due to the 
enormous complexities of psychiatric disorders, this approach tries to identify simpler clues to 
genetic underpinnings than the disease syndrome itself (Gottesman and Gould, 2003). 
Endophenotypes are characterized by several criteria (e.g. association with the disorder, 
heritability, state-independency and higher rate of occurrence in non-affected family members 
than in the general population). Using this approach, it has, for example, been proposed that 
autism spectrum disorder and ADHD partly share heritability traits and might be considered as 
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different manifestations of the same disorder (Rommelse et al., 2010, Rommelse et al., 2011). The 
authors therefore suggest that treatment for ADHD might also be beneficial in autism spectrum 
patients and collaborating networks of experts are needed for cross-fertilization of future research 
(Rommelse et al., 2011). 
Cognitive deficits in neuropsychiatric disorders are impacting everyday life of affected 
individuals and these deficits appear to be more responsible than other clinical symptoms for 
impaired functional outcome of, for example, schizophrenia (Lepage et al., 2014). Functional 
outcome describes abilities like living independently, planning and altering basic activities, and 
being employed (Warner, 2009, Lepage et al., 2014). Studies showed associations between 
cognition and social adjustments in schizophrenia patients (reviewed by Green, 1996, Lepage et 
al., 2014). Particularly, impairments in information processing and executive functioning were 
linked with social skills, problem solving, and community adjustment (Green, 1996). Other 
studies found that affected individuals with specific cognitive deficits were most likely to 
experience difficulties with elementary social behavior and first-episode psychosis patients with 
poor clinical outcomes showed difficulties in overall social cognition (Smith et al., 1999, 
Montreuil et al., 2010). Additionally, cognitive abilities appear to influence the abilities of 
patients for independent living and this influence exists in a reciprocal fashion (Lepage et al., 
2014). For example, one study found improved sustained attention and verbal memory in formerly 
homeless mentally ill people after moving to a residence. Interestingly, moving to supported 
housing revealed greater executive function improvements than moving to independent 
apartments (Caplan et al., 2006).  
Altogether, elucidating the underlying pathophysiologies of mental disorders, specifically 
cognitive deficits, is a crucial step to help improve clinical and functional outcomes of affected 
patients. 
1.1.4 Neuroenhancement 
When investigating cognitive abilities the idea to improve these skills is often discussed. The 
pharmacological improvement of cognitive skills without therapeutic intent is called 
neuroenhancement or brain doping, and some of the agents used are called “smart drugs” or 
“smart pills”. Some of the cognitive enhancing substances like caffeine and nicotine are freely 
available and their use is wide-spread throughout society. For example, caffeine helps staying 
awake, preventing fatigue, and reducing decline in cognitive performance by blocking adenosine 
A1 and A2A receptors, hence blocking increasing adenosine levels (Cauli and Morelli, 2005, 
Muller and Schumann, 2011). Nicotine is an agonist at the nicotinic ACh receptor that appears to 
improve attention and cognitive performance (Markou, 2008, Muller and Schumann, 2011). In 
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addition to increasing ACh, nicotine also increases norepinephrine and modulates the mesolimbic 
DA system (Mitchell, 1993, Wonnacott, 1997, Markou, 2008). Other employed substances can be 
obtained by medical prescription, e.g. Methylphenidate (MPH; see below) or modafinil. Both of 
these substances bind and inhibit the DA and norepinephrine transporter, however, modafinil also 
influences GABA, serotonin, and glutamate levels (Rasetti et al., 2010). Modafinil is usually 
prescribed to treat narcolepsy, sleep apnoea and shift-work sleep disorder (Repantis et al., 2010). 
Furthermore, illegal drugs like cocaine and amphetamines are also used to improve cognitive 
performance. These psychostimulants interact with the norepinephrine transporter, thereby 
blocking the uptake of norepinephrine in the cell (Ritz and Kuhar, 1989, Ritz et al., 1990).  
In a recent study the twelve-month prevalence of cognitive enhancing drug use (including freely 
available ones, medically prescribed, and illegal drugs; all only for the purpose to improve 
cognitive performance) among German university students was estimated to range around 20% 
(Dietz et al., 2013). Similar numbers were found in a poll among the readers of the magazine 
“nature” (Maher, 2008). Although the beneficial effects on cognitive performance are 
controversial and the long-term effects for healthy individuals have not been fully investigated, an 
increasing number of people appear to take substances like MPH (Repantis et al., 2010, Finger et 
al., 2013).  
Through blocking the DA and norepinephrine transporter and thereby preventing the reuptake of 
DA into the cell, MPH increases the DA concentration in the extracellular space (Volkow et al., 
1998, Challman and Lipsky, 2000, Madras et al., 2005). This effect was observed in the PFC and 
in its cortical and subcortical projection regions as well as in the NAc and the Hip (Kuczenski and 
Segal, 2001, Pliszka, 2005, Wilens, 2006). Because of its action on the catecholaminergic system 
MPHs effects during development appear to be especially pronounced on cognition, motivation 
and emotional behavior (Rosso et al., 2004, Britton, 2011).  
It is often prescribed for the treatment of ADHD and narcolepsy. It was shown to improve 
attentional focus, WM, and flexible control responses and is therefore also abused as a smart drug 
taken by healthy students to improve their academic performance (Greely et al., 2008).  
The increasing awareness for ADHD, which is characterized by inattention, hyperactivity and 
impulsivity (Faraone et al., 2003), in recent years led to a rise in diagnosis and prescription of 
pharmacological treatment agents such as Ritalin or Concerta which are trade names for MPH 
(Madras et al., 2005). This also causes the inadvertent treatment of healthy children misdiagnosed 
with ADHD (Carlezon and Konradi, 2004). Only little is known about the effects of MPH on 
healthy individuals, so far results imply improved vigilance, effects on spatial working memory 
and planning and improved predicted visually-guided saccades (Camp-Bruno and Herting, 1994, 
Elliott et al., 1997, Allman et al., 2012). However, these studies only investigated acute effects on 
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young adult individuals, not long-term effects on adolescents. Due to this and because of the 
rising number of adolescents and young adults using neuroenhancers, it is important to elucidate 
any possible behavioral changes caused by a chronic treatment with MPH. 
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1.2 Adolescence 
1.2.1 Terminology and Characteristics 
The transitional time period from childhood to adulthood is termed adolescence. During this phase 
an individual gradually acquires the skills and abilities it needs for an independent life. It is also a 
time when the individual achieves sexual maturity. In addition to hormonal changes, also 
neuroanatomical, -functional and behavioral changes occur. Puberty (lat. pubertas = maturity) as a 
part of adolescence describes the achievement of sexual maturation. Here, measurable, biological 
signs allow the determination of its beginning and endpoint. In contrast, adolescence (lat. 
adolescere = to grow up) describes the broader transitional period from a juvenile to an adult 
individual and includes achievements of adult social and cognitive behaviors (Spear, 2000, Sisk 
and Foster, 2004, Schneider, 2013).  
Elevation of the Gonadotropin releasing hormone initiates the onset of puberty which leads to a 
rise of the sex hormones luteinizing hormone and follicle-stimulating hormone (Sisk and Foster, 
2004, Schneider, 2013). In rodents puberty can be estimated by external physical signs (Korenbrot 
et al., 1977, Schneider, 2008). In male rats the balano-preputial separation (BPS), which describes 
the complete separation of the prepuce from the glans penis, indicates the onset of puberty around 
pd 40 (usually between pd 38 and pd 45; Korenbrot et al., 1977, Schneider, 2008). Around pd 60 
fertility is usually reached and indicated by the presence of mature spermatozoa in the vas 
deference and completion of spermatogenesis (Swerdloff et al., 1971, Schneider, 2008). An 
overview about the timing of puberty and adolescence is given in Figure 5. 
Furthermore, individual differences for the beginning of puberty exist between members of the 
same species and sex. Here, multiple permissive signals appear to be involved in the timing of 
puberty onset including internal signals (e.g. metabolic cues – has the individual attained 
sufficient energy stores for successful reproduction?) and external ones (e.g. environmental cues – 
is it the right seasonal time for mating?) (Sisk and Foster, 2004).  
 
 
 
 
 
Figure 5: Timing of puberty and approximated timing of adolescence in female and male rats (pd: postnatal day; 
Figure from Schneider, 2013).  
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1.2.2 Brain Changes during Adolescence 
During adolescence both progressive and regressive changes in the brain can be observed: 
synaptic overproduction and subsequent pruning, the maturation of neurotransmitter systems, as 
well as myelination (see Figure 6 and reviewed in Schneider, 2013). Synaptic overproduction and 
pruning, serving as refinement processes in development, have been analyzed for example in post 
mortem studies (Huttenlocher, 1979, Lewis, 1997) but also in MRI studies where regional 
differences in gray matter changes have been investigated (Giedd et al., 1999, Gogtay et al., 2004, 
Sowell et al., 2004). Overall, gray matter changes display an inverted U-shape maturation over 
adolescence whereas white matter maturation continues in a more linear fashion (Paus et al., 
2008, Brenhouse and Andersen, 2011). Pruning in the cortex occurs in a back to front direction 
with sensorimotor cortices maturing first, association cortices next and the frontal poles at the last 
stage. Subcortical regions like the NAc, CPu and cerebellum display gray matter changes that 
peak during adolescence (Durston et al., 2001). Within a structure, differential patterns of 
development can also be observed, e.g. in the Hip, posterior subregions show an increase in 
volume over time whereas anterior regions a reduction (Gogtay et al., 2006).  
Furthermore, alterations of receptor systems during adolescence have been observed and during 
that time receptor expression levels appear to rise, peak, and decline towards adult levels (see e.g. 
Brenhouse and Andersen, 2011, Schneider, 2013). These mechanisms are also regionally-
dependent and include receptors of a variety of systems like DA, endocannabinoid, glutamate, and 
GABA (Lidow et al., 1991, Andersen et al., 2000, Eggan et al., 2010). However, detailed 
information about receptor expression during the ontogeny of adolescence is scarce so far. 
Regarding DA receptor 1 and 2 (D1 and D2) density, a peak was observed at pd 40 in the striatum 
and at pd 50 in the PFC of male rats compared to lower levels before (pd 21) and after 
adolescence (pd 100 and pd 120) (Teicher et al., 1995, Andersen et al., 1997, Andersen et al., 
2000).  
Changes in receptor densities have also been observed in the ECS. Increased cannabinoid receptor 
1 (CB1R) densities have been observed between pd 30 and pd 40 in the striatum, limbic forebrain, 
mPFC and mesencephanlon of male rats (see also 1.3.5; Rodriguez de Fonseca et al., 1993, 
Klugmann et al., 2011b). Thus, both the DA system and the ECS appear to be increased around 
puberty (reviewed in Schneider, 2013). Close interactions between the ECS and the DA system 
and their role in reward have been shown previously (e.g. van der Stelt and Di Marzo, 2003, 
Gardner, 2005) and the changes in these systems during adolescence probably underlie some of 
the observed behavioral alterations.  
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The formation of a myelin sheath (i.e. white matter) around neuronal axons by oligodendrocytes 
increases the speed of information exchange and also modulates timing and synchrony of 
neuronal firing patterns creating functional networks in the brain (Fields and Stevens-Graham, 
2002, Giedd and Rapoport, 2010, Brenhouse and Andersen, 2011). Myelin acts as an electrical 
insulator on the axon and because of this, action potentials are generated only at the nodes of 
Ranvier along the axon, leading to a fast signal propagation in a so-called saltatory fashion 
(Purves, 2004). Improvements in WM are associated with increased white matter maturation 
(Bava et al., 2010). In humans the majority of myelination occurs within the first two years of life 
in most subcortical regions and primary motor and sensory regions but is ongoing in telencephalic 
areas, including frontal cortex and hippocampus, during adolescence and young adulthood. This 
region-specific protracted maturation has been confirmed by post-mortem and imaging data 
(Sowell et al., 1999, Lenroot and Giedd, 2006). In the largest myelin tract, the corpus callosum, a 
rostral to caudal pattern of myelination can be observed (Giedd et al., 1996).  
However, detailed information about the ontogeny of myelination in adolescent rodents is still 
lacking. Most studies in rodents omit the adolescent period or use animals that are still developing 
(i.e. adolescent animals) as adult reference points (Norton and Poduslo, 1973, Meier et al., 2004). 
One recent study used a longitudinal design combining MRI and histology to investigate the 
development of myelination and volume changes in total brain, cortex, and striatum of male rats 
(Mengler et al., 2014). They found a considerable increase in myelination until the third postnatal 
Figure 6: Timeline of developmental processes in humans and rodents. In females puberty and adolescence usually 
start earlier than in males, represented here in dark gray and light gray, respectively. Figure adapted from Brenhouse 
and Andersen (2011). 
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month and this continued until the sixth postnatal month in the cortex. However, in this study, 
again, the adolescent period was not studied in detail: tested ages were 3 weeks (approximately 
pd 21), 1, 2, 3 and 6 months (approximately pd 30, 60, 90, and 180). 
1.2.3 Behavioral Changes and Cognitive Development during Adolescence 
In many animals an age-related migration can be observed and this seems to be an adaptive 
process to avoid inbreeding (Spear, 2000). Thus, the migrating individuals must acquire skills to 
survive outside the territory they have been raised in. They need to interact with unfamiliar 
individuals of their species, avoid predators while searching for food in an unknown territory and 
find a mate. Adolescence is the time period where individuals learn to attain skills needed for 
independency away from their family. Adolescents display a variety in behavioral differences 
compared to juveniles or adults. These behaviors include increased social interaction with peers, 
risk taking, novelty-seeking, reward sensitivity and initiation of drug use and can be seen in 
various species (Spear, 2000, Casey et al., 2008, Schneider, 2013).  
In humans, basic cognitive functions like selective attention are established in early childhood. 
Yet other more complex functions like planning, cognitive control, problem solving, and 
reasoning continue to develop well into adolescence and involve increasing WM abilities (Catts et 
al., 2013). During achievement of increased WM capacity, the PFC and the parietal cortex show 
an increased activation and white matter connectivity (Klingberg et al., 2002, Nagy et al., 2004). 
There is supposedly a shift from using ventral to more dorsolateral regions of the PFC in WM 
tasks as children mature into adolescence (Catts et al., 2013). Also the protracted maturation of 
several association cortices has been linked to the development of mature cognition (Giedd et al., 
1999, Casey et al., 2000, Gogtay et al., 2004). Thus, an important part of adolescent cognitive 
development is to increase the efficiency of information transfer across widely distributed neural 
networks (Catts et al., 2013). This appears to be reflected by progressive myelination and faster 
and more synchronized axonal firing across long distances.  
Behaviorally, although some aspects of cognition appear to develop in a linear fashion, others do 
not. For example, in a sample of children between 7 and 13 years of age a linear increase in 
abilities of executive function and memory was observed, however, the employed strategy for task 
completion revealed a regression in the subgroup of children aged 12 and 13 (Anderson et al., 
2001). Accordingly, children aged 11 exhibited a better organizational ability compared to 12 and 
13 year-olds. In another study, performance in a face recognition test in children increased 
between 6 and 10 years of age but then remained at a fixed level or declined for several years 
before increasing further by the age of 16 (Carey et al., 1980). In a comprehensive study of the 
normal brain development of healthy children (an NIH MRI study; Waber et al., 2007) structural 
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and metabolic brain development as well as behavior was followed longitudinally. A steep 
improvement from age 6 to 10 was observed for several raw score measures but also a 
deceleration during adolescence for others.  
For rodents very little is known about the development of cognition during adolescence. 
Particularly longitudinal studies are scarce (e.g. Mengler et al., 2014, Molenhuis et al., 2014). 
Instead, most studies use separate groups of animals usually for a limited number of varying time 
points (e.g. Heyser and Ferris (2013): pd 21, 35, 42, and 90; Reger et al. (2009): pd 20-23, 29-40, 
and 50+ (as adults); Cyrenne and Brown (2011): pd 28, 40, and 80). However, some of the 
obtained results were rather contradicting. For example, while one study observed sex differences 
at mid adolescence in rats (Cyrenne and Brown, 2011), another study found similar recognition 
memory abilities across the investigated time points (Heyser and Ferris, 2013). These studies 
investigated the behavior of Lister Hooded and Spargue-Dawley rats respectively, whereas, 
apparently, so far no studies have investigated the ontogeny of recognition memory in Wistar rats. 
Furthermore, while a different study found that pd 18 old mice were not able to detect object 
novelty, suggesting immaturity in information processing at early ages, (Ricceri et al., 2000), 
Heyser and Ferris (2013) observed reliable object recognition memory skills in rats as early as pd 
21. More comprehensive studies are needed to understand the development of cognitive abilities 
in rodents, particularly to understand any possible subtle alterations throughout adolescence. 
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1.3 The Endocannabinoid System 
The endocannabinoid system (ECS) is a lipid signaling system involved in the modulation of 
neurotransmission. It consists of cannabinoid receptors (e.g. CB1R and CB2R), corresponding 
ligands (endogenous cannabinoids (eCBs)), and enzymes for their synthesis and degradation. 
Because both the CB1R and the CB2R are widely distributed in the body and the CNS, the ECS is 
involved in mediating a range of central and peripheral functions including neuronal development, 
hormone release and action, inflammation, cardiovascular, respiratory and reproductive functions, 
bone formation and energy metabolism, as well as cellular functions, such as cell architecture, 
proliferation, adhesion, motility, and apoptosis (Di Marzo, 2009). Additionally, it is involved in 
cognitive, motivational and affective processes (Di Marzo, 2009). 
There are also a number of exogenous ligands that can activate the receptors like the plant-derived 
cannabinoids (e.g. ∆9-THC (∆9-Tetrahydrocannabinol)) or synthetic ligands like WIN 55, 212-2 
(WIN). These have been important in elucidating the molecular mechanisms of the system. 
Plant extracts of Cannabis sativa, and cannabis preparations like marijuana, have been used for 
recreational and therapeutic purposes for thousands of years (for a review see Kano et al., 2009). 
However, it was not before in 1964 that the most psychoactive component, ∆9-THC was identified 
(Gaoni and Mechoulam, 1964). In addition to the psychoactive components of Canabis sativa, 
there are also non-psychoactive components like cannabinol and cannabidiol. ∆9-THC is highly 
lipophilic, allowing the passage across the blood brain barrier (see Ameri, 1999). Thus, prior to 
the identification of specialized cannabinoid receptors, effects of cannabinoids were thought to be 
due to cellular membrane disruptions or inhibition of membrane-associated enzymes (Hillard et 
al., 1985, Martin, 1986). 
1.3.1 Receptors 
CB1R was characterized by binding of the synthetic cannabinoid agonist CP55,940 (Devane et al., 
1988) and was subsequently cloned from rat brain in 1990 (Matsuda et al., 1990). Three years 
later CB2R was identified by sequence homology (Munro et al., 1993). Both receptors are Gi/o 
protein-coupled receptors (GPRs) with seven transmembrane domains (see Ameri, 1999, Castillo 
et al., 2012). Their N-terminal extracellular domain is glycosylated and the intracellular 
C-terminal domain couples to the G protein complex (Svizenska et al., 2008). Human CB1R and 
CB2R share only 44% amino acid sequence identity (Munro et al., 1993), but the human and 
murine CB1R share 97-99% of sequence homology (Kano et al., 2009). CB1R is suggested to 
exist as homodimers and to also form heterodimers with other classes of GPRs (e.g. D2 receptor 
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or orexin 1 receptor; see Kano et al., 2009) probably leading to a more direct cross-talk between 
the ECS and other neurotransmitter systems. CB1R is mainly found in the CNS implying its 
involvement for the main psychoactive effects of cannabinoids. In contrast, the CB2R is mainly 
found in the periphery and on immune cells (Kano et al., 2009).  
CB1R is one of the most abundantly expressed GPRs in the brain (Ameri, 1999). High densities 
are found in the olfactory bulb, the Hip, the lateral parts and the target nuclei of the striatum as 
well as the cerebellar molecular layer (Herkenham et al., 1990). Additionally, moderate levels are 
found in the forebrain regions, the amygdale, and the hypothalamus. High receptor expression in 
the frontal cortex and the cerebellum explains the effects of cannabinoids on memory and motor 
functions. Very sparse receptor expression in the lower brain stem areas (controlling 
cardiovascular and respiratory functions) are in accordance with the observation that high levels 
of ∆9-THC are not lethal (Herkenham et al., 1990, Kano et al., 2009). Cellular and subcellular 
distribution of CB1R was revealed at the perisynaptic sites of presynaptic cells (Kano et al., 
2009). Both excitatory and inhibitory synapses contain CB1Rs.  
Other ECS associated receptors include the TRPV1 (transient receptor potential vanilloid 1) and 
the orphan GPR55 receptors. The first is a Ca2+-permeable, non-selective cation channel, 
expressed on primary sensory neurons and involved in thermal hyperalgesia and pain sensation 
(Caterina et al., 2000). In the brain, however, TRPV1 is activated by endovanilloids (including 
anandamide (AEA); see 1.3.2 and Starowicz et al., 2007), implying a mechanism of interaction 
between the ECS and the endovanilloid system. The orphan GPR55 can be activated by 
endogenous (e.g. AEA) as well as exogenous cannabinoid ligands (e.g. ∆9-THC, CP55,940) 
eliciting a Ca2+ response (Lauckner et al., 2008). However, with some antagonists acting as 
agonists at this receptor while other ligands seem not to bind at all, it has a distinct, 
controversially discussed, pharmacological profile. Additionally, GPR55 mRNA was detected in 
the brain but functional receptor activation is still not proven (Ryberg et al., 2007). 
1.3.2 Endogenous Ligands 
The discovery of the cannabinoid receptors encouraged the research for eCB ligands (see Figure 
7). The first isolated lipid was called AEA, a mixture of the Sanskrit word for bliss (ananda) and 
“amid”, reflecting its chemical structure (Ameri, 1999). AEA belongs to one of the best 
characterized eCB families, N-acylethanolamines, or fatty acid ethanolamides (Fonseca et al., 
2013, Piomelli, 2014). Endogenous cannabinoids are synthesized on demand and, because of their 
lipophilic nature, are not stored in vesicles. Both AEA and the subsequently identified eCB 
2-Arachidonoylglycerol (2-AG; belonging to the family of monoacylglycerols), are derivates of 
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arachidonic acid and bind to CB1R and CB2R with different affinities and efficacies (Pagotto et 
al., 2006).  
 
Figure 7: Chemical structure of the main endogenous cannabinoids anandamide (AEA) and 2-arachidonoylglycerol 
(2-AG). Additionally, various endogenous cannabimimetic molecules have been identified so far (virodhamine, 
noladin ether, N-arachidonoyldopamine, N-arachidonoylglycine and oleamide). Furthermore, some endocannabinoid-
like compounds are shown (oleoylethanolamide, palmitylethanolamide and stearoylethanolamide). Figure from 
Fonseca et al. (2013). 
 
A two step, enzymatic, Ca2+ -requiring process must occur to form AEA. First, arachidonic acid 
must be transferred from the sn-1 position of phospholipids to the primary amino group of 
phosphatidylethanolamine (PE) yielding N-arachidonoyl - PE (NAPE). This step is catalysed by 
N-acyltransferase (NAT). The next reaction is the hydrolysis of NAPE to AEA and phosphatic 
acid catalysed by NAPE- phopholipid D (NAPE-PLD). However, NAPE-PLD independent 
pathways of generating AEA have also been proposed (for review see Piomelli, 2014). AEA is a 
lipid-derived messenger among which alternative routes of their synthesis are common. 
The activity of AEA is rapidly terminated by its re-uptake into cells and enzymatic degradation by 
fatty acid amino hydrolase (FAAH). This membrane-bound hydrolase breaks down AEA yielding 
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arachidonic acid and ethanolamine (Deutsch and Chin, 1993). Although other lipid hydrolases can 
also degrade AEA, FAAH seems to be the most important mechanism for this process since 
interrupting FAAH activity, genetically or pharmacologically, cause a profound enhancement of 
AEA mediated CB1R signaling (Cravatt et al., 2001, Kathuria et al., 2003). 
The monoacylglycerol 2-AG was first isolated in 1995 (Mechoulam et al., 1995, Sugiura et al., 
1995) and its levels in the CNS are higher than those of AEA (Sugiura et al., 1995). It binds both 
CB1Rs and CB2Rs and acts as a full agonist at the first one (Childers and Breivogel, 1998). 2-AG 
is also an important precursor and degradation product of phosphoglycerides (De Petrocellis et al., 
2004) and there are also several synthesis pathways known. One is the formation of diacylglycerol 
(DAG) from phosphatidylinositol (PI) by phospholipase C (PLC). Then DAG lipase hydrolyses 
DAG to 2-AG (Kano et al., 2009). Inactivation of 2-AG is catalyzed by degradation via 
monoacylglycerol lipase (MAGL) yielding glycerol and arachidonic acid, which can then be 
recycled into membrane phospholipids (Piomelli, 2014). Both AEA and 2-AG can also be subject 
to oxidation by COX-2 (cyclooxygenase 2) and various LOXs (lipoxygenases) (Kano et al., 2009, 
Fonseca et al., 2013, Piomelli, 2014).  
Other endogenous cannabimimetic molecules are virodhamine, noladin ether, N-
arachidonoyldopamine, N-arachidonoylglycine, and oleamide. Additionally, some 
endocannabinoid-like compounds have also been identified, for example oleoylethanolamide, 
palmitylethanolamide, and stearoylethanolamide (see Figure 7 and Fonseca et al., 2013 for a 
review).  
1.3.3 Signaling 
Synthesized either upon postsynaptic activation or constitutively, eCBs are released from the post 
synaptic membrane and travel across the synaptic cleft to the presynaptic CB1Rs in a retrograde 
fashion (Ohno-Shosaku et al., 2001, Mukhopadhyay et al., 2002). Activation of CB1Rs inhibits 
neurotransmitter release including glutamate, GABA, serotonin, glycin, ACh, and can indirectly 
modify DA transmission (reviewed by van der Stelt and Di Marzo, 2003, Kano et al., 2009, 
Castillo et al., 2012). Thus, neurotransmitter release can be modulated both at excitatory as well 
as inhibitory synapses by eCBs. These mechanisms are termed depolarization-induced 
suppression of inhibition or excitation (DSI or DSE respectively; Kreitzer and Regehr, 2001, 
Ohno-Shosaku et al., 2001, Wilson and Nicoll, 2001) and have been observed in various brain 
regions (Kano et al., 2009). Both short-term (eCB-STD) and long-term (eCB-LTD) 
neurotransmitter release suppression are modulated by eCBs.  
Upon ligand binding to the cannabinoid receptors various intracellular signaling cascades are 
activated (see Figure 8; Fonseca et al., 2013). Activation of the CB1R coupled Gi/o proteins 
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inhibits adenylyl cyclase (AC). Therefore the conversion of ATP in cyclic AMP (cAMP) is 
reduced. However, cAMP is needed for the regulation of protein kinase A (PKA) which in turn 
inhibits A-type potassium channels (K+A) via phosphorylation. The overall effect of cannabinoid 
receptor activation therefore results in an activation of K+A channels. Other effects of activated 
Gi/o proteins (e.g. CB1R) are inhibition of N- or P/Q type Ca2+ channels and activation of 
inwardly rectifying potassium channels (Kir) (De Petrocellis et al., 2004). This is regulated by 
protein kinase C (PKC) which can, after activation, phosphorylate CB1R and uncouple the 
receptor from the ion channels. Additionally, through the adapter protein FAN (factor associated 
with neutral sphingomyelinase activation), sphingomyelin (SM) is hydrolyzed via the 
sphingomyelinase (SMase) and consequently ceramide (an ubiquitous lipid second messenger) 
accumulates in the cell (Velasco et al., 2005). 
Intracellular kinases like focal adhesion kinase (FAK), extracellular signal-regulated kinase 
(ERK), c-jun N-terminal kinase (JNK), and p38 MAPK (p38) can also be stimulated by CB1R 
activation and can therefore mediate CB1R-induced expression of immediate early genes (IEG) 
like c-fos. Less is known about signaling associated with CB2R activation. However, ion channels 
do not seem to be modulated upon ligand binding (Felder et al., 1995). 
Altogether, the ECS can exert various effects via the complexity of possible metabolic pathways 
and signaling cascades it is involved in and it thus modulates a range of physiological functions.  
 
Figure 8: Main intracellular signaling pathways of CB1R activation. Stimulation of Gi/o protein-coupled receptor 
signaling inhibits adenylyl cylcase (AC), which mediates the conversion of adenosine triphosphate (ATP) into cyclic 
AMP (cAMP). cAMP binds to PKA. Modulated ion channels include activation of inwardly rectifying potassium 
channels (Kir) and inhibition of N- or P/Q type Ca2+ channels. Furthermore, ceramide accumulation is mediated via 
sphingomyelin (SM) hydrolysis by sphingomyelinase (SMase; activated by the adapter protein factor associated with 
neutral SMase activation: FAN). Additionally, intracellular kinases are stimulated including extracellular signal-
regulated kinase (ERK), c-jun N-terminal kinase (JNK), focal adhesion kinase (FAK), and p38 MAPK (p38). Figure 
from Fonseca et al. (2013). 
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1.3.4 Behavioral and Cognitive Effects of Cannabinoids  
In rodents a “tetrad” of symptoms is often observed after cannabinoid intoxication consisting of 
hypothermia, rigid immobility (catalepsy), analgesia, and decreased motor activity 
(hypolocomotion). In addition, euphoria, enhancement of sensory perception, difficulties in 
concentration, and impairment of memory have been observed in humans (Ameri, 1999). The 
initial period of euphoria can be followed by depression. Furthermore, anxiety, panic, and 
psychotic reactions can occur (Moreira and Lutz, 2008). Thus, behavioral effects of cannabinoids 
appear to vary depending on individual vulnerability to certain effects as well as concentration 
and route of administration. Low doses often produce stimulatory effects followed by sedation 
whereas high doses mainly produce sedative effects (Ameri, 1999). For example, in rodents the 
application of high doses of ∆9-THC increased anxiety-like behavior whereas low doses showed 
anxiolytic-like effects (Moreira and Lutz, 2008).  
Overall, the ECS exerts a modulatory role on diverse emotional, cognitive, and physiological 
regulatory circuits.  
Cognitive disturbances of acute effects of the CB1/CB2R agonist ∆9-THC in humans include 
STM and WM impairments (Ranganathan and D'Souza, 2006). On the other hand, cannabidiol, a 
CB1/CB2R antagonist, prevents these effects (Morgan et al., 2010). Therefore, the ratio of ∆9-
THC/cannabidiol might influence the effects of cannabis in humans. Additionally, differing 
methodologies (different tasks employed), small sample sizes and a lack of appropriate control 
groups make the comparison of human studies difficult. Further confounding factors in human 
studies are possible polydrug use, pre-existing cognitive differences between cannabis users, as 
well as the amount and potency of cannabis used (see Jager and Ramsey, 2008, Mechoulam and 
Parker, 2013). Therefore, animal studies provide essential and often better comparable insights 
into the impact of cannabinoids on mechanisms of learning and memory. For example, in OBJR 
tests in rats STM was impaired after acute administration of synthetic cannabinoid receptor 
agonists like WIN and CP55,940 (Schneider and Koch, 2003, O'Shea et al., 2004). Also, WM was 
impaired in an 8-arm radial maze task and in the Morris water maze after ∆9-THC administration 
(Lichtman and Martin, 1996, Varvel et al., 2001). Cannabinoid receptor antagonists (e.g. 
SR141716A; SR) appear to enhance STM possibly due to a prolonged retention of memory (e.g. 
Terranova et al., 1996, Lichtman, 2000). CB1R knockout mice displayed longer retention in an 
OBJR test (Reibaud et al., 1999).  
Manipulations of the ECS also influence the performance on more complex cognitive tasks in 
rodents. For example, acute application of ∆9-THC or overexpression of the CB1R (by viral 
mediated gene-transfer) impaired reversals in an attentional set shifting task (ASST; see 1.4.5 and 
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Egerton et al., 2005a, Klugmann et al., 2011a). Increased preservative errors were observed in a 
strategy set shifting task after application of the CB1R agonist HU-210 (Hill et al., 2006). 
In addition to acute effects of cannabinoids, long-term effects on cognition have also been 
observed. Particularly chronic treatment during developmentally vulnerable time periods like 
adolescence (see 1.3.5) impair recognition for objects and social partners, PPI, and progressive 
ratio performance (Schneider and Koch, 2003, 2007, Schneider et al., 2008, Leweke and 
Schneider, 2011). Interestingly, chronic treatment in adulthood did not reveal these effects on 
cognition. Earlier treatment periods also revealed impairments in learning and memory that 
persisted into adulthood (Mereu et al., 2003, Antonelli et al., 2005). Thus, critical developmental 
periods like the juvenile period and adolescence appear to be especially vulnerable to cannabinoid 
treatment (Jager and Ramsey, 2008, Schneider, 2008, 2009).  
1.3.5 The Endocannabinoid System during Development  
CB1Rs are already present during early development as demonstrated in binding studies of rat and 
human studies (Berrendero et al., 1999, Mato et al., 2003). Additionally, eCBs and mRNA 
expression of the CB1R have been demonstrated in gestational and early postnatal stages in the rat 
(Berrendero et al., 1999). However, the distribution pattern has been shown to be transient and 
atypical in distinct brain regions compared to adulthood. For example, CB1R has been 
demonstrated in white matter areas during early postnatal ages but not in adulthood implicating an 
important role in developmental processes (Berrendero et al., 1999, Mato et al., 2003).  
During embryonic development, eCBs appear to be involved in migration, cell proliferation, 
specification, differentiation, and survival of neuronal progenitors as well as in axonal growth and 
guidance and establishing synaptic communication (reviewed by Harkany et al., 2007, Saito et al., 
2013). Due to the important role of the ECS in these processes disturbances of the system by 
exogenous application of cannabinoids interfere with normal development (for a review see  
Trezza et al., 2008). This renders the developing organism particularly vulnerable to 
perturbations, for example by maternal cannabis abuse.  
During adolescence only few studies investigated the expression and distribution of ECS 
components. An increase in CB1R expression in the striatum, limbic forebrain, mPFC, and 
mesencephanlon has been demonstrated in rat brain between pd 30 and pd 40 (Rodriguez de 
Fonseca et al., 1993, Klugmann et al., 2011b). Additionally, levels of AEA, 2-AG, and CB1R are 
dynamically altered in the NAc, CPu and PFC as observed at pd 29, pd 38 and pd 50 after 
injection of vehicle or THC (Ellgren et al., 2008). In the PFC, AEA was found to gradually 
increase throughout adolescence, whereas 2-AG levels were lower in later stages compared to 
earlier ones both in the PFC and the NAc. Additionally, increased AEA levels have been observed 
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in the hypothalamus immediately before the onset of puberty in female rats (Wenger et al., 2002). 
Importantly, these alterations in the ECS take place while concomitantly other 
neurodevelopmental processes occur, including synaptic pruning, myelination, and maturation of 
other neurotransmitter systems with which the ECS interacts (Viveros et al., 2011; see also 1.2.2). 
Therefore, interference with this system during puberty and adolescence can lead to long lasting 
behavioral and neurobiological alterations as observed in a number of human and animal studies 
(see 1.3.4 and Grant et al., 2003, Jager and Ramsey, 2008). 
1.4 Behavioral Paradigms 
1.4.1 Rat Strain and Line Differences in Behavioral Testing 
The Wistar rat is an outbred strain very commonly used in behavioral analyses. A strain can be 
defined as “a group of animals of known ancestry maintained by a deliberate mating system” 
(Sabourdy, 1965). For example, outbred strains are bred by deliberately avoiding mating of 
closely related individuals (in contrast to inbreed strains). A line is considered as “part of a family 
of animals separated from other parts by one or more generations of independent ancestry.” 
(Sabourdy, 1965). Differences between different animal strains (like Wistar, Sprague-Dawley or 
Fischer rats) have been extensively investigated both behaviorally as well as neurochemically 
(e.g. Rex et al., 1999, Yilmazer-Hanke, 2008, Brand et al., 2012). However, even within the same 
line of a rat strain variations in behavior have been observed (Hirate et al., 1989, Honndorf et al., 
2011, Langer et al., 2011, Palm et al., 2011b, Goepfrich et al., 2013).  
As most laboratories receive all or parts of their animals from commercial breeders they are at 
least partially dependent on their conditions and breeding schedules. Many experimenters gain a 
lot of expertise about the behavior of a particular line for the testing paradigms they specialize in 
because they keep using the same line of animals. However, researchers can be forced to switch 
lines if the supplier abandons the breeding of that particular line. Consequently, the expertise 
gained in many years of previous research must be transferred to a new animal line. For the 
selections of the appropriate animal line for one’s experimental hypothesis it is important to be 
aware that there are differences between rat strains and lines. Additionally, important other factors 
like age, gender, holding, and handling conditions can impact the results of behavioral testing. 
Therefore, the more valuable information about these details is given (as well as line-specific 
behavioral information) the better the comparability between studies will be.  
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1.4.2 Open Field Test 
The open field test, introduced by Hall (1934), was originally employed to measure emotionality 
in rats. In this test, an animal is put into an unknown arena from which it cannot escape for a 
certain time (reviewed by Prut and Belzung, 2003). Open spaces, particularly brightly lit ones, are 
usually avoided by rodents. They tend to stay in the corners or near the walls (also termed 
thigmotaxis; see e.g. Simon et al., 1994) and spend less time in the center area. Therefore, the 
open field is often used as an anxiety-related paradigm (although this has frequently been debated; 
see e.g. Ennaceur, 2014). However, rodents also have a tendency to explore novel environments 
due to their natural foraging behavior. Therefore, the distance traveled in the arena can also be 
measured and is commonly used as an indicator of locomotor activity. In the context of this thesis 
the open field arena was not brightly illuminated and in addition, to obtain a locomotor index, the 
open field session often served as habituation for further testing in the same environment (e.g 
OBJR, object recency, or social recognition). Upon repeated exposure the locomotor activity 
decreases as the arena becomes familiar (see e.g. Thiel et al., 1999). This in turn renders any 
newly introduced objects or social partners in the arena as novel and directs novelty exploration 
towards these stimuli. 
1.4.3 Recognition Memory 
The one-trial OBJR test (Ennaceur and Delacour, 1988) is also called spontaneous OBJR test 
(Winters et al., 2008), or novel OBJR test (Anderson et al., 2004, Reger et al., 2009). It is used to 
test declarative memory, STM, as well as the preference for novelty, and is widely employed in 
rodent studies (Steckler et al., 1998, Dere et al., 2007, Winters et al., 2008, Ennaceur, 2010). The 
cognitive processes required in this type of memory integrate multimodal sensory information. To 
recognize a previously encountered item, two processes seem to be important: recollection and 
familiarity. In recollection, specific details about the context in which an item was encountered 
are remembered whereas familiarity entails the knowledge of having encountered an item before 
without more additional information (Squire et al., 2007). Two theories are trying to explain the 
involvement of these two processes in OBJR memory: According to the dual process theory, 
recollection depends on the Hip and familiarity depends on the adjacent perirhinal cortex (Brown 
and Aggleton, 2001, Eichenbaum et al., 2007). However, according to the unitary process theory, 
(an alternative view; see e.g. Squire et al., 2007) the structures of the medial temporal lobe and 
other brain areas operate rather cooperatively and the neuroanatomical distinction of recollection 
and familiarity might be too simple. It is argued that, instead, strong and weak memories are 
targeted by methods investigating separate processes of recognition memory.  
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In rodents, the OBJR test utilizes their natural tendency to explore novel stimuli (i.e. objects or 
social partners). Typically, it consists of a sample and a choice phase (Ennaceur and Delacour, 
1988, Dere et al., 2007). In the sample phase (usually ranging from 2 - 10 min; Dere et al., 2007) 
the animal encounters two identical objects in an open field arena. After a retention delay of 
various time intervals (from 1 min (Ennaceur and Delacour, 1988) to 24 h (Dere et al., 2007)) the 
animal encounters one familiar object and one that has not been seen before. The animal usually 
spends more time exploring the novel object in contrast to the time spend exploring the familiar 
object. The longer the retention delay the poorer the performance of the animal, because the 
familiar object tends to be forgotten and could be regarded as novel again (Dere et al., 2007). This 
depends on the time span of the sample phase and the rodent strain used but can also be 
influenced by pharmacological agents.  
This test does not require any pretraining or learning of reward-associations or other rules and is 
less stressful than, for example, hidden-platform tests in the morris water maze (Dere et al., 2007). 
It only depends on a natural behavior of the animal. It is therefore comparable to test situations for 
memory tests in humans (e.g. visual paired comparison; Ennaceur and Delacour, 1988, Ennaceur, 
2010).  
A number of variations for the OBJR test exist. For example in the object location test (see 
Ennaceur and Meliani, 1992b, Mumby et al., 2002) the animal encounters two identical objects 
one of which has a changed position in the choice phase. Usually more time is spent exploring the 
object in the new location. In the object recency (OBJRecency) variation of the test (Mitchell and 
Laiacona, 1998, Hannesson et al., 2004) the animal at first encounters two identical objects 
(sample phase 1), then, after a delay, another set of two novel, identical objects (sample phase 2) 
and in the choice phase it encounters one of the first encountered (less recent) and one of the 
recently encountered (more familiar) objects. Usually more exploration is directed towards the 
less recently encountered objects compared to the more recently (i.e. more familiar) encountered 
objects. In the social recognition test (SOCR; Everts and Koolhaas, 1997, Bielsky and Young, 
2004, Schneider et al., 2008), instead of objects, the test animal encounters novel conspecifics that 
can be explored for a certain time and, after a delay period, exploration of a novel versus a 
familiar social partner can be determined.  
A number of brain regions seem to be involved in the OBJR test and its variations (reviewed by 
Dere et al., 2007, Warburton and Brown, 2010). The Hip has been considered essential for OBJR 
memory for a long time; however, several studies using various techniques (e.g. lesions, 
pharmacological interference, immediate early gene expression) revealed controversial results 
(reviewed by Mumby, 2001, Dere et al., 2007, Warburton and Brown, 2010). One explanation 
might be that after damage of this structure, extra-hippocampal structures can possibly act in a 
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compensatory way for lost recognition abilities (Dere et al., 2007). More recently, the Hip has 
been suggested to be important particularly in OBJR tests when spatial and contextual cues are 
relevant during the encoding stage of the test (Winters et al., 2004, Forwood et al., 2005). The 
perirhinal cortex is also implicated in encoding and retrieval of OBJR memory (most likely 
involving AMPA receptors) as well as consolidation (possibly involving NMDA receptors; Dere 
et al., 2007). Memory of temporal order or relative recency is believed to rely on the mPFC in 
humans, non-human primates and rodents (Kesner and Holbrook, 1987, Mitchell and Laiacona, 
1998, Fuster, 2001, Hannesson et al., 2004) but additionally, a role for the perirhinal cortex has 
also been suggested in rats (Barker et al., 2007). Furthermore, a functional connection between the 
mediodorsal thalamus and the mPFC was implicated in OBJRecency but not in OBJR memory 
per se (Cross et al., 2012).  
In contrast to OBJR, in which visual and haptic perception of the objects seem to be critical, the 
SOCR test relies on olfactory cues (including pheromones), the action of the neuropeptides 
oxytocin, and vasopressin and possibly involves differential brain regions (see Bielsky and 
Young, 2004). One hypothetical brain circuit involves the vomeronasal organ and olfactory 
epithelium which project to the accessory and main olfactory bulbs, respectively. These structures 
both project to the medial amygdala and from here projections to the lateral septum and the Hip 
appear to be critical for SOCR memory. Oxytocin is critical for mediating SOCR in the medial 
amygdala and implicated in the initial processing or encoding of social cues (Ferguson et al., 
2001), while vasopressin is critical for SOCR memory in the lateral septum (Engelmann and 
Landgraf, 1994, Everts and Koolhaas, 1997). Moreover, these neuropeptides are suggested to 
affect SOCR memory by activating the norepinephrin neurotransmitter system (Dluzen et al., 
1998).  
Different neurotransmitter systems are implicated in OBJR memory. For example, the NMDA 
receptors of the glutamatergic system are involved in various brain regions and variations of the 
OBJR test (reviewed by Warburton et al., 2013). The involvement of the DAergic system has also 
been investigated by several pharmacological studies (Hotte et al., 2005, Hotte et al., 2006, de 
Lima et al., 2011). D1 receptor activation appears to enhance long-term OBJR memory (> 4h) but 
impairs OBJR memory after short intervals (15 min; Hotte et al., 2005, Hotte et al., 2006, de Lima 
et al., 2011). However, under certain conditions, DA receptors do not appear to be critical for 
memory formation as neither D1 receptor blockade nor D2 receptor activation impaired memory 
in another study (de Lima et al., 2011). Acute pharmacological inhibition of the cholinergic 
system (by administration of muscarinic ACh receptor antagonist scopolamine) impairs OBJR 
memory, possibly by decreasing attentional processes (Ennaceur and Meliani, 1992a, Dere et al., 
2007). On the other hand, nicotine improved OBJR memory (Puma et al., 1999). However, as 
1. Introduction 
 29 
mentioned in 1.1.2 this is possibly due to interactions with other neurotransmitter systems and 
these observations are in accordance with observations in other behavioral tests (see Blokland, 
1995). Furthermore, the ECS is important in OBJR performance. As mentioned in 1.3.4, acute 
application of exogenous cannabinoids can impair OBJR performance (Schneider and Koch, 
2003, O'Shea et al., 2004) while chronic application during critical developmental periods can 
exert long-term impairing effects (Schneider et al., 2008). CB1R knock out mice displayed 
enhanced OBJR memory (Reibaud et al., 1999).  
Altogether, it appears that an interacting network of the Hip, the perirhinal cortex, and the mPFC 
are involved in successful OBJR memory. The perirhinal cortex is believed to be particularly of 
interest for the judgement of the occurrence of an item whereas the recollection of an item in 
context or of multiple items involves interaction of perirhinal cortex, Hip, and mPFC (Warburton 
and Brown, 2010). In addition, multiple neurotransmitter systems appear to be involved in OBJR 
memory and its variations, partially influencing or modulating each other. However, there is also 
a debate about how animals solve the task and what they perceive while exploring the objects 
(Ennaceur, 2010) which makes it difficult to judge if the animals perceive an item without the 
context of its presentation (e.g. the arena, the experimental room, experimenter, room etc.). 
1.4.4 Acoustic Startle Response and Prepulse Inhibition 
In mammals, the response to an abrupt, intense auditory stimulus is a fast contraction of the 
skeletal and facial muscles called the acoustic startle reflex (ASR) (Geyer, 1999, Koch, 1999, 
Leumann et al., 2001). During this reaction the eye-lids are closed, the muscles contract, the body 
length is shortened, ongoing behaviors are interrupted and the heart rate accelerates (Koch, 1999). 
This behavior is believed to serve as a protective function to unexpected, aversive events and/or as 
preparation of a fight/flight response. The ASR is triggered by auditory stimuli > 80 dB and has a 
non-zero baseline which means it can be modulated by various stimuli which enhance or attenuate 
the magnitude of the ASR (e.g. PPI see below). A reduction of ASR magnitude after repeated 
presentation of the stimulus can also occur which is termed habituation. Sensitization is the 
enhancement of a response following a strong stimulus e.g. electric footshock (Koch, 1999). The 
ASR is very fast with a measured onset latency of 5 - 10 msec in rats and 14 - 151 msec in 
humans (Leumann et al., 2001). Therefore, only few synaptic relays participate in the neuronal 
circuit of this reflex, supposedly involving the auditory nerve, the ventral cochlear nucleus, the 
nuclei of the lateral lemniscus, the nucleus reticularis pontis caudalis (PnC), a spinal interneuron, 
and a neuromuscular junction (Davis et al., 1982). To date several models have been proposed in 
which the PnC is thought to have a central role. It receives inputs from the auditory pathway 
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(Davis et al., 1982) and projects to facial, cranial, and spinal motor neurons (Lingenhohl and 
Friauf, 1992). As a result the PnC is regarded as a sensorimotor interface of the ASR.  
If a weak, non-startling sensory event precedes the startle-eliciting signal by 30 - 500 msec, the 
magnitude of the ASR is reduced (Hoffman and Ison, 1980). This has been termed PPI and is used 
as an operational measure of sensorimotor gating mechanisms. Sensorimotor gating describes the 
ability of weak sensory events to inhibit or “gate” a motor response otherwise triggered by intense 
stimuli (Swerdlow et al., 2001).  
Several midbrain nuclei appear to be involved in a hypothetical circuit mediating the PPI of the 
ASR (see Figure 9; Koch, 1999, Fendt et al., 2001). An auditory perpulse activates the inferior 
colliculus and from here information is relayed to the superior colliculus. This in turn receives 
input from auditory, somatosensory and visual structures and projects to the pedunculopontine 
tegmental nucleus. This nucleus sends cholinergic projections to the PnC which mediates the PPI 
of the ASR. Lesions of the pedunculopontine tegmental nucleus do not completely block PPI, 
therefore an alternative pathway is also likely to exist (Koch, 1999). Additionally, other brain 
regions appear to be involved in modulating PPI including the NAc, the ventral Hip and the 
mPFC as well as the basolateral amygdala and the mediodorsal thalamus (Koch, 1999, Swerdlow 
et al., 2001). Various neurotransmitter systems influence the PPI of the ASR and manipulations in 
these systems disrupts PPI (Geyer et al., 2001). For example, DA agonists disrupt PPI which can 
be reversed by the antipsychotic haloperidol (Swerdlow et al., 1994). Serotonin agonists and 
NMDA antagonists also cause PPI deficits (Mansbach and Geyer, 1989, Sipes and Geyer, 1994).  
 
 
 
 
 
 
 
 
 
 
 
 
 
PPI occurs after the first exposure to a prepulse suggesting that it does not involve learning 
mechanisms. Increased prepulse intensity leads to an increase in PPI. Other parameters like the 
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Figure 9: A simplified hypothetical circuit mediating the PPI of the ASR. Gray shaded boxex represent brain nuclei 
mediating PPI while the lower white boxes are involved in the ASR. PnC: nucleus reticularis pontis caudalis. Figure 
adapted from (Koch, 1999).  
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background noise level can influence startle and PPI and hence a background noise between 50 - 
70 dB and prepulses 1 - 20 dB above that are often used (Leumann et al., 2001). Prepulse stimuli 
of different intensities are given in random order prior to startle stimuli during the test phase. The 
inhibition of the prepulse is calculated in percentage to the amplitude of the startle without 
prepulse. In neuropsychiatric disorders like schizophrenia and Huntington’s disease PPI and ASR 
are impaired (Koch, 1999).  
1.4.5 Attentional Set Shift Test 
The ASST is a complex cognitive test measuring behavioral flexibility. According to Tait et al 
(2013) an attentional set is a hypothetical “store” that maintains “the reward-predicting aspects of 
a stimulus, and the contents of an attentional set must be updated when new dimensions become 
relevant” (Tait et al., 2013). Successful performance in this test therefore requires a range of 
aspects of cognitive abilities including rule learning, updating of rules when changes occur, 
suppressing inappropriate responses, focused attention, and resisting distractibility. It was adapted 
for rodents by Birrell and Brown (2000) as an analog for the Wisconsin Card Sorting Test 
(WCST). The performance in the latter is often impaired in patients suffering from schizophrenia, 
ADHD, Parkinson’s, or Alzheimer’s disease (reviewed by Tait et al., 2013). In the WCST the test 
subject must sort a deck of cards according to shape, color, or number of the displayed symbols. 
The rule is not explicitly told but a feedback after each sorting is given. After a certain amount of 
cards the rule changes, thus the test subject has to find the new rule and adapt the sorting strategy. 
For rats often a digging task is employed (Birrell and Brown, 2000). The animal has to retrieve a 
reward from a pot containing scented digging material by either focusing on the odor or the type 
of digging medium. Newly introduced rules can, for example, reverse reward contingencies 
(reversal stage of the test). A new rule can also require the animal to employ the learned rule to a 
new situation (e.g. facing new odors and digging materials but relying on the rule that the type of 
digging media always predicts the reward) which is called an intradimensional shift (IDS). An 
extradimensinal shift (EDS) would then require the animal to shift the focus of attention from one 
stimulus dimension (e.g. type of digging material) to another (e.g. always to focus on the odor for 
finding the buried reward).  
Lesion studies in rodents revealed an important role of the mPFC for the EDS of the test (Birrell 
and Brown, 2000). The OFC seems to be particularly involved in the reversal stage (McAlonan 
and Brown, 2003) and the cingulate cortex is implied in set formation (Ng et al., 2007). In 
addition, pharmacological studies implied various neurotransmitter systems in performance in the 
ASST (Tait et al., 2013), like the DAergic, noradrenergic, and ECS (Egerton et al., 2005a, 
Egerton et al., 2005b, Lapiz and Morilak, 2006). Considering the tremendous interactions between 
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these neurotransmitter systems and their modulating influence on PFC functions a disruption by 
lesion or pharmacological intervention would reasonably affect normal PFC function (see Tait et 
al., 2013). 
1.4.6 Anxiety-related Paradigms 
Rodents have a natural tendency to explore a new environment. However, open spaces or heights 
are usually avoided, like the center of a brightly illuminated open field. This spontaneous 
exploratory behavior versus the retreat and staying in dark or enclosed compartments can be 
observed in a variety of anxiety-related tests, e.g. the light/dark emergence test (EMT) or the 
elevated plus maze (EPM; for a review see Ennaceur, 2014). 
In the EMT, the most commonly used apparatus consists of a dark compartment (1/3 of apparatus 
size) and a bright compartment (2/3 of apparatus size) (Crawley and Goodwin, 1980). The test 
animal can freely move between both compartments for a defined time. Emergence latency, 
number of movements between the two different compartments, as well as rearing can be 
measured to evaluate anxiety and exploratory behavior. Enhanced activity in the illuminated 
compartment as well as increased transitions between the compartments (without increased 
general motor activity) is considered as low anxiety-related behavior (Bourin and Hascoet, 2003). 
Modulation of EMT behavior can be observed after administration of various drugs (e.g. 
benzodiazepines act anxiolytic while amphetamines elicit anxiogenic behavioral effects). 
Interestingly, basal behavioral differences in EMT for different rat strains have been reported (e.g. 
van der Staay et al., 2009).  
The precursor of the EPM is a Y-maze with alternating open and closed arms invented by 
Montgomery (1955). In the EPM the test subject is placed in an elevated (50 -70 cm above ground 
level), plus-shaped maze which consists of two opposing open and closed arms (Handley and 
Mithani, 1984, Dawson and Tricklebank, 1995). Usually, animals spend more time in the closed 
arm of the maze. The EPM was validated physiologically and pharmacologically (Pellow et al., 
1985) suggesting that anxiolytic drugs increase the number of entries as well as the time spent in 
the open arms. In contrast, anxiogenic drugs reduce these behaviors. The test duration is 
commonly limited to 5 min because the avoidance effect is mainly observed during this time 
(Montgomery, 1955). The EPM is widely used, although the influence of various test parameters, 
for example the illumination level or height above ground, are still discussed (Garcia et al., 2005). 
However, the system has some clear advantages such as not requiring any pretraining, food or 
water deprivation, or the use of noxious stimuli and is conducted easily and quickly (Pellow et al., 
1985). 
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1.4.7 Intake Paradigms 
Intake of various foods or liquids can be measured in limited free access paradigms (Files et al., 
1994, Wong et al., 2009, Friemel et al., 2010, Goepfrich et al., 2013). The individual animal 
usually has ad libitum access to edible substances or liquids of variable palatability for a limited 
time span and the intake is measured and corrected for the animal’s bodyweight. Often the 
animals are habituated to the new food or liquid beforehand and the test is conducted in single 
cages after a short habituation period. Highly palatable substances like sucrose, sweetened 
condensed milk (SCM), and casein pellets (CPs) are known to be eagerly consumed by rats and 
therefore often used as rewards in positively reinforced test (e.g. ASST or radial arm maze). It is, 
however, important to verify that test and control groups of animals devote the same valence to 
the used reward. If one group of animals consumes less of the reward at basal levels, it is difficult 
to assign differences in performance of a learning task to cognitive instead of possible 
motivational or hedonic differences. Possible differences in the amount of intake could arise from 
different caloric requirements or differences in taste perception but could also be influenced by 
stress or satiety (Strouthes et al., 1974, Gronli et al., 2005). In contrast to palatable foods and 
liquids, ethanol (EtOH) is often used to model drug intake. Since it has a bitter taste (depending 
on the concentration) and less impact on the caloric demands than the above mentioned rewards, it 
is often used to analyze the hedonic values of a drug (reviewed by Green and Grahame, 2008). In 
free choice paradigms animals are presented EtOH solutions of varying concentrations along with 
normal water. Differences in EtOH intake have been observed between different rat strains and 
lines (Wilson et al., 1997, Palm et al., 2011b, Goepfrich et al., 2013).  
1.5 Study Aims 
In the present thesis, four associated projects were conducted, which investigated cognitive 
abilities and their development in the Wistar laboratory rat.  
In the first project possible differences between three different Wistar Han rat lines were 
investigated. Two rat lines (i.e. W[hsd] and W[rcc]) were obtained from the same breeder (i.e. 
Harlan Laboratories), and were compared with each other and to a line from another breeder (i.e. 
W[Jan] from Janvier). As Harlan plans to replace all W[hsd] colonies with W[rcc] (Harlan 
Laboratories, 2011), possible behavioral differences in these two lines were investigated in a 
variety of behavioral paradigms as well as in the Wistar line W[Jan]. Their performance in several 
behavioral paradigms including an open field test, an OBJR test, as well as the PPI of the ASR 
was analyzed and based on the results, one rat line was selected for the best performance in the 
cognitive tasks employed for the subsequent projects.  
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The second project addressed the ontogeny of cognitive abilities from before the onset of puberty 
throughout the period of adolescence until adulthood of the rat. Only few rodent studies have 
investigated the basic cognitive development during adolescence so far and particularly 
longitudinal studies are scarce. Therefore, animals were tested repeatedly for abilities in 
recognition memory and sensorimotor gating function by employing an OBJR and an 
OBJRecency tests, as well as ASR and PPI throughout adolescence and young adulthood. Based 
on these results, the influence of a pharmacological intervention by the CB1R antagonist/inverse 
agonist SR on OBJR and PPI performance on pd 40 was investigated. Due to the vast 
neuroanatomical changes in the brain during adolescence, including the proposed changes in the 
ECS and the alterations in myelination, the abundance of the CB1R and myelin was investigated 
histologically and the protein content of the CB1R was analyzed at corresponding time points to 
the behavioral tests.  
The third project investigated the long-term effects of a chronic pubertal WIN treatment in 
adulthood, particularly in cognitive tasks in the Wistar rat. The chronic pubertal WIN treatment is 
considered as an animal model of schizophrenia (Leweke and Schneider, 2011), yet little 
information is available on the influence of this treatment on complex cognitive abilities. 
Therefore, the performance of adult rats was investigated in the ASST. Additionally, it was 
intended to examine if the treatment yields the same effects in the W[rcc] line as in the W[hsd] 
line in recognition memory and sensorimotor gating, tested in an OBJR test and PPI, respectively. 
In the fourth project the possible long-term effects of a chronic pubertal MPH treatment was 
investigated in a broader range of behavioral tests. As most studies focused on the juvenile or the 
early adolescent period for MPH treatment, little is known about ongoing treatment throughout 
the period of adolescence. Here, the effects of a chronic pubertal MPH treatment of Wistar rats 
were investigated by behavioral characterization in adulthood (> pd 80) to elucidate long-term 
effects in a longitudinal design. 
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2. Material and Methods 
2.1 Animals 
296 male albino WistarTM Han (Wistar) rats with known birth dates (date of birth considered as 
pd 0) were purchased from Harlan Laboratories GmbH (Horst, Netherlands) or Janvier (Le Genest 
St Isle, France). They were delivered shortly after weaning and then housed in groups of four to 
six in MakrolonTM cages (Eurostandardtype IV) under a 12/12 hr light-dark cycle with the light 
phase starting at 7 am. During the light phase, a radio provided background noise. Animals had ad 
libitum access to food (‘V1536-000 ssniff R/M-H, ssniff Spezialdiäten GmbH, Soest, Germany) 
and tap water. All experiments were conducted in accordance with the ethical guidelines for the 
care and use of laboratory animals and were approved by the local animal care committee 
(Regierungspräsidium Karlsruhe, Germany). 
Behavioral testing was conducted between 10 am and 5 pm. For the ASST animals were 
maintained on a mild food restriction (12g / animal / day) from the first day of habituation and 
body weight was measured every day before experiments started. For behavioral tests the test 
subjects were transported from the holding room to an experimental room. The animals were 
conveyed to the room individually in MakrolonTM cages (Eurostandard type III) or in their home 
cage before being put in the test apparatus. In most experiments a radio provided constant 
background noise except during PPI of the ASR where white noise was used. After removing 
urine and excrements, the test apparatus was cleaned with water and antifect N liquid (Schülke & 
Mayr GmbH, Norderstedt, Germany) thoroughly between each subject to eliminate the smell of 
the former test subject.  
2.2 Experimental Design 
2.2.1 Project I: Differences of Cognitive Abilities in Three Wistar Han Rat Lines 
To assess the differences in cognitive abilities in the three Wistar Han rat lines, adult animals 
were obtained from commercial breeders and group housed in our vivarium for at least one week 
prior to testing. Three groups (n = 12 for each) were obtained from two different suppliers: In 
addition to Wistar Han animals obtained from Janvier (RjHan:WIST termed W[Jan]; Le Genest St 
Isle, France), HsdHan:WIST (termed W[hsd]) and RccHan:WIST (termed W[rcc]) animals were 
both obtained from Harlan Laboratories GmbH (Horst, Netherlands). After recovering from 
transport and habituating to their new environment the animals were tested in the open field test 
for locomotor activity, in an OBJR test for short-term memory and in a test of PPI of the ASR for 
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sensorimotor gating (see Figure 10). Based on the results Wistar Han rcc animals were employed 
for all further tests. 
 
 
 
 
 
 
 
 
 
 
2.2.2 Project II: Ontogeny of Cognitive Abilities 
To check for the possible influence of the ITI length during the OBJR test, two groups of animals 
were tested with different ITIs in a preliminary study. Therefore four animals aged pd 45 (n = 4) 
and six adult animals (> pd 100; n = 6) were tested in the OBJR test with ITIs of either 10 or 
20 min.  
To investigate the cognitive development during adolescence, one group (n = 16) of animals was 
tested in the open field test, in the OBJR test, in a PPI paradigm, and in an OBJRecency test every 
ten days from pd 30 to pd 80 as well as in adulthood (pd 100 and pd 130; see Figure 11). The 
animals were tested in an open field for 15 min on one experimental day (starting on pd 29) which 
also served as a habituation session for the OBJR test. The OBJR test was conducted starting 3 h 
after lights on the following day (starting on pd 30). After a break of approx. 4 h, the animals were 
tested for PPI. The next day the animals were tested for OBJRecency (starting on pd 31). This 
testing sequence took place throughout the period of adolescence until pd 80. After a break the 
animals were then tested in the same test sequence at two adult time points: pd 100 and pd 130. 
Another group of adult animals (n = 16; > pd 100) underwent the same behavioral test battery as a 
control group for a possible impact of repeated testing. This group was tested in an open field, 
OBJR, PPI and OBJRecency test three times every ten days at the same intervals as the adolescent 
animal group (see Figure 11). 
 
 
 
 
OBJR PPIOpen 
field
W[Jan]
W[hsd]
W[rcc]
Figure 10: Test sequence for the comparison of cognitive abilities in three 
different Wistar Han rat lines: RjHan:WI (W[Jan]) obtained from Janiver, 
RccHan:WIST (W[rcc])] and HsdHan:WIST (W[hsd]) both obtained from 
Harlan Laboratories GmbH. All animals were tested for in the open field, OBJR 
and PPI. 
2. Material and Methods 
 37 
 
adulthood
pd 30 pd 40 pd 50 pd 60 pd 70 pd 80 pd 100 pd 130
adolescence
pd29 pd30 pd31
Locomotor activity 
+ Habituation
OBJR
PPI
OBJRecency
Test 1 Test 2 Test 3
 
Figure 11: Test sequence for the development of cognitive abilities during adolescence. Animals were tested in the 
open field, OBJR, PPI, and OBJRecency on three consecutive days every ten days from pd 30 to pd 80. After a break 
they were tested again at two adult time points (i.e. pd 100 and pd 130). In parallel, one control group of adult animals 
was tested in the same sequence three times for possible effects of repeated testing. 
 
Based on the results, three other groups of animals (pd 30, pd 40, and pd 130) were tested for 
OBJR and PPI under pharmacological treatment with the synthetic CB1R antagonist / inverse 
agonist SR (0.3 mg/kg SR or vehicle; see Figure 12 and Table 1). Thus, SR was administered 
intraperitoneally (i.p.) 30 min prior to testing in the OBJR. PPI was tested immediately after 
OBJR. 
 
 
 
 
 
 
 
 
 
Table 1: Numbers of animals for SR (0.3 mg/kg ) or vehicle treatment in the OBJR and PPI tests. 
Number of animals per group Vehicle SR 
pd 30 12 12 
pd 40 16 17 
Pd 130 18 14 
 
OBJR PPISR (0.3 mg/kg i.p.)
30 min
P1 P2
15 min
Figure 12: Experimental design of tests for 
pharmacological treatment of SR (0.3 mg/kg) at pd 
30, pd 40, or pd 130. Animals were injected 
vehicle or SR i.p. 30 min prior to testing. 
Afterwards they underwent OBJR and PPI. 
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In addition, the brain tissue of behaviorally naïve animals were collected for molecular analysis at 
the same time points during development (pd 30, 40, 50, 60 and 130; n = 5 for each time point). 
One group of animals was perfused and cryo-sectioned for staining of myelin and CB1R. Another 
group of animals (n = 6 for the time points pd 30, 40, 50 and 130) was CO2-anesthetized and brain 
regions (mPFC, CPu, NAc, Hip) were dissected for western blot analysis of CB1R. 
2.2.3 Project III: Long-term Effects of Chronic Pubertal WIN 55, 212-2 Treatment on 
Cognition 
To assess the long term-effects of chronic pubertal WIN treatment on cognition, 24 animals were 
tested in adulthood for OBJR, PPI, CP intake, and in an ASST (see Figure 13). Before testing, 
animals received either the synthetic cannabinoid WIN (1.2 mg/kg; n = 12) or vehicle (n = 12) for 
25 days from pd 40 to pd 65 (Schneider et al., 2008). During this period the rats irregularly 
received 20 injections (i.p.) (Schneider and Koch, 2003, Leweke and Schneider, 2011) with either 
1, 2 or 0 injections every day (in total 10 times one injection, 5 times two injections and 10 times 
no injection). This chronic intermittent treatment schedule mimics the irregular consumption of 
cannabinoids in human users. Long-term effects of treatment were assessed with behavioral tests 
starting on pd 80. 
 
 
 
 
 
 
 
 
After behavioral testing animals were CO2-anesthetized in adulthood (> pd 100) and brain regions 
(mPFC, Cpu, Hip) were dissected for western blots analysis of CB1R, FAAH and MAGL. 
2.2.4 Project IV: Long-term Effects of Chronic Pubertal Methylphenidate Treatment on 
Cognition 
To study the long-term effects of chronic pubertal MPH treatment, 24 rats underwent chronic 
treatment of either MPH (2 mg/kg; n=12) or saline (i.p.; n=12) from pd 40 to pd 55 (see Figure 
14). Injections were conducted at 9 am every day for 16 days. All animals remained undisturbed 
after treatment cessation except for changing of cages and weighing twice a week. The following 
pd 40
Chronic intermittent
WIN treatment
(1.2 mg/kg i.p.)
pd 80pd 65
PPI ASSTCP intakeOBJR
Figure 13: Experimental design of chronic, intermittent pubertal WIN treatment from pd 40 to pd 65 followed by 
tests of OBJR, PPI, CP intake, and ASST after pd 80. 
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behavioral tests were conducted after all animals had reached pd 80: Open field, EPM, EMT, 
SCM and EtOH intake, PPI, OBJR and SOCR. 
 
 
 
 
 
 
 
 
2.3 Drugs 
2.3.1 SR141716 
The cannabinoid antagonist SR141716 (SR; RTI International, North Carolina, USA) was 
dissolved in EtOH, Tween 80 (0.1%) and saline (0.9% NaCl) in ratios of 1:5:54. First it was 
dissolved in EtOH and Tween 80 in a glass vial on a magnetic stirrer. Saline was added later to a 
final concentration of 0.3 or 0.6 mg/kg and administered i.p. Animals were weighed before 
treatment and the injection volume (1 ml/kg) was adjusted according to their current body weight.  
2.3.2 WIN 55, 212-2 
Cannabinoid agonist WIN 55,212-2 (WIN) (Sigma-Aldrich, Germany) was dissolved in 0.1% 
Tween 80 and diluted in NaCl (0.9 %). The drug was administered i.p. in a dose of 1.2 mg/kg. 
Animals were weighed daily before treatment and the injection volumes (1 ml/kg) were adjusted 
according to their current body weight.  
2.3.3 Methylphenidate  
The DA transporter / norepinephrin transporter blocker methylphenidate (MPH) (Sigma-Aldrich, 
Germany) was dissolved in saline (0.9 % NaCl). The drug was administered i.p. in a dose of 
2 mg/kg. Animals were weighed daily before treatment and the injection volumes (1 ml/kg) were 
adjusted according to their current body weight.  
pd 40
daily 2 mg/kg MPH or
Sal treatment
pd 80pd 55
OF
EPM
EMT
SCM intake
EtOH intake
PPI
OBJR
SOCR
Figure 14: Experimental design of chronic pubertal MPH (2mg/kg) or saline (Sal) treatment was conducted from 
pd 40 to pd 55. After pd 80 the following tests were conducted: Open field (OF), EPM, EMT, SCM intake, EtOH 
intake, PPI, OBJR, SOCR. 
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2.3.4 Anesthetics 
The NMDA receptor antagonist ketamin (10% hydrochloride injection solution, CP-Pharma 
GmbH, Burgdorf, Germany) was administered in combination with the alpha-2 receptor agonist 
xylazin (Rompun 2%: xylazinhydrochloride injection solution, Bayer Vital GmbH, Leverkusen, 
Germany) as an anesthetic 100 mg : 5 mg i.p. before perfusion. Animals were weighed before 
treatment and the injection volume (1 ml/kg) was adjusted according to their current body weight. 
2.4 Behavioral Testing 
2.4.1 Open Field Test 
Locomotor activity was measured in a dark gray PVC open field apparatus consisting of four 
equally sized arenas (51 cm x 51 cm x 50 cm) for parallel analysis of four animals. The light in 
the center of the arena was adjusted to 50 lx. The animal was placed in the center of the arena at 
the beginning of the test. The behavior was analyzed by using the observation program Viewer2 
(Biobserve GmbH, Bonn, Germany). In project I and IV, the distance traveled [cm] was recorded 
digitally for a period of 30 min while in project II, the distance traveled [cm] was recorded for a 
period of 15 min.  
2.4.2 Object Recognition Test  
The OBJR test was performed in one of the open field arenas in which the open field test had been 
conducted on the previous day (see 2.4.1). The open field test also served as a habituation session 
in which the animal could familiarize itself with the testing environment in order to avoid a lack 
of exploring the object in the subsequent test sessions. The light was adjusted to 50 lx. The objects 
were placed in the arena 10 cm away from the wall in order to allow the animal to walk around it. 
The OBJR test consisted of two exploration trials: a sample (P1) and a test trial (P2) separated by 
an ITI. First the animal was placed into the arena containing two identical, clean, unfamiliar 
objects which it was allowed to explore for 3 min (sample trial). Then the animal was put back 
into its home cage for an ITI of 15 min (except for a varying ITI in the preliminary study of 10 or 
20 min). After that the animal was again placed into the same open field arena which contained 
one identical copy of the object from the sample trial and a second, unfamiliar object and was 
allowed to freely explore for 3 min (test trial). The animals were always placed into the arena with 
its back turned to the objects. The arena and the objects were thoroughly cleaned with antifect N 
liquid (50% diluted with water), then with water and subsequently dried between animals and 
trials. Both trials were recorded by a video camera and later analyzed by an experienced 
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experimenter. Exploration behavior was defined as sniffing, touching with whiskers or nose, and 
licking of the object but not by standing or sitting on it. The time spent with each object as well as 
the total exploration time were determined. The percentage of the time spent with the new object 
versus the familiar one was calculated as 
 
 
and a discrimination index was calculated as the difference of time spent exploring the new object 
versus the familiar one. 
2.4.3 Object Recency Test 
The OBJRecency test was performed in an open field arena and conducted similarly to the OBJR 
test (see 2.4.2). Different objects from the OBJR test were used to avoid any possible confounding 
effects of familiarity. It consisted of two sample trials (P1 and P2) and a test trial (P3). Each trial 
lasted 3 min and was separated by an ITI of 45 min in which the animal was transferred back into 
its home cage. In P1 the animal was allowed to explore two identical, clean, and new objects. In 
P2 it was again allowed to explore two identical, clean objects which were different from the 
objects of P1. In P3 a clean copy of an object from P1 (an old familiar object) and one from P2 (a 
recently familiar object; (Dere et al., 2007) were placed in the arena. The time spent with the old 
familiar vs. the recently familiar object was calculated as in the OBJR test (as percentage 
discrimination and discrimination index). 
2.4.4 Social Recognition Test 
The SOCR test was conducted in the open field arena and the design and time course were similar 
to the OBJR test (see 2.4.2). The time intervals of P1 and P2 were both 3 min and the ITI was 
15 min. All animals were habituated to the environment separately on the previous day. On the 
test day, the social partner animal was placed into the arena shortly before the test animal so the 
social partner could adapt to the environment. After P1 both the test animal and the social partner 
animal were put back into their individual home cages. Following an ITI of 15 min, the familiar 
social partner and a new social partner animal were placed into the open field arena. The test 
animal was then also placed into the open field arena for P2. 
Again the behavior was recorded by a camera and social investigation (anogenital exploration, 
non-anogenital exploration and approach/following) of the test animal was later analyzed (see also 
Schneider et al., 2008). The time spent with the familiar vs. the novel social partner was 
calculated as percentage social discrimination as in the OBJR test. 
(time exploring familiar object + time exploring new object) * time exploring new object
100% =
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2.4.5 Acoustic Startle Reflex and Prepulse Inhibition 
The PPI of the ASR was measured in a startle chamber (SR-LAB; San Diego Instruments, San 
Diego, USA). A white noise pulse with an intensity of 115 dB sound pressure level (SPL) and a 
duration of 40 msec (0 msec rise/fall times) was used as a startle stimulus. Four pulses with 
different intensities (72, 76 80, 84 dB SPL, duration 20 msec) were used as prepulses and were 
presented 100 msec before the startle stimulus. White noise (65 dB SPL) served as background 
noise. The PPI program consisted of an acclimatization period, an initial startle exposure and the 
test period. In the acclimatization period, the animals were only exposed to the background noise 
for 5 min. Five initial startle stimuli followed. The test program comprised six different trial types 
in a pseudorandomized order: startle pulse alone, startle pulse preceded by prepulses of different 
intensities (see above) or background noise alone. The ITI varied between 10 and 20 sec. All 
combinations were presented 10 times thus resulting in a series of 60 trials. 
The initial five startle pulses were excluded from further analysis. PPI was calculated as the 
percentage decrease of the ASR magnitude in trials when the startle stimulus was preceded by a 
prepulse:  
 
 
 
2.4.6 Casein Pellet Intake 
CPs were purchased from Bio Serve Dustless Precision Pellets®, Bilaney, Kent, UK, and also 
used as a reward in the ASST (see below). All rats were habituated once in their home cage to the 
pellets and the experimenter observed that each rat consumed at least one pellet during 
habituation. The test was conducted in single cages (MakrolonTM, Eurostandard type III). For 
testing, the body weight was assessed and animals were placed in the single test cages. After an 
initial cage habituation for 5 min, the rats had free access to the CPs for 5 min. The amount of 
consumed CPs was measured by weighing CPs before and after animals had access to them. 
Testing was always conducted at the same time in the middle of the light phase. CP intake was 
then calculated as [g] intake per kg body weight (g/kg BW). 
2.4.7 Attentional Set Shift Test 
The ASST was adapted from Birrell and Brown (2000) and Colacicco et al. (2002); (see Figure 
15). Extensive habituation to the test apparatus, the food reward, and some materials is required to 
ensure good response of the animals during the test. Therefore, the animals were acquainted with 
100 * mean ASR amplitude on prepulse-pulse trials
mean ASR amplitude on pulse alone trials
% PPI = 100 -
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the reward (CPs; Dustless Precision Pellets®, Bio Serve, see 2.4.6), the ceramic pots, and 
different digging materials. For a few nights the pots were filled with home cage bedding and with 
rewards placed on top of them, as well as buried in them. The experimenter assured that each 
animal consumed at least one pellet during the habituation. The pots were rebaited several times 
and left in the home cage overnight (not more than three pots per cage). The following nights 
some of the digging materials were introduced in the same manner (up until the intradimensional 
shift (IDS); see below). On the second day of habituation, two animals were placed in the test 
apparatus to explore it with a familiar animal. The test apparatus was made of dark gray PVC (see 
Figure 16). First, the animals were placed into the small start compartment for 30 sec. Then the 
sliding door was lifted to give them access to the test chamber. As soon as they were both in the 
test chamber the sliding door was lowered again. They were left in the apparatus for 15 min 
before the sliding door was lifted again and the animals were gently pushed back into the start 
compartment. This was done to familiarize them with the course of events during the testing 
procedure. They were then returned to the home cage. The next day each rat was placed in the 
apparatus individually and had the possibility to explore the box again for 15 min.  
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Figure 16: Dimensions of the ASST box. The small compartment on top is 
considered the start compartment. The test chamber below contains two 
fixed rings in which the ceramic pots with the scented digging material and 
reward were placed into. 
Days 7654321 8
Habituation Pre SD CD CDrev CDrep IDS IDS 2 EDS
Figure 15: Timeline of the ASST. After a habituation phase, 1-2 rules per day were tested over a period of 8 days in 
total. Pre: pretraining; SD: simple discrimination, CD: compound discrimination, rev: reversal, rep: repetition, IDS: 
intradimensional shift, EDS: extradimensional shift. 
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The next day the rats completed the pretraining (Pre). Therefore they were placed into the 
apparatus individually. After entering the test chamber they were now facing two otherwise empty 
pots with one CP in every one. The experimenter recorded the time from lifting the door until the 
animal retrieved the reward. It was then gently pushed back into the start compartment to eat its 
reward. During a 30 sec ITI, the pots were replaced by pots filled with familiar, unscented digging 
material. Each had a reward on top of the digging material. The animal had to retrieve the reward 
again while the time was recorded. Then the reward was increasingly buried deeper in the pot. 
The animal had to retrieve it four times in less than one minute after it had been completely 
buried. The rat was then returned to its home cage.  
The next day each rat was presented two bowls containing two different odors (but the same 
digging material). The rats had to learn that only in the bowl with a certain odor a reward could be 
obtained (simple discrimination, SD). This perceptual stimulus would be important in the next 
trial. In the following trial, the rat was presented two bowls each containing an odor and a 
diverging digging material (complex stimuli). Only by attending to the previously important 
dimension, it would find the food reward (compound discrimination, CD). This was ensured by 
changing material odor combinations. In the next trial, the previously learned rule was reversed 
(CDReversal, CDRev) meaning that the cue that had previously been unimportant was now 
leading to the food reward (for example the previously unimportant smell of basil now led to the 
reward whereas the previously important smell of capsicum did not regardless of the type of 
digging material presented with it).  
Then two new complex stimuli were introduced (intradimensional shift, IDS) and the rat had to 
learn that, again, one of the cues with the same perceptual dimension led to the food reward. Two 
new odors and materials were then introduced applying the same rule (IDS 2). In the next trial, 
again, two new complex stimuli were presented but this time a cue of the other perceptual 
dimension was important to find the food reward (extradimensional shift, EDS). For example: if 
the rat had previously learned that the odor had always led to the reward, it now had to focus on 
the type of digging material to obtain the reward. An example of employed combinations of 
digging materials and odors is shown in Table 2. 
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Table 2: Employed combinations of digging materials and odors for different trials. The rewarded material or odor is 
shown in italics. The colored silica sand had a grain size of 3-4mm whereas the black silica sand had a grain size of 1-
2mm. Pre: pretraining; SD: simple discrimination, CD: compound discrimination, rev: reversal, rep: repetition, IDS: 
intradimensional shift, EDS: extradimensional shift. 
Trial Digging material 1 Digging material 2 Odor 1 Odor 2 
Pre Seramis ®    
SD colored silica sand hamster bedding  cumin 
CD colored silica sand hamster bedding capsicum cumin 
CD rev colored silica sand hamster bedding capsicum cumin 
CD rep colored silica sand hamster bedding capsicum cumin 
IDS beech chipping rough stones nutmeg basil 
IDS 2 straw pellets pine bark thyme dill 
EDS cork granules black silica sand rosemary curcuma 
 
A test subject completed one rule stage when it obtained the reward within one minute in six 
consecutive trials (trails to criterion). The position of the rewarded pot was randomized and the 
experimenter ensured that the animal did not follow a false rule (e.g. always retrieving the reward 
from the left pot).  
2.4.8 Light/Dark Emergence Test 
The EMT was conducted in a light/dark box made of pale gray PVC. The apparatus consisted of 
two compartments, separated by a dividing wall with a 10 cm x 15 cm wide opening which 
enabled the test subject to move freely between the compartments. The smaller, dark compartment 
with black walls (25 cm x 25 cm x 40 cm) could be closed by a lid and was used as start box. The 
larger, bright compartment had gray walls (25 cm x 50 cm x 40 cm) and was brightly illuminated 
(80 lx). Rats were initially placed in the dark, closed compartment which was opened after 1 min 
and their behavior was videotaped for 5 min. Subsequent video analysis manually scored the 
latency of the animals to emerge from the dark compartment into the lit compartment [sec] (an 
entry was defined when the animal entered the compartment with all four limbs), the emergence 
frequency, the duration of time spent in the lit compartment [sec], the number of rearings, and risk 
assessment behavior (only head or forepaws are placed in the open compartment without 
concomitant movement of the hind limbs, even if the rat subsequently entered the area). The 
apparatus was thoroughly cleaned with antifect N liquid between the sessions.  
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2.4.9 Elevated Plus Maze 
The EPM is a plus-shaped apparatus consisting of dark gray PVC elevated 50 cm above the floor 
with two opposing open arms (12 cm x 50 cm x 50 cm) which were illuminated by 80 lx and two 
enclosed arms (12 cm x 50 cm x 50 cm) extending from a central square (10 cm x 10 cm). At the 
beginning of each trial, each rat was placed on the central platform facing a closed arm. Each rat 
was videotaped for 5 min and the following behaviors were analyzed: number of entries into open 
or closed arms (an entry was defined if all four paws were placed on that arm), time spent in open 
and closed arms [sec], head dips (the whole head is lowered beneath the edge of an open arm), 
risk assessment (only head or forepaws are placed in an open arm without concomitant movement 
of the hind limbs, even if the rat subsequently entered the arm), self grooming frequency, and self 
grooming time [sec]. Percentage of open arm entries (open arm entries / (open + closed arm 
entries) x 100) and percentage of time spent in open arms (open arm time / (open + closed arm 
time) x 100) were calculated as well. The apparatus was thoroughly cleaned with antifect N liquid 
between the sessions.  
2.4.10 Sweetened Condensed Milk Intake 
The SCM (Nestle AG, Frankfurt, Germany) was freshly diluted 1:3 with water on the day of use. 
All rats were habituated once in their home cage to the SCM overnight, at least 48 h before 
testing. The test was conducted in single cages (MakrolonTM, Eurostandard type III). On the test 
day, the body weight was assessed and the animals were placed in the single test cages. After an 
initial cage habituation for 5 min, the rats had free access to the SCM bottle for 15 minutes. The 
weight of the bottles was assessed before and after the trial and SCM intake was then calculated 
as intake in [ml] per kg body weight (ml/kg BW). 
2.4.11 Ethanol Intake 
The initial consumption of an EtOH solution (6%) was measured in a 24 h experiment, followed 
by a 24 h experiment for the consumption of a higher concentrated EtOH solution (10%). The rats 
were separated in single cages (MakrolonTM, Eurostandard type III) in the experimental room. 
During the test session the animals were given ad libitum access to water or EtOH and laboratory 
food. After 24 h the animals were returned to their home cage. The weight of the water and EtOH 
bottles was recorded before and after the test session and the drinking volume as well as the EtOH 
intake in [g] per kg bodyweight was calculated for each rat. Additionally, preference scores 
(EtOH volume / total drinking volume) were calculated.  
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2.5 Molecular Analysis 
Immunohistochemistry 
2.5.1 Tissue Preparation and Fixation 
Behaviorally naïve animals were used for histology at the same age (pd 30, 40, 50, 60, and 130) as 
the behaviorally analyzed animals. Animals were anaesthetized with Ketamine : Xylazin (100 mg 
: 5 mg i.p.) (Meinhardt et al., 2013) and then transcardially perfused with 80 ml ice cold 
phosphate buffered saline (PBS; including 10.000 I.E. Heparin-Natrium (Ratiopharm GmbH, 
Ulm, Germany) / 1000ml PBS) followed by 100 ml 4% paraform aldehyde (PFA). Brains were 
removed and stored at 4°C in 4% PFA over night for post-fixation. Brains were then put into a 
10% sucrose solution for 2 days for dehydration before they were snap-frozen in isopentane and 
stored at -80°C before sectioning. Sectioning was conducted at a cryostat into 30 µm slices, 
collected in a cryoprotect solution (30% glycerol, 30% ethylenglycol, 10% 2xPO4), and stored at 
-80°C.  
2.5.2 Goldchloride Staining 
Goldchloride is used for staining of myelin (Schmued, 1990, Wahlsten et al., 2003, Schneider and 
Koch, 2005). Sections were washed in PBS, mounted on Superfrost Plus slides (Thermo Fisher 
Scientific Inc., Waltham, MA, USA) and airdried over night. Subsequently, sections were placed 
in a 0.2% goldchloride solution (1 g Tetrachlorogold(III)säure-Trihydrat, Carl Roth, Karlsruhe, 
Germany, dissolved in 0.02M PBS with 4.5 g NaCl, pH 6.8-7) for 2 h. Sections were washed in 
aqua dest. and then fixed in freshly mixed 2.5% sodium thiosulfate solution for 5 min. Sections 
were then washed with running tap water for 30 min and briefly rinsed in aqua dest. Then the 
sections were dehydrated in rising EtOH steps (70, 80, 90, 100, 100%; 10 min each), and xylol 
(10 min) and embedded in Eukitt (O. Kindler GmbH, Freiburg, Germany).  
2.5.3 Cannabinoid Receptor 1 Staining 
The staining was conducted with free floating sections adapted from (Egertova and Elphick, 
2000). Sections were washed with PBS (2 x 50 min and 2 x 20 min) on a stirrer at room 
temperature (RT). Then sections were blocked with normal goat serum (NGS; 5%) and H2O2 
(0.3%) in PBS containing 0.1% Tween (PBS-T) for 4 h at RT. After 2 x quick washes and 3 x 
15 min washes in PBS-T, sections were incubated over night at 4°C with antiserum against the 
CB1R (a gift from Prof. Elphick at Queen Mary University, London) 1:1000 in PBS-T and 5% 
NGS. On the next day the antibody was recycled and the sections washed 4 x 20 min in PBS-T. A 
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secondary antibody (goat-anti-rabbit IgG HRP, Vectastain Elite ABC Kit (Rabbit IgG) Vector 
Laboratories, Inc. Burlingame, CA, USA) was applied 1:500 in PBS-T and 2,5% NGS for 3 h at 
RT. Sections were washed 2 x 20 min in PBS-T followed by 2 x 20 min in PBS. ABC solution 
was prepared 30 min prior to use by mixing solution A and solution B 1:400 in PBS (Vectastain 
Elite ABC Kit, Vector Laboratories, Inc. Burlingame, CA, USA). Sections were then incubated in 
ABC solution for 1 h at RT. After that sections were washed 3 x quickly in PBS while the 
2,4 diaminobutyric acid (DAB, Sigma-Aldrich, Taufkirchen, Germany) solution was being 
prepared. Sections were incubated in DAB for approximately 5 min until staining could be 
observed. Care was taken to expose all sections for the same time to the DAB solution. The DAB 
reaction was stopped with PBS. Sections were then mounted on Superfrost Plus slides (Thermo 
Fisher Scientific Inc., Waltham, MA, USA) and airdried over night. Following dehydration in 
rising EtOH steps and xylol (see above), sections were embedded in Eukitt. 
2.5.4 Histological Analysis 
Histological images were captured using an Axioskop 2 microscope (Zeiss, Jena, Germany) with 
a 2.5x air objective and an Olympus ColorView 3 camera. Semiquantitative analysis of the myelin 
and CB1R staining was performed using ImageJ software (Schneider et al., 2012). 
The region of interest (ROI: mPFC, CPu, Hip) was outlined manually for each image based on the 
rat brain atlas by (Paxinos G., 1998). At least three sections (right and left hemisphere) of each 
ROI were analyzed per brain.  
The captured images were uniformly processed for the analysis of staining intensity. For the 
myelin staining each image was converted into a binary image after the contrast was enhanced by 
40%. The outside of the ROI was cleared and the myelin staining was visible as black staining. If 
the colors were switched the image was inverted. Subsequently, the white [0] and black [255] 
values were extracted from the histogram. Percentage of myelination per ROI was calculated as 
% =
value [255]
(value [255] + value [0]) * 100
 
For the CB1R staining, images were first converted to 8-bit grayscale images. Subsequently, the 
ROI was outlined and its mean gray value (optical density; OD) was measured. A rectangle of 
constant size in corpus callosum was used as a background control and its mean gray value was 
subtracted from the mean value of the ROI. The mean OD was then divided by the mean area size 
of the ROI.  
CB1R staining =
OD (ROI) – OD (background)
mean area size (ROI)
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2.5.5 Western Blots 
Western blot analysis was conducted as described before (Schneider et al., 2014). Rats were 
briefly anesthetized with CO2 and decapitated. Brains were removed and mPFC, CPu, NAc, and 
Hip were quickly dissected and homogenized in 500 µl lysis buffer (10 nM Tris-HCl, 2 mM 
EDTA, pH 8.0) containing protease inhibitors (cOmplete Tablets Mini, EDTA-free EASYpack, 
Roche Diagnostics, Penzberg, Germany) and stored at -80°C. Protein content was measured by 
Bradford Protein Assay (BioRad Laboratories GmbH, Munich, Germany) using bovine serum 
albumin as a standard (Sigma-Aldrich, Munich, Germany). Protein samples (25 µg for mPFC, 
CPu, and NAc, 50 µg for Hip) were mixed with 2 x mercapto/SDS sample buffer (Sigma-Aldrich, 
Munich, Germany) and heated at 95°C for 5 min. Electrophoresis was subsequently carried out at 
200 V in NuPage® Novex Bis-Tris Mini Gel 4-12% gels (Invitrogen, Darmstadt, Germany). 
Separated proteins were then blotted (400 mA for 90 min) onto PVDF membranes (BioRad 
Laboratories, Munich, Germany) using Towbins buffer.  
Membranes were then blocked with OdysseyTM blocking buffer (LiCor Biosciences GmbH, Bad 
Homburg, Germany; 1:1 in tris-buffered saline (TBS) solution) on a shaker at RT for 30 min 
(FAAH) or 1 h (MAGL). For CB1R staining membranes were blocked in 2.5% nonfat dry milk / 
TBS solution at RT for 1 h. 
Membranes were subsequently incubated with either rabbit polyclonal anti-FAAH antibody 
(1:1000, item number 101600, Cayman Chemical Company, Ann Arbor, Michigan, USA) or with 
rabbit polyclonal anti-MAGL antibody (1:500, item number 100035, Cayman Chemical 
Company, Ann Arbor, Michigan, USA) at 4°C over night in OdysseyTM blocking buffer / TBS 
solution. For CB1R analysis a rabbit polyclonal anti-CB1R antibody (1:1000, IMG-pAb001, 
ImmunoGenes, Zug, Switzerland) was incubated in 2.5% nonfat dry milk / TBS solution for 24 h 
at 4°C. Every blot was simultaneously co-incubated with goat polyclonal ß-Actin antibody 
(1:2000, sc-1615, Santa Cruz Biotechnology Inc., Heidelberg, Germany).  
After 3 washing steps with TBS containing 0.1% Tween (TBS-T), the secondary antibody was 
incubated in OdysseyTM blocking buffer / TBS solution for 1h at RT. To allow simultaneous 
detection of MAGL/FAAH/CB1R and ß-Actin, secondary antibodies with two different 
fluorescent wavelengths were used: donkey-anti-rabbit 800 (1:10000 for FAAH and MAGL, 
1:15000 for CB1R; Cat. Nr. 926-32213 LiCor Biosciences GmbH, Bad Homburg, Germany) and 
donkey-anti-goat 680 (1:10000 for 25 µg protein and 1:15000 for 50 µg protein; Cat. Nr. 926-
68024, LiCor Biosciences GmbH, Bad Homburg, Germany). Membranes were washed with TBS-
T, rinsed with ultrapure water, and subsequently scanned with the Odyssey Imaging System 
(LiCor Biosciences GmbH, Bad Homburg, Germany). The band density was quantified using the 
LiCor Imaging system. Background-corrected values of FAAH, MAGL and CB1R were corrected 
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for the corresponding ß-Actin contents and expressed as arbitrary units. To allow group 
comparisons between different blots without the interference of gel variations, percentage changes 
were calculated separately for each blot (with mean of control group = 100%).  
2.6 Statistical Analysis 
Project I:  
Differences between W[Jan], W[hsd] and W[rcc] animals were analyzed by one-way analysis of 
variance (ANOVA) for OF and OBJR. Differences in PPI were analyzed by repeated 
measurement (RM) ANOVA. For post-hoc testing Tukey’s test was used.  
Project II:  
In the preliminary study of assessing the influence of varying ITIs on OBJR, RM ANOVA was 
employed. Differences in the development of adolescent rats and repeated testing in adult animals 
were analyzed by RM ANOVA and by subsequent time point comparison for OF, OBJR, 
OBJRecency, PPI and ASR (except for adult controls in OF and ASR; here, paired Student’s t-test 
was used). The pharamcological influence of SR was analyzed seperately for each age group with 
Student’s t-tests. For PPI, RM ANOVA with subsequent post-hoc testing was used. The 
development of myelination and western blots for CB1R were analyzed by one-way ANOVA 
with subsequent Fisher LSD post-hoc tests. 
Project III:  
Student’s t-test was used to analyze OBJR, PPI, CP intake and western blots. MANOVA followed 
by multiple ANOVAs was applied for ASST. 
Project IV:  
Student’s t-test was employed for the analysis of EMT, EPM, SCM, and EtOH intake, PPI, OBJR, 
and SOCR. 
All data are presented as means with standard error (means + standard error of the mean 
(S.E.M.)). Significant differences (p < 0.05) between groups are marked with *, statistical trends 
(p < 0.1) are marked with #. The level of significance was set at p ≤ 0.05. All calculations were 
performed in SPSS software 21.0 (IBM, Somers, USA). 
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3. Results 
3.1 Project I: Differences of Cognitive Abilities in Three Wistar Han Rat 
Lines 
3.1.1 Open Field 
Locomotor activity measured in the open field differed significantly between the rat lines 
regarding the distance traveled (Figure 17; F2,33 = 5.154; p = 0.011). Post-hoc Tukey test revealed 
that W[Jan] were more active in the open field than W[rcc] rats (p = 0.008), while the other lines 
did not differ (W[Jan] vs. W[hsd]: p = 0.265; W[hsd] vs W[rcc]: p = 0.251). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.2 Object Recognition 
There was a significant difference between the rat lines regarding the percentage discrimination 
observed in the OBJR test (Figure 18; F2,33 = 4.565; p = 0.018). Post-hoc Tukey’s test revealed a 
higher object discrimination for W[rcc] compared to W[Jan] animals (p = 0.013;), while no 
difference was found between the other rat lines (W[rcc] vs W[hsd]: p = 0.334; W[hsd] vs. 
W[Jan]: p = 0.267). 
Initial exploration time (during P1) differed significantly between the animals (F2,33 = 15.064; 
p < 0.001). Post-hoc Tukey’s test revealed that W[hsd] displayed a higher exploration time 
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Figure 17: Distance traveled in the open field test of W[Jan], W[hsd] and W[rcc] 
animals. W[Jan] animals showed a significantly higher locomotor activity than 
W[rcc] rats. Data are expressed as mean + S.E.M. (* p ≤ 0.05, n = 12) 
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compared to W[rcc] and W[Jan] (p ≤ 0.001), while no difference was found between the other 
lines (W[rcc] vs. W[Jan]: p = 0.979). Total exploration values in P1 ± S.E.M: 
W[Jan] = 21.9 sec ± 2.9; W[rcc] = 22.8 sec ± 2.1; W[hsd] = 42.5 sec ± 3.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.3 Prepulse Inhibition of the Acoustic Startle Reflex 
Measurement of the PPI revealed a significant difference between groups (Figure 19; 
F 2,33 = 3.435; p = 0.044). Post-hoc Tukey’s test showed that W[Jan] displayed a higher PPI 
compared to W[hsd] (p = 0.05) while the other rat lines did not differ (W[Jan] vs W[rcc]: 
p = 0.114; W[hsd] vs W[rcc]: p = 0.925). Additionally, the rat lines also differed in their initial 
ASR amplitude (F 2,33 = 22.822; p < 0.001) with W[rcc] displaying a significantly higher ASR 
than W[hsd] and W[Jan] (p ≤ 0.001) while no difference was observed between W[hsd] and 
W[Jan] rats (p = 0.6). Total ASR values [arbitrary units] ± S.E.M: W[Jan] = 792.2 ± 77.2; 
W[rcc] = 4511.5 ± 649.4; W[hsd] = 1368.1 ± 314.8).  
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Figure 18: Percentage object discrimination in the OBJR test of W[Jan], W[hsd] and 
W[rcc] animals. W[rcc] animals displayed a higher object discrimination than W[Jan] 
animals. Data are expressed as mean + S.E.M. (* p ≤ 0.05, n = 12). 
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3.2 Project II: Ontogeny of Cognitive Abilities 
3.2.1 Influence of Intertrial Interval Length on Object Recognition Performance 
The influence of varying ITIs in an OBJR test was investigated in a preliminary study. Adult 
animals showed a similar object discrimination performance and discrimination index for both 
10 min and 20 min ITIs (Figure 20). However, pd 45 animals showed a higher object 
discrimination performance and a higher discrimination index at an ITI of 10 min compared to 
20 min (Figure 20). Although the results were not statistically significant (possibly caused by the 
limited sample size of n = 4 for pd 45 and n = 6 for adult) based on these observations an ITI of 
15 min was chosen for the following study design. 
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Figure 19: PPI of W[Jan], W[hsd] and W[rcc] animals. W[Jan] showed a higher PPI 
compared to W[hsd] animals. Data are expressed as means + S.E.M. (* p ≤ 0.05, n = 12). 
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3.2.2 Locomotor Behavior during Development 
A significant variation in the distance traveled in the open field was observed over the course of 
development during repeated testing (Figure 21; F4.7,70.0 = 4.384; p = 0.002). Time point 
comparisons showed a significantly higher locomotion of the animals on pd 59, pd 69, pd 79, and 
pd 99 compared to pd 129 (p ≤ 0.05; Figure 21A), while no difference was observed in the same 
animals on pd 29, pd 39, and pd 49 compared to pd 129 (p ≥ 0.113). Locomotor behavior was also 
repeatedly tested in a separate group of adult control animals. Due to technical difficulties one test 
point had to be excluded from the analysis. However, for two repeated test points paired Student’s 
t-test did not show any differences in the distance traveled in the open field (t15 = -0.553; 
p = 0.588; Figure 21B).  
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Figure 20: Percentage object discrimination (A) and discrimination index (B) in the OBJR for pd 45 and adult 
animals with varying ITIs of 10 and 20 min. Although not statistically significantly different, object discrimination 
was lower at an ITI of 20 min in pd 45 animals compared to an ITI of 10 min (A). In addition, the discrimination 
index showed a reduction after 20 min ITI compared to 10 min ITI in pd 45 animals (B). In adult animals both 
percentage object discrimination and discrimination index did not differ with varying ITIs. Data are expressed as 
mean + S.E.M. (pd 45: n = 4, adult: n = 6). 
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3.2.3 Basal Development of Object Recognition and Object Recency 
In the OBJR test, RM ANOVA revealed no significant effect for the development of the animals’ 
abilities to discriminate novel versus familiar object (Figure 22A; F5.7,85.9 = 1.667; p = 0.142). 
However, time point comparison revealed a significantly lower percentage object discrimination 
on pd 40 (p = 0.041) as well as a trend for a lower percentage object discrimination on pd 50 
(p = 0.085) compared to percentage performance on pd 130. No difference was observed in the 
same animals on any other time point compared to pd 130 (p ≥ 0.478). 
No significant effect was shown for the discrimination index (Figure 22B; F5.4,80.8 = 1.438; 
p = 0.216) however, time point comparison found a trend for a lower discrimination index on 
pd 40 (p = 0.059) compared to pd 130. No difference in discrimination index was found in the 
same animals on any other time point compared to pd 130 (p ≥ 0.129). 
In addition, object exploration times during P1 differed significantly over the course of 
development (Table 3; F5.6,83.5 = 12.296; p < 0.001). Animals tested between pd 30 and pd 80 
displayed significantly higher exploration times (p ≤ 0.01) compared to when the same animals 
were tested on pd 130. In contrast, no difference was observed in the same animals between 
pd 100 and pd 130 (p = 0.373). 
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Figure 21: Mean distance traveled in the open field between age pd 29 and pd 129 (A) and in adult rats (B). 
Locomotor activity was significantly increased at pd 59 - 99 compared to pd 129 (A). Adult animals displayed no 
difference in total distance traveled upon repeated testing (B). Data are expressed as mean + S.E.M. (* p ≤ 0.05, 
n = 16). 
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Table 3: Exploration time during P1 for the age of pd 30 – 130 in the OBJR test. Exploration time was significantly 
higher during pd 30 - 80 compared to pd 130. Data are expressed as mean [sec] and S.E.M. (* p ≤ 0.05, n = 6). 
 
Time P1 pd 30 pd 40 pd 50 pd 60 pd 70 pd 80 pd 100 pd 130 
 
        
mean 36.81 * 36.56 * 31.44 * 29.56 * 27.31 * 24.00 * 19.06 16.69 
S.E.M. 2.54 2.88 2.43 2.16 2.02 1.26 1.75 2.07 
 
Repeated testing in adult control animals revealed neither significant changes in percentage object 
discrimination nor in discrimination index (Figure 23; F2,30 = 0.143; p = 0.867 and F2.0,29.5 = 0.704; 
p = 0.501 respectively). Also exploration time was similar over three repeated test sessions (Table 
4; F2,30 = 1.929; p = 0.163). 
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Figure 22: Percentage object discrimination (A) and discrimination index (B) in the OBJR test during the development 
from pd 30 - 130. Object discrimination was significantly lower at pd 40 compared to pd 130 and at pd 50 a trend for a 
lower object discrimination compared to pd 130 was detected (A). A trend for a reduced discrimination index was found 
at pd 40 compared to pd 130 (B). Data are expressed as mean + S.E.M. (* p ≤ 0.05; # p ≤ 0.1, n = 16). 
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Table 4: Exploration time during P1 of adult animals in the OBJR test. No difference in exploration time was 
observed upon three repeated test sessions. Data are expressed as mean [sec] and S.E.M. (n = 16). 
 
Time P1  Test 1 Test 2 Test 3 
adult animals 
      
mean 30.31 25.75 27.44 
S.E.M. 2.17 1.91 2.46 
 
The OBJRecency performance revealed no global effect over the course of development (Figure 
24A; F7,98 = 1.924; p = 0.074). However, time point comparison revealed that the percentage 
object recency discrimination performance on pd 31 compared to pd 131 was significantly lower 
than in the same animals on any other test point (p = 0.026).  
Comparison of the discrimination index revealed no significant variation in performance over the 
course of development (Figure 24B; F6.8,95.1 = 1.453; p = 0.196).  
The exploration time during P1 varied significantly over the course of development (Table 5; 
F6.4,89.7 = 7.442; p < 0.001). Time point comparison showed that adolescent and early adult 
animals (pd 41, pd 51, pd 61 and pd 71) displayed a higher exploration time compared to pd 131 
(p ≤ 0.004) but the same animals tested on pd 31, pd 81, and pd 101 showed no significantly 
higher exploration time compared to pd 131 (p ≥ 0.1). 
One animal had to be excluded from the analysis due to low performance in one trial (exploration 
time < 1sec). 
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Figure 23: Percentage object discrimination (A) and discrimination index (B) of adult rats upon repeated 
testing in the OBJR test. Neither for the percentage object discrimination nor for discrimination index could a 
significant difference be observed. Data are expressed as mean + S.E.M. (n = 16). 
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Table 5: Exploration time during P1 for the age of pd 31-131 in the OBJRecency test. Exploration time was 
significantly higher during pd 41-71 compared to pd 131. Data are expressed as mean [sec] and S.E.M. (* p ≤ 0.05, 
n = 15). 
 
Time P1 pd 31 pd 41 pd 51 pd 61 pd 71 pd 81 pd 101 pd 131 
 
                
mean 40.40 55.53 * 53.13 * 44.40 * 45.67 * 33.33 33.53 31.47 
S.E.M. 5.28 4.51 2.83 2.95 2.63 2.42 3.21 3.50 
 
Repeated testing in adult control animals revealed neither significant changes in percentage object 
recency discrimination nor in discrimination index (Figure 25; F2,30 = 0.795; p = 0.461 and 
F1.7,25.3 = 0.062; p = 0.914 respectively). Also exploration time was similar over three repeated test 
sessions (Table 6; F1.5,22.2 = 0.084; p = 0.866).  
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Figure 24: Percentage object recency discrimination (A) and discrimination index (B) of the OBJRecency test 
during the development from pd 31 – 131. A significantly lower percentage object recency discrimination at pd 31 
compared to pd 131 was observed (A). Discrimination index did not vary over the course of development (B). 
Data are expressed as mean + S.E.M. (* p ≤ 0.05, n = 15). 
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Table 6: Exploration time during P1 of adult animals in the OBJRecency test. No difference in exploration time was 
observed upon three repeated test sessions. Data are expressed as mean [sec] and S.E.M. (n = 16). 
 
Time P1  Test 1 Test 2 Test 3 
adult animals 
      
mean 35.94 37.63 37.44 
S.E.M. 3.16 3.39 3.60 
3.2.4 Basal Development of Prepulse Inhibition of the Acoustic Startle Reflex 
The PPI performance varied significantly over the course of development (Figure 26A; 
F6.2,93.1 = 32.726; p < 0.001). Compared to when tested in adulthood (pd 130), the same animals 
tested in adolescence and as early adults (pd 30 - pd 80) displayed significantly lower mean PPI 
values (p ≤ 0.001), whereas no difference was observed in the same animals when tested between 
pd 100 and pd 130 (p = 0.197) or pd 120 and pd 130 (p = 0.803). Adult control animals displayed 
no significant alterations of mean PPI values over three repeated test sessions (Figure 26B; 
F2,30 = 0.369; p = 0.695). 
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Figure 25: Percentage object recency discrimination (A) and discrimination index (B) of adult rats upon 
repeated testing in the OBJRecency test. Neither for the percentage object recency discrimination nor for 
discrimination index could a significant difference be observed. Data are expressed as mean + S.E.M. (n = 16). 
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Comparison of ASR values also revealed a significant change over the course of development 
(Table 7; F1.8,26.8 = 20.109; p < 0.001). Time point comparison showed that when tested in 
adolescence and as early adult rats (pd 30 - pd 80), animals displayed significantly lower ASR 
value (p ≤ 0.005) compared to when the same animals were tested in adulthood (pd 130). No 
differences were observed between pd 100 and pd 130 or pd 120 and pd 130 (p = 0.344 and 
p = 0.803 respectively). 
Due to technical difficulties, test 1 of the ASR in adult controls could not be analyzed however, 
paired Student’s t-test did not show any differences between tests 2 and 3 (Table 8; t15=-0.303; 
p = 0.766). 
 
Table 7: Mean ASR values [arbitrary units] over the age of pd 30 – 130. ASR of pd 30 – pd 80 was significantly 
reduced compared to pd 130. Data are expressed as mean [sec] and S.E.M. (* p ≤ 0.05, n = 16). 
 
ASR pd 30 pd 40 pd 50 pd 60 pd 70 pd 80 pd 100 pd 130 
 
                
mean 481.98 * 903.87 * 1208.17 * 1466.57 * 1361.61 * 2848.51 * 4342.87 4814.94 
S.E.M. 33.56 57.50 93.90 187.63 172.98 502.79 723.43 895.38 
 
Table 8: Mean ASR value [arbitrary units] of adult control animals. No difference was observed between two test 
sessions. Data are expressed as mean [sec] and S.E.M. (n = 16). 
 
ASR  Test 2 Test 3 
adult animals 
    
mean 4823.60 4920.89 
S.E.M. 651.45 607.83 
0
20
40
60
80
100
Test 1 Test 2 Test 3
0
20
40
60
80
100
30 40 50 60 70 80 90 100 120 130
M
ea
n
PP
I [%
]
age [pd]
M
ea
n
PP
I [%
]
adult
A B
* * * * * *
M
ea
n
PP
I [%
]
M
ea
n
PP
I [%
]
Figure 26: Mean PPI values over the age of pd 30 – 130 (A) or of adult rats (B). PPI of pd 30 – pd 80 was 
significantly reduced compared to pd 130 (A). In adult rats no difference in PPI was observed upon three 
repeated tests (B). Data are expressed as mean + S.E.M. (* p ≤ 0.05, n = 16). 
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3.2.5 Pharmacological Influence of SR141716 on Behavior during Development 
Student’s t-test revealed a significantly improved object discrimination at pd 40 in SR (0.3 mg/kg) 
compared to vehicle treated animals (Figure 27B; t31 = -2.594; p = 0.014). No difference was 
observed between groups on pd 30 or 130 (Figure 27A and C; t21 = 1.012; p = 0.323 and 
t30 = 0.77; p = 0.447 respectively). Exploration time during P1 was significantly reduced in SR 
compared to vehicle treated animals on pd 30 (Table 9; t21 = 5.736; p < 0.001). No differences in 
exploration time during P1 were observed for any other time point (t31 = 0.609; p = 0.547 on pd 40 
and t30 = 0.771; p = 0.446 on pd 130). One animal had to be excluded from OBJR analysis due to 
low object exploration time (< 1 sec) of one of the objects in P1. 
RM ANOVA revealed no difference between treatment groups for PPI (Figure 27D-F; pd 30: 
F 1,22 = 2.083; p = 0.163; pd 40: F 1,31 = 0.003; p = 0.954 and pd 130: F 1,30 = 2.045; p = 0.163). 
However, in line with the previous results (see 3.2.4), a gradual development of the PPI from 
pd 30 through pd 40 to pd 130 was observed. No difference in ASR amplitude between treatment 
groups was found at any time point (Table 10; Student’s t-test: p ≥ 0.2). 
 
Table 9: Exploration time of P1 [sec] for pd 30, 40 and 130 old animals after vehicle or SR (0.3 mg/kg) treatment. 
Exploration time on pd 30 was significantly reduced in SR treated animals compared to vehicle. No differences were 
observed for any other time point. Data are expressed as means +S.E.M. (* p ≤ 0.05, pd 30: vehicle n = 12; SR 
n = 11; pd 40: vehicle n = 16; SR n  = 17; pd 130: vehicle n = 18; SR n = 14). 
 
Time P1 pd 30 pd 40 pd 130 
 Vehicle SR Vehicle SR Vehicle SR 
mean 37.92 21.55 * 35.69 33.41 32.33 28.79 
S.E.M. 1.67 2.36 2.71 2.58 3.52 2.58 
 
 
Table 10: ASR amplitude [arbitrary units] of pd 30, 40 and 130 old animals after vehicle or SR (0.3 mg/kg) 
treatment. No differences were observed between vehicle or SR treated animals for any time point. Data are 
expressed as mean + S.E.M. (pd 30: vehicle n = 12; SR n = 12; pd 40: vehicle n = 16; SR n = 17; pd 130: vehicle 
n = 18; SR n = 14). 
 
ASR pd 30 pd 40 pd 130 
 Vehicle SR Vehicle SR Vehicle SR 
mean 618.22 532.59 776.55 785.11 5572.78 4697.46 
S.E.M. 60.34 32.14 97.78 77.99 677.09 553.67 
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Figure 27: Percentage object discrimination of the OBJR test (A-C) and PPI (D-F) of pd 30 (A+D), pd 40 
(B+E), and pd 130 (C+F) old animals after vehicle (VEH) or SR (0.3 mg/kg) treatment. In pd 40 animals a 
significantly increased object discrimination was observed after SR treatment (B). No significant differences 
were found for various prepulses in the PPI (D-F). Data are expressed as mean + S.E.M. (* p ≤ 0.05, pd 30: n  
(VEH) = 12; n (SR) = 11; pd 40: n (VEH) = 16; n (SR) = 17; pd 130: n (VEH) = 18; n (SR) = 14). 
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3.2.6 Molecular Analysis 
Myelination 
Brain sections of different age points were stained with goldchloride to assess myelination across 
the development (for representative brain sections see Figure 28). Analysis of the CPu revealed 
significant differences of myelination at different ages (Figure 29A; F4,20 = 5.549 p = 0.004). Post-
hoc Fisher LSD test showed that on pd 30, pd 50, and pd 60 animals displayed significantly less 
myelination than on pd 130 (p ≤ 0.004). 
In the NAc, no differences of myelination at the different ages were found (Figure 29B; 
F4,20 = 1.784 p = 0.172).  
Analysis of the Hip revealed a trend for changes of myelination across different age points (Figure 
29C; F4,20 = 2,507 p = 0.075). Post-Hoc Fisher LSD test showed that, at all tested time points, 
animals displayed significantly less myelination than at pd 130 (p ≤ 0.031). 
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Figure 28: Representative brain sections of pd 130 (A-C) and pd 40 (D-F) stained for myelin. A,D: CPu, B,E: 
NAc, C,F: Hip. Pictures were taken with a 2.5x magnification. 
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Figure 29: Percentage myelination in CPu (A), NAc (B) and Hip (C) over the development from pd 30 – pd 130. 
In the CPu, myelination was significantly lower at pd 30, 50, and 60 compared to pd 130 (A). No difference in 
myelination was observed in the NAc (B).In the Hip, myelination was significantly lower at all time points 
compared to pd 130 (C). Data are expressed as mean + S.E.M. (p ≤ 0.05, n = 5 for each time point). 
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Cannabinoid Receptor 1 Staining 
Staining for the CB1R were done for pd 40 and pd 130 and brain sections are representatively 
shown in Figure 30. Student’s t-test showed no difference in CB1R density in the mPFC 
(t6 = 0.088; p = 0.932), CPu (t6 = -0.449; p = 0.669), and Hip (t6 = 1.27; p = 0.251) between pd 40 
and pd 130 old animals (Figure 31). For the analysis of CB1R staining two animals had to be 
excluded due to technical difficulties. 
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Figure 30: Representative brain sections of pd 130 (A-C) and pd 40 (D-F) stained for CB1R. A,D: mPFC, B,E: CPu, 
C,F: Hip. Pictures were taken with a 2.5x magnification. 
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Figure 31: Mean CB1R optical density (OD) per area size in pd 40 (n = 4) and pd 130 (n = 4) old animals. Data are 
expressed as mean + S.E.M.  
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Western Blot of the Cannabinoid Receptor 1 
Western blot analysis revealed a differential protein expression of CB1R in the analyzed brain 
regions (see Figure 32 for representative western bands of mPFC). In the mPFC CB1R expression 
was significantly different at distinct age points (Figure 33A; F3,22 = 3.386; p = 0.036) and post-
hoc analysis showed a significantly lower expression of CB1R of adolescent animals (on pd 30, 
pd 40, and pd 50) compared to adult rats at pd 130 (p ≤ 0.033.) In the CPu no significantly 
different expression was detected (Figure 33B; F3,22 = 2.171; p = 0.120) although, in the NAc a 
trend for a differential expression was observed (Figure 33C; F3,22 = 2.642; p = 0.075). Post-hoc 
testing revealed an increasingly higher expression of CB1R with further development which was 
significant at pd 40 (p = 0.026) and pd 130 (p = 0.019) compared to pd 30 (pd 50 vs pd 30: 
p = 0.163). Analysis of the Hip also showed a trend for a changing CB1R expression (Figure 33D; 
F3,22 = 2.407; p = 0.095) and post-hoc showed a higher CB1R expression in adolescent animals, 
significant at pd 30 (p = 0.05) and pd 40 (p = 0.047) compared to pd 130 (pd 50 vs pd 130: 
p = 0.681). 
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Figure 32: Representative western blot of mPFC 
samples of animals aged pd 30, 40, 50, and 130. 
First lane contains Odyssey Molecular Protein 
marker followed by mPFC samples of indicated 
ages. CB1R is visible in green and the internal 
standard ß-Actin in red. 
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Figure 33: Western blot analysis of CB1R (percentage of pd 130) in mPFC (A), CPu (B), NAc (C), and Hip (D) 
over the development from pd 30 until pd 130. CB1R in the mPFC was significantly lower at pd 30, pd 40, and 
pd 50 compared to pd 130 (A). In the CPu no differential expression of CB1R was found at any age point (B). In 
the NAc, CB1R was significantly lower at pd 30 compared to pd 130 and compared to pd 40 (C). In the Hip, 
CB1R was significantly higher at pd 30 and pd 40 compared to pd 130 (D). Data are expressed as mean + S.E.M. 
(* p < 0.05, n = 6 for each time point).  
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3.3 Project III: Long-Term Effects of Chronic Pubertal WIN 55, 212-2 
Treatment on Cognition 
3.3.1 Object Recognition 
A significant difference between vehicle and WIN (1.2 mg/kg) treated animals was found in the 
OBJR test. Student’s t-test revealed a significantly impaired object discrimination for WIN treated 
animals after 15 min (Figure 34A; t22 = 2.843 p = 0.0095). Additionally, the discrimination index 
was significantly lower in WIN treated animals (Figure 34B; t22 = 2.658 p = 0.014) although, the 
initial exploration did not differ between groups (t22 = 0.444 p = 0.661; P1 ± S.E.M: WIN = 44.83 
sec ± 3.03; vehicle = 46.5 sec ± 2.22). 
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Figure 34: Percentage object discrimination (A) and discrimination index (B) in the OBJR test of 
chronically WIN and VEH treated animals. Both object discrimination and discrimination index were 
significantly reduced in WIN treated animals compared to VEH treated ones. Data are expressed as mean + 
S.E.M. (* p < 0.05, n = 12). 
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3.3.2 Prepulse Inhibition and Acoustic Startle Reflex 
No difference was observed for mean PPI values between vehicle and WIN treated animals 
(Figure 35A; t22 = -0.196 p = 0.846). Neither did ASR differ between the two groups (Figure 35B; 
t22 = -0.481 p = 0.635).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Casein Pellet Intake 
CP intake did not differ significantly between vehicle and WIN treated animals (Figure 36; 
t22 = -0,454 p = 0.655). 
 
 
 
 
 
 
 
 
Figure 36: CP intake of chronically WIN and VEH treated animals. No 
difference was observed between treatment groups. Data are expressed as 
mean + S.E.M. (n = 12). 
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Figure 35: Mean PPI (A) and ASR (B) of chronically WIN and VEH treated animals. No difference was observed 
between treatment groups. Data are expressed as mean + S.E.M. (n = 12). 
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3.3.4 Attentional Set Shifting 
All animals learned to perform a series of six consecutively correct trials at each stage of the set 
shifting paradigm (Figure 37). Over the course of the whole training, animals needed gradually 
less trials to reach the learning criterion for Pre, SD and CD as well as for IDS. To successfully 
complete the EDS, all rats needed more trials to criterion. MANOVA analysis revealed a 
significant treatment difference between vehicle and WIN treated animals over the whole course 
of set shifting training (Wilk’s λ = 0.008 F8,15 = 238.073 p = 0.000). Further analysis by multiple 
ANOVAs indicated a significant difference between vehicle and WIN treated animals for CDrev 
(F1,23 = 6.993 p = 0.015) with WIN animals needing more trials to criterion (14.33 ± 1.3) than 
vehicle animals (10.42 ± 0.6) to complete the CDrev. No statistical differences between vehicle 
and WIN rats were found in the learning performance at the other stages (p ≥ 0.155). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.5 Western Blot of Cannabinoid Receptor 1, Fatty Acid Amino Hydrolase, and 
Monoacylglycerol Lipase 
CB1R protein content was significantly elevated in the mPFC of WIN treated animals compared 
to vehicle treated controls (Figure 38; t13 = -3.343; p = 0.005). No differences were observed in 
the CPu or Hip (t22 = 0.424; p = 0.676 and t20 = -0.389; p = 0.702 respectively) for the percentage 
protein content.  
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Figure 37: Behavioral performance in the ASST of chronically WIN and VEH treated animals. WIN treated 
animals needed significantly more trials to reach criterion in the CDrev stage of the test compared to VEH 
treated ones. Pre: pretraining; SD: simple discrimination, CD: compound discrimination, rev: reversal, rep: 
repetition, IDS: intradimensional shift, EDS: extradimensional shift. Data are expressed as mean + S.E.M. (* 
p < 0.05, n = 12). 
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Neither were there any differences between WIN and vehicle treated rats for the percentage 
protein content of FAAH or MAGL in the mPFC, CPu and Hip (see Table 11). For the western 
blot analysis, several samples had to be excluded due to too low protein contents (see Figure 38 
and Table 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
50
100
150
CPu
Hip
*
A
B
C
mPFC
50
37
kDA
Marker  WIN   VEH
50
37
kDA
Marker   VEH  WIN
kDA
50
37
Marker  VEH WIN
pe
rc
en
ta
ge
 
[%
]
pe
rc
en
ta
ge
 
[%
]
VEH
WIN
0
50
100
150
pe
rc
en
ta
ge
 
[%
]
0
50
100
150
pe
rc
en
ta
ge
 
[%
]
pe
rc
en
ta
ge
 
[%
]
pe
rc
en
ta
ge
 
[%
]
Figure 38: CB1R protein expression (percentage of VEH treatment group) in mPFC (A), CPu (B), 
and Hip (C) for WIN and VEH treated animals. Left column shows representative western bands for 
the respective indicated brain regions. CB1R is visible in green and the internal standard ß-Actin in 
red. A significantly higher percentage CB1R protein content was found in the mPFC of WIN treated 
animals compared to VEH treated ones (A). No differences were observed in the CPu (B) or Hip (C). 
Data are expressed as mean + S.E.M. (* p < 0.05, mPFC: n (VEH) = 8, n (WIN) = 7, CPu: 
n (VEH) = 12 n (WIN) = 12, Hip: n (VEH) = 11, n (WIN) = 11). 
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Table 11: Western blot analysis of mPFC, CPu, and Hip samples for FAAH, and MAGL of vehicle or WIN treated 
animals. No significant differences in protein expression of FAAH and MAGL were observed in mPFC, CPu and 
Hip. Data are expressed as mean ± S.E.M. FAAH: mPFC: n (VEH) = 12, n (WIN) = 11, CPu: n (VEH) = 12, n (WIN) 
= 12, Hip: n (VEH) = 11, n (WIN) = 10. MAGL: mPFC: n (VEH)=12, n (WIN) = 11, CPu: n (VEH) = 12, n (WIN) = 
12, Hip: n (VEH) = 11, n (WIN) = 11. 
 
 mPFC CPu Hip 
 Vehicle WIN Vehicle WIN Vehicle WIN 
FAAH 
      
% 100 ± 
12.02 
116 ± 
18.58 
100 ± 
13.32 
127 ± 
10.45 
100 ± 5.96 108.95 ± 
8.02 
MAGL 
      
% 100 ± 
16.25 
123 ± 
39.29 
100 ± 
12.26 
124 ± 
11.65 
100 ± 6.17 102 ± 9.47 
 
3.4 Project IV: Long-Term Effects of Chronic Pubertal Methylphenidate 
Treatment on Cognition 
3.4.1 Open Field  
The open field test did not show any differences in locomotion between the groups (t18 = -0.185; 
p = 0.856). Mean values of total distance traveled: saline treated animals: 4340.27 cm ± 556.64; 
MPH (2.0 mg/kg) treated animals: 4480.79 cm ± 426.75. Due to technical difficulties 4 animals 
were excluded from the analysis (n = 3 of the saline group and n = 1 of the MPH treated group). 
3.4.2 Anxiety-Related Behavior 
In the EMT no differences between saline injected control and MPH treated animals were found 
for latency, rearing, time spent in the lit compartment, emergence frequency, or risk assessment 
(Table 12; p ≥ 0.4). Similarly, no differences were observed in the EPM for percentage open arm 
time, head dips, risk assessments, self grooming, self grooming time, and closed arm entries 
(Table 13; p ≥ 0.1). Only a trend for a higher number of open arm entries by MPH treated animals 
was observed (total open arm entries: t22 = -1.787; p = 0.088; percentage open arm entries: 
t22 = -1.85; p = 0.078). 
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Table 12: Performance of saline and MPH treated animals in the EMT. Latency [sec], number of rearings, time spent 
in the lit compartment [sec], emergence frequency, and number of risk assessments did not differ between groups. 
Data are expressed as mean ± S.E.M. (Saline n = 12, MPH n = 12). 
 
EMT Saline MPH 
Latency 223.25 ± 22.61 208.08 ± 32.09 
Rearing 2.5 ± 1.12 1.83 ±0.97 
Time spent in lit compartment 21.92 ± 8.03 18.75 ± 9.62 
Emergence frequency 1.75 ± 0.52 1.25 ± 0.48 
Risk assessment 4.08 ± 0.86 4.5 ± 0.69 
 
Table 13: Performance of saline and MPH treated animals in the EPM. Percentage open arm time, number of head 
dips, risk assessments, self grooming, self grooming time [sec], and open arm entries did not differ between groups. A 
trend for a higher number of open arm entries and a higher percentage of open arm entries was observed for MPH 
treated animals indicated by #. Data are expressed as mean ± S.E.M. (# p ≤ 0.1, saline n = 12, MPH n = 12). 
 
EPM Saline MPH 
percentage open arm time 5.14 ± 2.00 8.96 ± 3.13 
head dips 3.33 ± 0.70 5.25 ± 1.26 
risk assessments 7.83 ±0.77 8.92 ± 0.69 
self grooming 0.75 ± 0.22 0.92 ± 0.19 
self grooming time 6.33 ± 2.1 8.41 ± 1.9 
closed arm entries 6.67 ± 0.82 7.33 ± 0.7 
open arm entries 0.92 ± 0.31 2.17 ± 0.63 # 
percentage open arm entries 10.85 ± 3.56 21.17 ± 4.29 # 
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3.4.3 Intake of Liquids of Variable Palatability  
No difference in SCM intake between the saline and the MPH treated group was found (Figure 
39A; t22= -0.407; p = 0.688). Similarly, the preference for both 6% and 10% EtOH intake did not 
differ in a 24 h free choice intake paradigm (Figure 39B and C; t22 = 0.272; p = 0.788 and 
t22 = 0.288; p = 0.776 respectively).  
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Figure 39: SCM intake (A) in a 15 min intake paradigm, preference for a 6% (B) and 10% (C) EtOH solution of 
Saline (Sal) and MPH treated animals  in a 24 h free choice intake paradigm. No difference was observed between 
groups. Data are expressed as mean + S.E.M. (Sal n = 12, MPH n = 12). 
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3.4.4 Cognitive Tests 
There was no difference between the saline and the MPH treated group in mean PPI (Figure 40A; 
t22 = -0.653; p = 0.52) and ASR (Figure 40B; t22 = 1.55; p = 0.878).  
 
 
 
 
 
 
 
 
 
 
 
The percentage of OBJR and discrimination index did also not differ between groups (Figure 41; 
t22 = 0.578; p = 0.569 and t22 = 0.482; p = 0.635 respectively). In addition, total exploration times 
during P1 in the OBJR test did not differ between groups (t22 = -0.135; p = 0.894). 
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Figure 40: Mean PPI (A) and ASR amplitude [arbitrary units] (B) performance of saline (Sal) and MPH treated 
animals. No difference was observed between groups. Data are expressed as mean + S.E.M. (Sal n = 12, MPH 
n = 12). 
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Figure 41: Percentage discrimination (A) and discrimination index (B) of saline (Sal) and MPH treated 
animals in the OBJR test. No difference was observed between groups. Data are expressed as mean + S.E.M. 
(Sal n = 12, MPH n = 12). 
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Likewise, the percentage of SOCR did not differ between groups (Figure 42; t22 = 0.215; 
p = 0.832). And additionally, total exploration time during P1 in the SOCR test did not differ 
between groups (t22 = 0.489; p = 0.629).  
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Figure 42: Percentage discrimination of saline (Sal) and MPH 
treated animals in the SOCR test. No difference was observed 
between groups. Data are expressed as mean + S.E.M. (Sal 
n = 12, MPH n = 12). 
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4. Discussion 
4.1 Project I: Differences of Cognitive Abilities in Three Wistar Han Rat 
Lines 
This project revealed behavioral differences between the three Wistar rat lines W[hsd], W[rcc] 
and W[Jan]. W[Jan] animals were obtained from a different supplier (Janvier) than W[hsd] and 
W[rcc] ones (both obtained from Harlan Laboratories). Behavioral variations were observed in 
locomotor activity during an open field test, in cognitive processing during an OBJR test, and 
during PPI of the ASR (the two latter paradigms representing tests for STM and sensorimotor 
gating abilities, respectively). 
Altogether, the results of the present project add to the increasing picture of line and supplier 
variations observed in the field of behavioral research in rodents. The main goal of this project 
was to evaluate possible behavioral differences in three Wistar rat lines, particularly in cognitive 
tests. The Wistar rat strain is commonly employed in scientific, particularly in behavioral research 
(Clause, 1993, Palm et al., 2011b). For many researchers who have been using the W[hsd] line, 
the intended substitution of W[hsd] line by W[rcc] animals by Harlan Laboratories poses an 
unknown variable to their experimental practice.  
In the open field test W[Jan] rats displayed a higher locomotor activity compared to W[rcc] rats. 
In addition to measuring locomotor activity, the open field arena is also used to measure anxiety-
like behavior under aversive conditions e.g. when brightly lit. For example, one study found 
differences in female Wistar rats of different suppliers in an open field arena and in an EPM test 
(Honndorf et al., 2011). They observed higher locomotor acitivity of Wistar rats from Janvier 
compared to those from Charles River which appear to be in line with the presently observed 
higher locomotor activity of the W[Jan] rats. 
The object recognition test is often employed to analyze cognition and short-term memory 
because it can be easily performed and is based on the natural tendency of rodents to prefer novel 
objects over familiar ones (Ennaceur and Delacour, 1988). W[rcc] rats showed the best 
performance in the OBJR test, significantly better than W[Jan] animals. This result indicates a 
better STM processing in the W[rcc] rat line. W[hsd] animals displayed an intermediate object 
discrimination performance but the highest exploration time during P1, significantly higher than 
W[rcc] and W[Jan], who displayed similar exploration times. Therefore, exploration times do not 
appear to be linked to object discrimination performance.  
Strain differences in object recognition memory have been investigated before (for review see 
Andrews, 1996). However, a comparison of Long-Evans, Wistar, and Sprague-Dawley rats from 
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Harlan, Netherlands, revealed a sufficient discrimination of the new vs. familiar object in an 
object discrimination task only in Long-Evans rats (Andrews et al., 1995). In contrast, several 
studies have found that Wistar rats can be tested successfully in this paradigm (Schneider and 
Koch, 2002, Kosiorek et al., 2003, Ennaceur et al., 2005, Schneider et al., 2008, de Bruin et al., 
2011). Furthermore, one study compared both male and female, Wistar and Hooded Lister rats, 
that were all obtained from Charles River, Kent, UK (Ennaceur et al., 2005). In this study, all 
animals displayed a sufficient discrimination of novel vs. familiar objects except for female 
Wistar rats. One possible explanation could be the confounding effect of a higher neophobia 
towards novel objects in female rats (Ennaceur et al., 2005). In the present project, W[rcc] rats 
were able to discriminate a novel object from a familiar one presented 15 min earlier. However, 
the performance of W[Jan] animals reached only chance level and these animals therefore, appear 
to have difficulties performing this task.  
The reduction of the ASR by a preceding prepulse, termed PPI, is generally considered an 
operational measure of sensorimotor gating (Hoffman and Ison, 1980, Koch, 1999). Several 
studies have investigated strain and supplier differences in ASR and PPI before (Rigdon, 1990, 
Varty and Higgins, 1994, Swerdlow et al., 2000). For example, in one study differences between 
Wistar rats and Sprague Dawley derived CD rats under the influence of the dopamine agonist 
apomorphine were detected (Rigdon, 1990). Apomorphine injection led to a blockade of PPI 
without affecting the startle amplitude in Wistar rats. In contrast, apomorphine caused an increase 
in the startle amplitude without affecting PPI in CD rats. Another study examined differences 
between Wistar and Spargue Dawley rats of the two different suppliers: Harlan laboratories, USA 
and Bantin-Kingman (UK) (Swerdlow et al., 2000). Supplier differences in the sensitivity to the 
disruptive effects of dopamine agonists were observed in this study. Specifically Harlan derived 
Sprague Dawley rats displayed greater sensitivity towards PPI disruptive effects of apomorphin 
compared to Bantin-Kingman derived Sprague-Dawley rats. One more study analyzed the effect 
of different prepulse parameters on Wistar, Lister Hooded, and Sprague-Dawley rats (Varty and 
Higgins, 1994). A lower sensitivity of Wistar rats compared to Lister Hooded and Sprague-
Dawleys for various prepulse durations and intensities was observed. In the present project, 
differences in startle amplitude and PPI between the three Wistar lines tested were detected. 
W[hsd] and W[rcc] animals were indeed found to differ in their behavioral performance for 
startle-reactivity. Although the Wistar line obtained from a different supplier (Janvier, W[Jan]) 
was found to show similarities in startle reactivity with the W[hsd] line, a distinct difference was 
observed for sensorimotor gating, indicating that this Wistar line constitutes no adequate 
alternative, either.  
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In general, behavioral differences in Wistar rats, all originating from the original colony at the 
Wistar Institute at the beginning of the last century, were analyzed in the context of this project. 
Since this time, many generations of rats have been bred as offspring from the founder colony. 
Considering how quickly behaviors can change when selectively bred for, the observations 
detected here, along with the observations of many other researchers, are not unexpected. When 
selecting an appropriate rat line for a particular hypothesis and testing paradigm, researchers 
should be aware of possible differences in the animal’s behavior and further evaluations of line 
and supplier differences will help to make studies more comparable. The present results therefore 
emphasize the high behavioral diversity even among Wistar rat lines. Due to the best performance 
of W[rcc] animals in the OBJR test and their intermediate performance in PPI, this line was 
selected for all following projects.  
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4.2 Project II: Ontogeny of Cognitive Abilities 
In this project, the longitudinal development of cognitive abilities was measured behaviorally in 
Wistar rats from adolescence to adulthood and additionally, molecular analysis investigated the 
development of myelination and CB1R levels and distribution throughout this age period.  
The main finding was that developmental trajectories for the behavioral tests applied differed 
greatly throughout adolescence. For OBJR a non-linear course in performance was observed that 
appeared to vary with onset of puberty whereas the PPI of the ASR displayed a gradual increase 
until early adulthood. Performance in the OBJRecency test showed a later onset than in the OBJR 
test but displayed less variation throughout development. Findings from a pharmacological 
treatment with a low dose of the CB1R antagonist/inverse agonist SR implicated the involvement 
of the ECS in OBJR performance specifically on pd 40. CB1R protein level measurements 
displayed a brain region-dependent variation including increases in development (in the mPFC 
and the NAc) and decreases (in the Hip). The development of myelination also displayed a 
gradual increase with increasing age and variations within these regions. 
 
Influence of Intertrial Interval Length on Object Recognition Performance 
In a preliminary study the possible influence of varying ITI lengths on OBJR performance 
revealed that adolescent animals displayed better recognition memory at shorter ITIs. Animals 
tested on pd 45 showed a higher percentage object discrimination and a higher discrimination 
index after an ITI of 10 min compared to an ITI of 20 min. Adult animals (> pd 100) did not show 
differences for both measurements after either ITI length.  
It has been shown before that the length of the ITI during an OBJR test can influence performance 
of the test animal (e.g. Baker and Kim, 2002, Winters and Bussey, 2005, Bertaina-Anglade et al., 
2006). For example, one study in rats and mice showed that the ability to discriminate the novel 
from the familiar object decreases when the ITI is extended (Bertaina-Anglade et al., 2006). They 
observed successful novel object discrimination for short ITIs (10 min, 1, 2, and 3h) but not after 
long ITIs (4 and 24h after the first exposure to two objects) in rats, and in mice successful 
discrimination was found after short ITIs (10 min and 1h) but not after longer ITIs (2, 3, and 6h). 
However, the impact of ITI length during development has gained less attention. In one study the 
length of ITI was investigated during the ontogeny of Sprague Dawley rats (Reger et al., 2009). 
Weanling rats (pd 20 – 23) could recognize a previously encountered object after 15 min and 1h, 
however, after 24h, only older animals (pd 29 – 40 and > pd 50) were able to display a preference 
for a novel object. Although this study employed age points and ITIs varying from the present 
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project, similarly to the present results, younger animals had difficulties discriminating objects 
encountered before when the ITI was longer.  
Many protocols and testing procedures exist for the OBJR test and it is important to reduce the 
risk of possible confounding factors a priori, like object affordances (see Ennaceur, 2010), strain 
differences, and the length of the ITI. The present data show that pd 45 old male Wistar rats can 
discriminate the novel object after 20 min, however, performance is even better if the ITI is 
shorter. In adult animals, ITIs of 10 and 20 min yielded similar percentage discrimination 
performance and discrimination indices. Therefore, an ITI of 15 min was chosen for the 
subsequent testing paradigm. 
 
Locomotor Behavior during Development 
The development of locomotor behavior in an open field arena during repeated testing every ten 
days revealed a higher distance traveled of animals during late adolescence and early adulthood 
(from pd 59 – 99) compared to when the same animals were tested on pd 129. Repeated testing in 
a separate group of animals in adulthood showed no variation in locomotor activity. 
Altered locomotor activity at various age points has been observed before in mice and rats (Spear 
et al., 1980, Darmani et al., 1996, Ricceri et al., 2000, Erickson et al., 2014). In some studies an 
increased activity was observed earlier during development than in the present results, i.e. in early 
adolescence. For example, one study showed increased locomotor activity during a 20 min open 
field test in mice (Darmani et al., 1996). Locomotor activity increased gradually from pd 7 (over 
pd 14, 18, 22, and 28) to pd 35, and afterwards decreased as measured on pd 42, 63, 120, and 180. 
However, this study investigated mice (vs. rats as observed here) immediately after an injection 
procedure, which may have had a stressful effect. In another study, locomotor activity of Sprague 
Dawley rats during a 10 min measurement in a hole poke open field displayed higher numbers of 
matrix crossings in animals tested on pd 35 and 36 compared to earlier (pd 23 and 24) and later 
(pd 47 and 48) ages (Spear et al., 1980). In contrast to an observed higher activity in early 
adolescence, an increased distance traveled was observed in a recent study in early adult animals 
(at 3 months of age) compared to younger and older ones tested (Erickson et al., 2014), 
comparable to the results of the present thesis. In this study the locomotor behavior of Long Evans 
rats has been investigated on several time points in late adolescence and adulthood (Erickson et 
al., 2014) where animals were tested repeatedly with 1.5, 3, 7, and 13 months of age 
(corresponding to approx. pd 50, 84 – 90, 196 – 210, and pd 364 – 390). Animals were tested for 
10 min in an open field arena and the results resemble the ones observed in this project during the 
15 min open field test. Unfortunately no earlier time points than pd 50 were analyzed in the study 
by Erickson et al. (2014). Similarly to the present results, higher locomotor activity in an open 
4. Discussion 
 82 
field test in mice was also observed on pd 90 compared to earlier test points on pd 18, 28 and 46 
(Ricceri et al., 2000). 
The increased locomotor activity during late adolescence displayed in the present experiment may 
be due to an increased exploratory drive during this age period. It has been observed before that 
adolescent rodents display higher exploration of novel environments and increased novelty 
seeking (Spear, 2000, Laviola et al., 2003). This probably reflects an age-related migration of 
young animals in order to find new living environments and avoid inbreeding (Spear, 2000). 
Although the animals in the present project had been placed in the open field every ten days 
starting on pd 29, this increased locomotor acitivity was only observed starting from pd 59 
indicating a developmental alteration. Furthermore, the test-free time period of seven days 
between experiments (from the last OBJRecency test to the next open field exposure) appears to 
be sufficient to avoid a habituation effect to the open field environment (usually resulting in 
decreased locomotor activity; see Ricceri et al., 2000, Heyser and Ferris, 2013). It rather appears 
like the open field may be perceived as a novel environment again by the test animals when tested 
every ten days. However, repeated testing in a separate group of adult animals did not display 
alterations in locomotor activity, further indicating that the increase in adolescent animals appears 
to be a developmental effect. 
Additionally, a longer test-free period may explain the finding of a still increased locomotor 
activity on pd 99 which is already considered early adulthood. Animals tested on pd 99 were not 
placed in the open field arena for 18 days giving them a longer test-free period, thus possibly 
eliciting a higher novelty exploration response again than the younger animals with only seven 
days of test-free period.  
Altogether, altered adolescent behavior in rats includes locomotor activity and in the present part 
of the project this behavior was found to be increased during late adolescence and early 
adulthood. 
 
Basal Development of Object Recognition and Object Recency 
 
Object Recognition Test 
Here, the ability of animals to discriminate a novel from a familiar object displayed a 
developmental variation from adolescence to adulthood. In the OBJR test animals already showed 
percentage object discrimination levels on pd 30 that were similar to levels of adult animals (on 
pd 130) after a 15 min ITI. However, the performance was significantly lower on pd 40 and 
tended to be lower on pd 50 compared to the same animals tested as adults on pd 130. After pd 50, 
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performance levels increased again until displaying stable levels in adulthood. Furthermore, the 
discrimination index revealed a trend for a lower level on pd 40 compared to adult animals.  
The reduced level of object discrimination on pd 40 observed in this project did not depend on the 
repeated testing employed, since adult control animals tested repeatedly in the same paradigm did 
not show any variation of percentage object discrimination or discrimination index.  
Additionally, the exploration time during P1 of adult animals tested repeatedly did not differ 
whereas the animals tested throughout development displayed a higher object exploration time on 
every test point from pd 30 – 80 compared to pd 130. This observation implies that the decrease in 
object discrimination on pd 40 is not due to a decreased exploration of the objects at this test 
point. The adolescent animals rather seem to explore the objects more intensively than in 
adulthood. This would reflect an increased novelty seeking behavior which is commonly observed 
during adolescence (Adriani et al., 1998, Laviola et al., 2003) and is partially similar to 
observations in several studies investigating the ontogeny of object recognition in rodents (Reger 
et al., 2009, Cyrenne and Brown, 2011, Heyser and Ferris, 2013). Although in one study a higher 
object exploration time was observed in rats on pd 90 compared to pd 42 (hence later than found 
in this project), the animals still displayed a higher object exploration time on pd 42 than animals 
on pd 35 and pd 21 (Heyser and Ferris, 2013). Another study found that mice displayed the 
highest object exploration on pd 46 compared to earlier (pd 18 and pd 28) or later age points (pd 
90; Ricceri et al., 2000), similarly to the present findings.  
Alternatively, an increased object exploration of adolescent animals may also be necessary in 
order to sufficiently encode the objects. For example, Reger et al. (2009) hypothesized that 
younger rats required “more time for exploration to acquire comparable levels of object 
interaction and memory performance”. However, the animals are not instructed to remember the 
presented objects actively and do not know that they will be tested again for exploration of a 
novel and a familiar object in a subsequent session. Therefore, the increased time exploring novel 
surroundings appears to be an unconscious process and is more likely driven by the higher 
novelty-seeking behavior during adolescence. 
Although it has been debated if this test is suitable for rodents at very young ages (Ricceri et al., 
2000, Anderson et al., 2004), refinement of some test conditions (e.g. ITI) produced reliable 
performance levels of animals as early as pd 20 – 23 (Reger et al., 2009, Heyser and Ferris, 2013). 
It is important to choose testing conditions carefully (e.g. illumination, ITI), and thereby reduce 
possible confounding factors to avoid low discrimination performance of animals due to non-
mnemonic related issues (e.g anxiety or arousal). In the present study animals were already able to 
discriminate a novel from a familiar object on pd 30, suggesting that the testing conditions were 
suitable to measure recognition memory in animals at this age. Interestingly, after displaying the 
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ability to discriminate a novel from a familiar object on pd 30, the performance on pd 40, 
approximately the beginning of puberty in male rats (Korenbrot et al., 1977, Schneider, 2013), 
was decreased compared to adult performance levels. Only few studies have investigated the 
ontogeny of object discrimination in rodents, so far yielding contradicting results (Ricceri et al., 
2000, Anderson et al., 2004, Reger et al., 2009, Cyrenne and Brown, 2011, Heyser and Ferris, 
2013). One study found an increased preference for a novel object in male Lister Hooded rats on 
pd 40 compared to earlier (pd 28) and later ages (pd 80) (Cyrenne and Brown, 2011), whereas 
other studies found a similar performance across adolescence (e.g. in Sprague Dawley rats on 
pd 21, 35, 42, and 90; (Heyser and Ferris, 2013) and on pd 20 – 23, 29 – 40, and > pd 50; (Reger 
et al., 2009), as well as in CD-1 mice on pd 28, 46, and 90; (Ricceri et al., 2000)).  
Most of these studies focused on various additional factors, thus almost all of them used different 
groups of animals for every age point (e.g. Ricceri et al., 2000, Cyrenne and Brown, 2011, Heyser 
and Ferris, 2013) or used only some of the test subjects repeatedly (Reger et al., 2009). For 
instance, Reger et al. (2009) additionally investigated the influence of ITI length on different ages 
of Sprague Dawley rats (as mentioned above). Moreover, the test points employed comprised 
animals of broad age ranges (e.g. pd 29 – 40) and early adult animals that might still be 
considered adolescent on pd 50. In contrast to this, testing of the same subject repeatedly (as in 
the present project) has the advantage to minimize possible differences between separate cohorts 
of animals (see Palm et al.).  
One study testing mice repeatedly in an OBJR test found strain dependent differences across 
development when testing animals on the following test points: 4, 6, 8, and 10 – 12 weeks of age 
(corresponding to approx. pd 28, 42, 56, and 70 - 84; Molenhuis et al., 2014). In a comprehensive 
characterization of four mouse strains they found that the reference strain of C57 mice displayed 
object recognition memory from 6 weeks of age whereas two other strains (129Sv and BTBR) 
showed a delayed onset of discrimination capacity only from 8 weeks of age. Puberty onset in 
mice starts earlier than in rats and complete BPS has been observed around pd 26 and pd 30 but 
appears to be strain-dependent (Schneider, 2013). Furthermore, another strain, AJ mice, did not 
display reliable object recognition memory at any of the tested age points (Molenhuis et al., 
2014). However, in addition to species differences (mice vs. rats), the OBJR test was conducted 
differently than in the present project. The test was part of an extensive screen involving the 
placement of the animals from one arena to a novel one in which they encountered two objects, 
one of which had been presented for at least 48h before in their home cage for habituation. It is 
therefore difficult to compare the results with the ones in the present part of this project but the 
study indicates that there is a development of OBJR memory abilities and earlier age points may 
differ from later ones.  
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In their ontogenetic study, Cyrenne and Brown (2011) additionally focused on possible sex 
differences in Lister Hooded rats. Interestingly, an increased preference for the novel object over a 
familiar one on pd 40 was only observed in male rats (compared to successful but lower 
preference on pd 28 and pd 80). This appears to be in contrast with the present results, however, 
in their study the authors employed shorter ITIs (2 min) and longer presentation intervals (5 min) 
in which the animals were allowed to explore the objects (Cyrenne and Brown, 2011). 
Furthermore, a different rat strain was observed (Lister Hooded vs. Wistar rats). Females, in 
contrast, displayed no novel object preference on pd 40, but did so when tested earlier (on pd 28) 
and later (on pd 80). The authors interpreted their results by means of sex differences in the 
context of sexual selection pressure, which would favor riskier strategies in males than in females. 
However, it has been observed that in various species, puberty in females starts before and sexual 
maturity is reached earlier than in males (Spear, 2000). It is therefore very important to keep the 
possibly resulting gender differences in mind. Males would have to have been tested a few days 
later than females in order to directly compare the developmental status. Additionally, only three 
time points during development were investigated in the study by Cyrenne and Brown (2011) and 
these were spaced further apart than the ones investigated in the present project. Thus, several 
differences between this study and the present project make direct comparison difficult and a 
possible non-linear performance in the OBJR memory of Lister Hooded rats may have been 
missed. 
In human studies a non-linear development of cognitive abilities has been observed for various 
measurements (e.g. Carey et al., 1980, Anderson et al., 2001, Waber et al., 2007). It is believed 
that periodic functional reorganization processes lead to spurts and plateaus in cognitive 
development which is probably also subject to individual development (Elman, 2005, Waber et 
al., 2012). The organizational abilities of children between 7 and 13 years of age showed a 
regression in organizational strategies used for recalling and drawing a complex figure in 12 – 13 
year-olds (Anderson et al., 2001). Younger children (11 years of age) displayed better 
organizational abilities, employing conceptual strategies to a greater extend than older children 
(12 – 13 year-olds), who used fragmented or piecemeal approaches more often. Unfortunately, no 
older subjects were investigated in this study and both male and female children were pooled in 
each age group. In another study, face recognition abilities were investigated in children and 
adolescents from 6 – 16 years of age (Carey et al., 1980). Interestingly, a marked improvement 
was observed until 10 years of age followed by a period of decline or no improvement in 
performance until further improvements were observed from 14 – 16 years of age. Although both 
boys and girls were analyzed in this study no effects for sex of the subjects were found. This 
remarkable developmental pattern resembles the observations in the present project, where 
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animals were first able to discriminate a novel object from a familiar one at young age, but then 
this ability temporarily decreased and picked up again at older ages.  
Interestingly, the decreased performance on pd 40 was found at a time when numerous 
developmental alterations take place, inter alia in neurotransmitter systems. Both the ECS and the 
DA system display highest receptor densities at this age and both transmitter systems are involved 
in cognitive processes (Rodriguez de Fonseca et al., 1993, Andersen et al., 2000, Myhrer, 2003, 
Wotjak, 2005). A possible explanation may be that alterations in these neurotransmitter systems 
could impair successful performance in the OBJR test at this particular age point. Application of 
ECS agonists are known to impair OBJR memory (Schneider and Koch, 2003, O'Shea et al., 
2004) thus, an enhanced eCB tone during adolescence may decrease performance in this test. 
Hence, adolescent animals would hypothetically display a higher eCB tone or a higher ECS 
activity compared to adult animals. Similarly, acute administration of a D1 agonist impaired 
recognition memory after 15 min (Hotte et al., 2005). Moreover, these neurotransmitter systems 
have been shown to interact indirectly (reviewed in van der Stelt and Di Marzo, 2003, Fernandez-
Ruiz et al., 2010) and therefore a combination of ongoing alterations in both may underlie the 
present findings. In the mesocorticolimbic pathway, for example, medium spiny neurons from the 
NAc exert a tonic inhibition on DA releasing cells in the VTA (van der Stelt and Di Marzo, 2003). 
These medium spiny neurons in the NAc are in turn controlled by glutamatergic afferents from 
the PFC that also contain CB1Rs. Upon activation of these CB1Rs the excitatory transmission is 
reduced (Robbe et al., 2001, Pistis et al., 2002, Robbe et al., 2002) and the medium spiny neurons 
exert less inhibition on the DA releasing VTA neurons. Thus, an overall increased DA release 
from the VTA to the PFC and the NAc is the result of the CB1R activation. This process may be 
enhanced during adolescence when increasing levels of CB1R and DA receptors are expressed. 
Taken into account that both cannabinoid agonist application and D1 agonist administration were 
shown to impair OBJR performance, increased receptor densities at this age may imply increased 
activity in one or both of these neurotransmitter systems and thereby underlie the reduced 
decrease in OBJR performance. 
Taken together, the longitudinal development of object recognition over the adolescent period 
displayed first of all the ability of pd 30 old animals to discriminate a novel from a familiar object 
after a 15 min ITI. This is followed by a decrease in performance on the approximate onset of 
puberty on pd 40 and a subsequent improvement until performance levels of adult ages (on 
pd 130). Thus, this particular aspect of cognition, namely the ability to recognize a novel object 
presented shortly before, demonstrates a non-linear development over the course of the rats’ 
adolescence. 
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Object Recency Test 
In the OBJRecency test, the percentage recency discrimination during development revealed a 
lower level on pd 31 compared to adulthood tested on pd 131. Thereafter, performance did not 
differ significantly from adult levels and displayed similar values over the complete 
developmental period. Additionally, no variation was observed upon repeated testing in adult 
animals. An increased object exploration during P1 was observed from pd 41 – 71 in the 
adolescent group of animals but not in the adult control group after repeated testing. 
In contrast to the OBJR test with a 15 min ITI, the OBJRecency test consisted of 3 sessions 
separated by two 45 min ITIs, yielding a total test duration of over 90 min for each animal. This 
rather long time span puts a high temporal load on the mnemonic capacities of the animals and the 
prolonged time interval between test sessions may be too long for pd 30 old animals to remember 
at P3 having explored the objects from P2 more recently than those from P1. As mentioned 
before, younger animals can have difficulties in OBJR tests with longer time intervals (Reger et 
al., 2009) and in turn younger animals perform better when the ITI length is shorter as was 
observed in the preliminary study of this project.  
The prior experience of the animals to the previously encountered open field and OBJR test could 
have resulted in a habituation effect, thus decreasing the object exploration time. However, rather 
a contrary effect could be observed since the exploration time during P1 of the OBJRecency test 
appears generally higher than during P1 of the OBJR test. Although on pd 31 the exploration time 
was not significantly different from when the animals were tested in adulthood (pd 81, 101, and 
131), they still displayed a rather high exploration time. One possible explanation for a higher 
exploration in adolescence may be that younger animals need more time exploring a novel object 
for sufficient encoding and retrieval abilities (as mentioned for the OBJR test). Additionally, the 
previously conducted OBJR test may have elicited a general arousal state in the animals that 
resulted in an overall higher exploration activity during the OBJRececy test on the day following 
the OBJR test. Therefore, the previously conducted OBJR test may have influenced performance 
on the OBJRecency test.  
Apparently, no rodent studies have so far investigated the development of OBJRecency 
discrimination abilities. However, in a human study of associative episodic memory in children 
and adolescents, the developmental trajectory of temporal memory processes has recently been 
investigated (Guillery-Girard et al., 2013). In this test children were asked to encode a sequence of 
animals and were subsequently asked to match them with their corresponding placement. 
Interestingly, the authors observed a marked increase in performance from 9 – 10 years of age 
followed by a plateau afterwards (measured at 11 – 12, 14 – 15, and 20 – 23 years of age). This 
test setting relied on several factors and processes like recency, location, and sequential memory. 
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Furthermore, the children were instructed to encode, remember, and later actively retrieve the 
sequence of animals. Debriefing after the test revealed that many adolescents employed language 
to encode a script in order to remember which animal followed after which one. Of course, this 
test setting for humans varies tremendously from the present OBJRecency test, as rats were 
presented with a test situation without any instructions or the knowledge of a possible subsequent 
test situation. Moreover, the rats’ performance was deducted from their natural exploratory 
behavior; they did not (actively) have to recall the objects in the correct order. Additionally, in the 
rodent test one cannot be certain if the animal remembers a specific episode of having an object 
encountered before or if it has some sense of familiarity about it. Nevertheless, it is interesting 
that in both tests investigating temporal memory abilities first an increase at early ages before 
adolescence is found and this is then followed by no further variation until adulthood. 
In the study by Guillery-Girard et al. (2013), the increase of associative memory was related to a 
decrease in gray matter volume in a network of cerebral structures including the dorsolateral and 
ventrolateral parts of the PFC, temporal regions and the Hip. Therefore, the developmental 
alterations of these structures appear to be linked to the observed behavioral performance. 
However, these regions were described to “subserve episodic memory efficiency as a whole” 
(Guillery-Girard et al., 2013), thus also including additional aspects of episodic memory like 
spatial and factual information measured in their paradigm. Finer relationships between the 
temporal component and brain structures could not be detected in this study. Lesion studies 
implicated the mPFC and the perirhinal cortex in the ability of rodents to successfully perform an 
OBJRecency test (Mitchell and Laiacona, 1998, Hannesson et al., 2004, Barker et al., 2007). 
Therefore maturational processes in these brain regions may contribute to the observed behavioral 
findings. Particularly the PFC displays a prolonged development (Paus et al., 1999, Sowell et al., 
1999) and immaturities in this region on pd 31 may account for deficits in OBJRecency 
performance.  
Altogether, the abilities of adolescent rats to perform an OBJRecency test appear to develop later 
than recognition abilities for an OBJR test with shorter ITIs. However, during the adolescence and 
early adulthood the ability to discriminate a more recently encountered object from an earlier 
encountered one remains approximately stable when tested every ten days. Therefore, recognition 
memory focusing especially on temporal aspects, i.e. recency of encountered objects, does not 
display the same developmental trajectory as object recognition memory. A delayed onset of these 
abilities was shown here with no significant variation of performance until adulthood. 
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Basal Development of Prepulse Inhibition of the Acoustic Startle Reflex 
The longitudinal analysis of the development of PPI of the ASR and baseline ASR revealed a 
gradual increase for both measurements until adult ages. Both the percentage PPI and the startle 
amplitude of adolescent and young adult animals (from pd 30 – 80) were significantly lower than 
on pd 130, when the same animals were tested in adulthood. This difference was, however, not 
present anymore when the same animals were tested on pd 100 and pd 120, implicating that both 
the PPI and the ASR had already reached adult levels on these time points. Additionally, repeated 
testing in adulthood did not show any variation of PPI and ASR in a control group of adult 
animals (> pd 100), implicating that repeated testing every ten days does neither influence 
percentage PPI nor the startle amplitude per se.  
The acoustic startle response is a reflex and, although it can be modulated by pleasant or 
unpleasant stimuli and is subject to individual variability (Koch, 1999), the reaction to a loud 
startling noise is a reliable measurement often used in animal research. Additionally, this reflex 
and its inhibition by a preceding weaker prepulse can be investigated in humans and has a high 
translational value (Braff et al., 2001). The startle reaction can be measured in rats as early as 
pd 18 (Engel et al., 2000, Martinez et al., 2000) although, it has been shown that the onset of 
hearing abilities in rats predates this age with auditory functioning starting at about the age of 
pd 12 – 14 and adult thresholds being reached on pd 22 (Geal-Dor et al., 1993). Yet, little is 
known about the basal development of the startle amplitude and the percentage PPI during 
adolescence in rats. Most studies interested in PPI during development employ a pharmacological 
interference prenatally or early in development and subsequently measure ASR and PPI in test 
animals and controls on distinct age points (e.g. Lipska et al., 1995, Engel et al., 2000, Martinez et 
al., 2000, Romero et al., 2010). However, the basal ontogeny of untreated animals has seldom 
been analyzed. In one study the ontogeny of the PPI in Sprague Dawley rats was investigated and 
animals were tested on pd 18, 20, 22, 25, 29, and 40 (Engel et al., 2000). In this study an increase 
of the PPI of the ASR was observed until pd 40 which was the last test point analyzed. The 
authors stated that adult levels of PPI had been reached by then. However, the adult levels, to 
which pd 40 PPI performance was compared to, were obtained from animals aged pd 58, thus 
from animals still categorized as late adolescent (Schneider, 2013). Furthermore, the percentage 
PPI still continued to increase further up until pd 100 in the present project. Similarly, PPI levels 
have been found to increase from pd 35 – 70 in control animals in a study investigating the 
influence of prenatal LPS treatment on the offspring of Wistar rats (Romero et al., 2010). In this 
study, both male and female rats displayed an increase of PPI through these age points. Although, 
the test points investigated in this study were spread further apart than in the present project 
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(pd 28, 35, 70, 170, and 400) so that the development between pd 35 and pd 70 was not analyzed 
in detail. Nevertheless, the continued increase of PPI fits the present results.  
Interestingly, in human studies the modulation of the startle amplitude was first reported to have 
reached mature levels by the age of 8 years in children (compared to adults of 18 - 22 years of 
age; Ornitz et al., 1986, Ornitz et al., 1991). However, another study investigating the 
development of PPI during aging revealed an inverted U-shaped curve for PPI in adult subjects 
(Ellwanger et al., 2003). In this study, four age groups were analyzed for PPI and startle reaction: 
college (approx. 21 years of age), young (approx. 29 years), middle (approx. 41 years), and old 
(approx. 74 years). The mean startle magnitude decreased with age but PPI was highest in middle 
or young aged participants. Hence, the authors emphasized the importance of similarly aged 
groups when comparing PPI of adults. This is certainly also true for animal studies, particularly in 
developmental studies which compare “adult” animals that are often tested on various age points 
which are often still late adolescent ones. 
Altogether, the present project shows the gradual increase of PPI and ASR in developing Wistar 
rats and reveals that both values increase up until pd 100 in the animals under basal conditions. It 
is therefore important to consider the age of test subjects, for example when comparing control 
groups between studies. Furthermore, this precognitive measurement shows a rather linear 
increase up until adult levels compared to the non-linear development of the OBJR discrimination 
performance.  
 
Pharmacological Influence of SR141716 on Behavior during Development 
Previous studies showed that the ECS is involved in OBJR memory (Schneider et al., 2008, 
Campolongo et al., 2013, Galanopoulos et al., 2014). Therefore, developmental alterations in the 
ECS during adolescence may be involved in the reduced object discrimination observed in the 
OBJR test on pd 40. Studies indicate an increased level of CB1R during the approximate onset of 
puberty (Rodriguez de Fonseca et al., 1993, Klugmann et al., 2011b) implicating a possible 
upregulation of the ECS around that time. Therefore, during this time in development, the animals 
may be more sensitive to the effects of the selective CB1R antagonist/inverse agonist SR than on 
earlier or later age points. In this part of the project the previously observed decrease in the object 
discrimination abilities of animals on pd 40 was observed again in vehicle treated animals and this 
deficit was ameliorated by a low does of SR (0.3 mg/kg i.p.). This effect was specifically 
observed on pd 40 but did not affect performance on earlier (pd 30) or later (pd 130) age points.  
Apparently, no studies have so far investigated the effects of SR on basal cognitive abilities 
during development. However, one recent study observed impairing effects of a low dose of WIN 
(0.3 mg/kg) on OBJR memory in rats (aged 3 months) that were ameliorated by a very low dose 
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of SR (0.03mg/kg) (Galanopoulos et al., 2014). Although this was observed for longer ITIs than 
employed in the present project (both for short-term and long-term intervals of the OBJR test: 1h 
and 24h ITI respectively), these observations appear to be similar to the present project, in which 
a low dose of SR specifically improved the age-dependently decreased object discrimination 
abilities. Additionally, no correlation of discrimination performance and altered object exploration 
during P2 was observed in the study by Galanopoulos et al. (2014). Furthermore, injections of SR 
and vehicle (without WIN) did not display any effects on OBJR (Galanopoulos et al., 2014), 
similar to the present lack of an altered performance on earlier or later age points. Observations in 
operant studies revealed no improved memory performance when SR was administered alone 
(Brodkin and Moerschbaecher, 1997: 1mg/kg , Mallet and Beninger, 1998: 0 - 2 mg/kg ). In 
contrast, SR alone has been shown to enhance memory in a radial arm maze and in a SOCR test 
(Terranova et al., 1996, Lichtman, 2000). However, in addition to employing different behavioral 
tests, these latter studies used higher doses of SR (3 mg/kg) making a direct comparison to the 
present project even more difficult. 
Strain differences regarding the effects of low doses of SR have been observed before (Brand et 
al., 2012). In this study, Wistar and Fischer rats were compared in paradigms for reward 
sensitivity and additionally, ECS alterations were investigated. The Wistar rats displayed higher 
reward sensitivity for SCM and this was paralleled with higher CB1R and FAAH levels in the Hip 
compared to Fischer rats, indicating a basic higher eCB tone. Additionally, Wistar rats were more 
sensitive to the effects of SR regarding their SCM intake. Already a low dose of 0.3 mg/kg SR 
reduced the SCM intake in Wistar rats significantly whereas only higher doses (0.6 and 
1.2 mg/kg) reduced the SCM intake in Fischer rats. Although this study did not investigate 
cognitive abilities, several important considerations have to be taken into account. Wistar and 
Fischer rats displayed differences in several ECS components (CB1R and FAAH levels), similar 
to the hypothesized differences between adolescent and adult rats (see above as discussed for 
OBJR memory; Rodriguez de Fonseca et al., 1993, Klugmann et al., 2011b). Additionally, the 
impact of a low dose of SR (0.3 mg/kg) was more effective in animals with a higher eCB tone. 
This may be comparable to the present observations in adolescent rats since a higher ECS during 
this time period was observed previously (Rodriguez de Fonseca et al., 1993, Klugmann et al., 
2011b). 
Alternatively, developmental alterations in other neurotransmitter systems may account for the 
observed ameliorated OBJR performance since the ECS modulates other neurotransmitter 
systems, e.g. indirectly the DA system (as discussed above for the findings in the OBJR test; van 
der Stelt and Di Marzo, 2003). In the context of the mesocorticolimbic pathway, inhibiting the 
ECS with a low dose of SR could restore the effects of potentially increased neurotransmitter 
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levels or activity in adolescence to adult levels. Thus, a low dose of SR could counteract the 
CB1R–mediated reduction of excitation of glutamatergic afferents from the PFC to the NAc. As 
mentioned above (in the context of the basal OBJR memory abilities), an enhanced ECS during 
adolescence may confer a stronger reduction of excitation, yielding a net increase of DA to the 
NAc and the PFC. Complementary, restoring the adult-like levels of inhibition of the medium 
spiny neurons from the NAc to the VTA would also restore adult-like DA release levels from the 
VTA to the PFC and NAc and thereby explain the ameliorated OBJR memory abilities of pd 40 
old animals. Overall, in adolescent animals the DA release into the PFC and the NAc could be 
reduced to a level comparable to adult animals by a low dose of SR, enabling them to display 
similar OBJR performance. This would particularly affect adolescent animals since they display 
higher CB1R and DA receptor levels (Rodriguez de Fonseca et al., 1993, Andersen et al., 2000) 
whereby older animals with lower receptor levels may be less sensitive to low doses of SR. 
Therefore, it is possible that by influencing the ECS, and thereby indirectly the DA system, SR 
differently modulates recognition memory performance specifically on pd 40.  
In the present part of the project, the object exploration time during P1 of animals on pd 30 was 
reduced by SR without affecting the object exploration at other age points. Interestingly, this 
reduction in exploration time on pd 30 did not impair the animals’ ability to discriminate a novel 
from a familiar object. Although locomotor activity was not directly measured in this part of the 
project, it is possible that this low dose of SR reduced locomotor activity specifically in younger 
animals. Studies investigating the effects of SR alone on locomotor activity found contradicting 
results. For example, while some studies observed a reduction in locomotor activity (Jarbe et al., 
2002, Jarbe et al., 2006), another study observed increased locomotor activity in an open field test 
(Costa and Colleoni, 1999). However, all of these results were found after considerably higher 
doses of SR (5.6 and 3 mg/kg SR respectively) were administered in Sprague Dawley rats. Thus, 
the low dose SR employed here was unlikely to induce locomotor effects in the adult animals and 
in fact did not influence exploration times of animals on pd 40 and pd 130. The youngest animals 
may have been more sensitive to the effects of SR on locomotor activity as they displayed a lower 
exploration time during P1, however, this did not influence their ability to recognize a novel from 
a familiar object.  
Alternatively, if younger animals needed more time encoding the encountered objects (see Reger 
et al., 2009), the low dose of SR may have enabled them to perform successfully in this test even 
with a lower exploration time. However, the animals are not instructed to actively encode the 
objects for later retrieval, therefore if this was indeed the effect of the low SR treatment, it was an 
unconscious process.  
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Furthermore, the low dose of SR in the present project was ineffective in altering the startle 
amplitude or PPI performance on any of the tested age points. Similar to the present results, SR 
did not alter PPI or ASR in control Wistar rats in a study in which possible effects of the drug in 
SHR rats were investigated (Levin et al., 2014). Additionally, in another study investigating the 
ameliorating effects of SR on a PCP induced PPI deficit, SR administered alone did not influence 
PPI or ASR in Sprague-Dawley rats (Ballmaier et al., 2007). These results fit the present findings 
although in both studies higher doses of SR were used (0.75, 1.5, and 3 mg/kg) compared to the 
present study.  
It is possible that the previously conducted OBJR test may have influenced the PPI of the ASR. If 
this was the case, the animals may have displayed a higher arousal state during pulse alone trials. 
However, this was not detected in ASR amplitude and is therefore less likely. Another issue may 
be the elapsed time between SR administration until the test for PPI and ASR which was 
conducted directly after the OBJR test. However, care was taken that all animals completed the 
tests within less than 2h after drug administration. Previous studies investigating the time-course 
of functional effects of SR administration showed that SR displayed a rather long duration of 
action (e.g. 15 h; McLaughlin et al., 2003). One recent study argued for a shorter duration of 
action, however, in their study the functional in vivo half-life was still around 2h (Jarbe et al., 
2010), thus during the presently analyzed time-window SR should have not yet been completely 
washed-out of the animals’ system. The previously mentioned studies investigating the influence 
of SR on PPI conducted the test 30 min after drug administration (Ballmaier et al., 2007, Brand et 
al., 2012, Levin et al., 2014) whereas in the present experimental design first the OBJR test was 
conducted 30 min after drug administration followed by the PPI test approx. 60 min after drug 
injection. 
Further reasons may be involved for the differential findings of the influence of SR on the OBJR 
test and the PPI of the ASR. Although both tests analyze cognitive abilities, each paradigm 
investigates different aspects of cognition (i.e. pre-attentive filtering mechanisms vs. short-term 
recognition memory). Moreover, each test involves differently involved sensory modalities 
(acoustic vs. visuo-tactile) that are processed distinctly in the brain. The present results imply that 
these two aspects of cognition may be differently influenced by prior administration of SR but 
further experiments carefully eliminating any possible confounding factors should be conducted 
to confirm the lack of effect of the low dose of SR on PPI of the ASR during development. 
Taken together, SR appears to affect the behavior of younger (pd 30 and pd 40) animals 
differently than older ones depending on the test paradigm employed. The altered ECS during 
adolescence may render the pd 40 old animals sensitive to effects of low doses of SR that are 
ineffective in younger and adult rats as observed in the OBJR test. 
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Molecular Analysis 
 
Myelination 
Ongoing myelination throughout adolescence and early adulthood has been observed in human 
studies (Sowell et al., 1999, Lenroot and Giedd, 2006) but the development of myelination in the 
adolescent rodent brain has been less well investigated. Measurements taken in this experiment on 
different time points during adolescence revealed a brain region dependent increase of 
myelination. In the CPu lower levels of myelination were found for adolescent animals (on pd 30, 
50, and 60) compared to adult ones (pd 130). Interestingly, levels on pd 40 were not different 
from adult ones, thus already displaying comparably high levels of myelination. In the NAc no 
significant difference from adolescence to adulthood was observed. In the Hip all adolescent time 
points displayed lower myelination levels than adult animals, indicating an increase of 
myelination after pd 60 until adult levels were reached 
Human studies investigating the development of myelination found links between increasing 
white matter and cognitive functions (Bava et al., 2010, Yeatman et al., 2012, Peters et al., 2014). 
For example, white matter connections between several brain regions are critical for proficient 
reading (Yeatman et al., 2012). In a MRI study possible associations between white matter 
maturation and reading skill development in children aged 7 – 15 years were investigated 
(Yeatman et al., 2012). In this study fractional anisotropy was measured in two important white 
matter tracts for reading abilities (the inferior longitudinal fasciculus and the arcuate fasciculus). 
Fractional anisotropy (i.e. directionality of diffusion) is influenced both by myelination and 
synaptic pruning (Yeatman et al., 2012) and high fractional anisotropy reflects highly myelinated 
fibers (Cascio et al., 2007, Bava et al., 2010). In their study the authors observed that children 
with above-average reading skills displayed initially a low fractional anisotropy followed by an 
increase of the latter. Complementary, below-average readers initially displayed high fractional 
anisotropy and a decrease over time. Furthermore, correlations of cognitive data and white matter 
changes were found in another MRI study comprising 16 – 20 year-olds (Bava et al., 2010). 
Increased myelination was observed (16 months after being tested for the first time in the same 
test subjects) and associated with higher performances in tests of complex attention, working 
memory, and verbal fluency.  
Only few studies have investigated the development of myelination in rats so far (Jacobson, 1963, 
Norton and Poduslo, 1973, Meier et al., 2004, Mengler et al., 2014). Early studies described the 
progressive intensities of myelination semi-quantitatively (“faint, light, medium and dark”, 
Jacobson, 1963) or investigated myelin changes in brain myelin composition by isolating myelin 
components (Norton and Poduslo, 1973). However, more recent studies employed similar 
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methods as in the present part of the project and are partially in accordance with the present 
findings. One study investigating brain changes in volume and myelination during brain 
maturation focused on the cortex and the (dorsal) striatum (Mengler et al., 2014). In their analysis 
they combined longitudinal MRI scans of male Wistar rats with histological evaluations by black 
gold staining for myelin and cresyl violet staining for cell density levels. Although they 
investigated different time points histologically than in the current project (3 weeks, 3, and 6 
months which corresponds approx. to pd 21, 90, and 180), their results correspond to the present 
findings for the CPu because the myelination was found to increase significantly from 3 weeks to 
3 months of age. At 3 weeks of age only 5% of myelination was found which is still lower than 
the 26% measured in the present project on pd 30. However, at 3 months of age about 28% of the 
striatum was myelinated in their study (with no further increase from 3 – 6 months of age) and 
this corresponds to the approx. 30% found presently on pd 130. Interestingly, in the current 
project the myelination on pd 40 was already about as high as in adults, followed by lower levels 
on pd 50 and 60 and again higher levels in adulthood on pd 130. Thus, a non-linear development 
appears to take place in the CPu. Rather than interpreting this as a possible peak in myelination 
and a subsequent decrease thereafter (with a following increase to adult levels), other explanations 
may account for this observation. Myelination was quantified as percentage of the whole area and 
therefore changes in gray matter are likely to contribute to changes in relative myelination in this 
brain region. Concurrently, Mengler et al. (2014) found a pronounced increase in striatal volume 
between 3 weeks and 2 months of age (approx. pd 60) as measured by MRI. Furthermore, cell 
density decreased between 3 weeks and 3 months of age (Mengler et al., 2014). Therefore, 
additional processes of maturation and reorganization appear to take place in the CPu, possibly 
including synaptic overproduction and pruning. It is therefore likely that instead of a decrease in 
myelination taking place after pd 40, it is other processes which increase gray matter in this brain 
region and thus the relative amount of white matter, hence myelin appears lower.  
Another study investigated the development of myelination particularly in the Hip (Meier et al., 
2004). Myelin was analyzed from pd 17 and increased myelination until pd 25 was found 
employing a black gold staining method. Unfortunately, no further time points were investigated 
because the myelination levels on pd 25 “showed no remarkable difference compared with the 
adult” (Meier et al., 2004). However, the study did not specify the age of their adult control 
Wistar rats and instead stated that their weight ranged from 200 – 300g which is a large variation 
in bodyweight for a control group of animals. Therefore, it is unclear how old those controls had 
been at the time of analysis and if they may have still been adolescent. Wistar rats with a body 
weight of 200g are usually about 10 weeks old and a body weight of 300g corresponds to approx. 
15 weeks (Harlan Laboratories, 2011). The results of the present project indicate that myelination 
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in the Hip increases profoundly between pd 60 and pd 130. It is therefore quite likely that the 
adults in the afore-mentioned study were investigated during adolescence.  
In the current project the myelination in the mPFC was not quantifiable. Interestingly, Mengler et 
al. (2014) also found barely detectable myelinated fibers in the cortex at 3 weeks of age (about 
1%). At 3 months they measured still only about 15% of myelinated fibers. This suggests a slowly 
increasing myelination over a prolonged period in the cortex. Thus, the age points investigated in 
the current experiment were presumably in a period when the relative myelination of the mPFC 
was too low to be quantified. 
The present results imply an ongoing myelination process during adolescence in the Wistar rat 
that varies in different brain regions involved in cognition. Although myelination in the CPu did 
show an overall increase, this increase was not linear and the measured relative amount of white 
matter was possibly influenced by additional developmental processes. While no particular 
differences were detected on the presently investigated time points in the NAc, the Hip revealed 
an overall increase from all adolescent time points to early adulthood.  
The last analyzed time point of the present investigation was pd 130 based on the plateau reached 
in the behavioral performance of the analyzed cognitive tests (i.e. OBJR; OBJRecency, PPI, and 
ASR) at that age although, it is possible that alterations of myelination are still ongoing in rats 
after this age point. Human studies indicate that peaks in white matter volume are reached 
between the twenties to mid-forties depending on the investigated tract (Hasan et al., 2010, 
Westlye et al., 2010, Kochunov et al., 2012, Lebel et al., 2012) and Mengler et al. (2014) still 
found increases of myelination from 3 – 6 months of age in the rat. However, as these time points 
are relatively far spaced (and the last measured time point here was in between of the time points 
analyzed by Mengler et al. (2014), the highest amount of myelination may be found somewhere in 
between these age points. Further analysis comprising both earlier and more detailed time points 
after adolescence and in young adulthood (between pd 60, pd 130, and pd 180) may delineate a 
more thorough picture of the development of myelination in the rat.  
The present findings of the development in myelination over the course of adolescence in various 
brain regions involved in cognition shows an overall increase in myelination. This increase is 
brain region dependent and can be non-linear as in the CPu or gradually increasing as in the Hip. 
The behavioral performance in the OBJR test revealed a non-linear developmental pattern as well 
but the performance in other tests displayed a gradual increase (PPI of the ASR) or a delayed but 
less varied (OBJRecency) pattern. Increasing myelination during development is associated with 
WM improvements (Bava et al., 2010) and faster information exchange (Brenhouse and 
Andersen, 2011) and thus the increasing myelination observed in the present project probably also 
subserves increased performance observed in the cognitive tests. Conversely, deficits in 
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subcortical myelination have been associated with impairments of OBJR in rats (Wu et al., 2008) 
and myelin loss in the mPFC, CPu and Hip were associated with PPI deficits in mice (Xu et al., 
2010). Because several brain regions are most likely to function in a coordinated network together 
in the investigated behavioral tests (Warburton and Brown, 2010) or are involved in the 
modulation of a certain cognitive aspect e.g. in the PPI of the ASR (Swerdlow et al., 2001), one 
can probably not simply conclude from the myelination pattern observed here in one brain region 
to a particular behavioral finding. It seems more likely that the myelination pattern in different 
brain regions develops differently throughout the adolescent time period as do various behavioral 
cognitive abilities. The myelination patterns (together with other neurodevelopmental alterations 
during adolescence) may contribute to the various behavioral performance patterns in cognitive 
tests until adult levels are reached. However, further and more detailed analyses are needed to 
establish the exact connections of myelination patterns linked to distinct behavioral output 
behaviors. 
 
Staining and Western Blot Analysis of the Cannabinoid Receptor 1 
CB1R staining in brain slices of animals aged pd 40 and pd 130 are in accordance with the 
staining pattern shown before (Egertova and Elphick, 2000). In the study by Egertová and Elphick 
(2000), staining in the mPFC was specifically found in layers II-III and layer VI, and this pattern 
was also detected in the stained sections in the current project for both age points. Similar staining 
patterns as in the study by Egertová and Elphick (2000) were also found in the CPu and 
additionally in the Hip, where intense staining was detected in the Stratum pyramidale, most 
intensely in the CA1-3 region but also in the DG on both age points. However, no significant 
difference between the age points could be obtained by quantification. In contrast, western blot 
analysis for CB1R in the current project revealed differences between early and adult age points 
in several brain regions. In the mPFC and in the NAc adult animals displayed a higher CB1R 
content than animals on earlier age points. In the CPu no differences were detected while in the 
Hip adolescent animals displayed higher levels of CB1R protein expression than adult ones. 
The discrepancies between the results of the two methods could be due to several reasons. On the 
one hand, the samples were processed differently for each method (perfused and sectioned vs. 
dissected and homogenized) and different antibodies were used. On the other hand, staining of the 
CB1R reveals its distribution on the brain sections and this method may be more suitable for 
demonstrating its particular localization than its quantification. For western blot analysis whole 
regions of the brain were dissected whereas the stained sections only represent a small part of the 
designated brain area. Thus, the quantification of the staining in the sections may be more 
sensitive to larger differences than those detected here. Additionally, a lack of significant 
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differences could be due to the limited number of animals available for quantification in the 
section-based approach. Conversely, in western blot analysis the protein content of the CB1R in a 
certain brain region can be quantified but the cellular localization of it cannot be determined. 
The expected molecular mass of CB1R is 52 kDA (Matsuda et al., 1990) but a prominent band of 
approx. 46 kDA was revealed by western blot analysis. The slightly lower band detected may 
represent the N-terminally unglycolsylated protein which is expected at about 46 kDA (Shire et 
al., 1995, Egertova and Elphick, 2000). Furthermore, a lower protein band of approx. 45 kDA for 
the CB1R has been observed before (Sim-Selley et al., 2006). Alternatively, the detected lower 
protein band may be due to possible alternative splice variants or differences in the amino acid 
sequence of the CB1R protein between species because the employed antibody was specifically 
raised against the mouse and human peptide sequence and its reactivity for homologues in the rat 
had not yet been tested (ImmunoGenes AG). Therefore, the stable protein band of about 46 kDA 
was used for quantification of the western blot analysis. 
Previous studies showed partially controversial findings of CB1R levels during development. 
Either an increase of CB1R levels until adult levels was observed (Belue et al., 1995, Berrendero 
et al., 1999, Mato et al., 2003, Verdurand et al., 2011) or a peak during early adolescence 
followed by a reduction until adult levels (Rodriguez de Fonseca et al., 1993). For example, one 
study found CB1R binding levels peaked on pd 30 and pd 40 in male and female rats in limbic 
regions, the striatum and the mesencephalon (Rodriguez de Fonseca et al., 1993). Another study 
found higher CB1R binding levels in the frontal cortex, (further caudally located) cortex, Hip and 
cerebellum in young adult rats (pd 70 – 72) compared to adolescent ones (pd 35 - 37; Verdurand 
et al., 2011). However, studies during adolescence are limited as most of them focused on earlier 
developmental periods and omitted adolescence (Mato et al., 2003). Additionally, in some of 
these studies animals that may be still considered as adolescent (Schneider, 2013) are employed as 
an adult reference point (Belue et al., 1995: pd 60, Berrendero et al., 1999: > pd 56 ) similarly to 
conflicting results of behavioral findings (as discussed for the OBJR and PPI tests), thus 
complicating a direct comparison. Moreover, most studies investigated either radioactive ligand 
binding (e.g. Rodriguez de Fonseca et al., 1993, Belue et al., 1995, Berrendero et al., 1999, Mato 
et al., 2003, Verdurand et al., 2011) or in situ mRNA measurements (Heng et al., 2011, Long et 
al., 2012, Van Waes et al., 2012) instead of protein levels. Analyses of mRNA revealed a different 
pattern from CB1R levels and showed a general decrease until adult ages. One study found the 
highest levels of mRNA expression on pd 1 compared to pd 5 and 56 in various brain regions of 
Wistar rats including the cerebral cortex and the Hip (Berrendero et al., 1999). Others detected 
similar patterns of decreasing mRNA expression from pd 25 to pd 40 and 70 in the prefrontal 
cortex, limbic areas and the striatum of Sprague Dawley rats (Heng et al., 2011, Van Waes et al., 
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2012). Furthermore, similar results were found in the human dorsolateral PFC where highest 
mRNA expression was detected in neonates and toddlers (Long et al., 2012). However, mRNA 
measurements do not necessarily predict the corresponding protein levels (Pascal et al., 2008, 
Bedse et al., 2014). Particularly for the CB1R discrepancies between protein levels and mRNA 
measurements may be explained by a differential distribution of these components. The CB1R is 
mainly expressed on synaptic terminals whereas the mRNA is synthesized in the cell body (Bedse 
et al., 2014). Furthermore, post-translational modifications and different half-lives of the 
components may also account for the detected variations (Pascal et al., 2008). 
One study investigated the CB1R expression by fluorescent immunosorbent assay during 
adolescence (pd 29, 38, 50; Ellgren et al., 2008). In the NAc shell an age-dependent increase was 
measured, whereas in the NAc core, densities were decreased from pd 29 compared to pd 50. 
Similar to the present results, no differences were found in the CPu. But in contrast to the present 
findings a decrease was found in the PFC (from pd 29 to pd 38 in the study by Ellgren et al. 
(2008)). Unfortunately no earlier and later time points were investigated. Additionally, the 
animals had been injected with THC or vehicle (the older ones repeatedly) which may have posed 
a stress effect and makes the comparison of the vehicle group to the measurements in this 
experiment here difficult. Therefore comparison with the basal levels of the untreated animals of 
the present project should be considered cautiously. The higher CB1R levels in the Hip on pd 30 
and pd 40 compared to adulthood measured in the present project are in accordance with the 
analyzed peak during this time in a study employing radioactive ligand binding (Rodriguez de 
Fonseca et al., 1993) although, no earlier time point was investigated in the present project. This 
finding may also explain the increased sensitivity of the adolescent animals to a low dose of SR as 
discussed before. During this time an elevated ECS activity with increased levels of CB1R protein 
content would render the animal more susceptible to pharmacological influences of a CB1R 
antagonist/inverse agonist, e.g. SR. Unfortunately, although the study by Rodríguez de Fonseca 
(1993) investigated many age points in both male and female animals, the brains were dissected 
into broader areas (into limbic regions, the striatum and the mesencephalon).  
In the present project, no elevated levels during adolescence compared to adulthood were detected 
in other brain regions (mPFC, NAc, CPu). These results are in contrast to earlier findings in the 
(ventral) striatum and PFC where elevated CB1R levels were found in adolescent animals (pd 40) 
compared to adult ones (pd 100) animals (Klugmann et al., 2011b). Differences between the two 
studies include different rat lines (Wistar han hsd vs. rcc), different antibodies employed (both 
primary and secondary) and further methodological variations that may be accountable for the 
discrepancies.  
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Altogether, the western blot analysis showed regionally dependent differences in CB1R protein 
content over development that is only partially in line with findings from previous studies. In fact, 
these results add to the somewhat ambiguous picture in the present field of research. The 
increased CB1R levels in the Hip during early adolescence fit the hypothesized increased ECS at 
this age that may also explain the behaviorally observed decreased OBJR performance and 
ameliorated recognition memory after a low dose of SR. However, the role of the Hip in OBJR 
memory is still controversial (see Warburton and Brown, 2010). Several studies found that the 
Hip is not involved in OBJR per se but is rather needed in recognition memory that involves 
contextual cues like location or temporal information (Mumby et al., 2002, Barker and 
Warburton, 2011) and may therefore rather be connected to the observed delayed performance in 
the OBJRecency test. This would additionally rely on the interaction with other brain regions like 
the mPFC (Warburton and Brown, 2010). The findings that the Hip is less important in the OBJR 
test mainly rely on lesion studies and this kind of manipulation usually destroys a brain region 
(and sometimes adjacent tissue) to a great extend, thus direct comparison to the present 
developmental alterations has to be considered cautiously. Other studies showed an involvement 
of the mPFC and the striatum in OBJR memory as demonstrated by upregulation of the immediate 
early gene c-fos (Rinaldi et al., 2010, Barbosa et al., 2013). This may rather implicate functional 
interactions between multiple brain regions in the OBJR test. Furthermore, although in the present 
version of the OBJR test additional contextual cues like location information were minimized, it is 
difficult to deduce how the animals perceive the objects and the test situation (Ennaceur, 2010), 
thus contextual cues may be important and this would also argue for the involvement of multiple 
brain regions in the OBJR. 
If a brain region involved in a cognitive process cannot entirely functionally operate (either if it is 
damaged or not fully developed yet) there is the possibility that other regions may compensate its 
function to a certain degree. For the Hip suggestions have been made according to which a mal-
functioning one is worse than a non-existent one (Warburton and Brown, 2010). This may also 
contribute to the observed behavioral differential performance patterns in various cognitive tests. 
Furthermore, it has been shown that during working memory tests in children a shift from using 
more ventrally to more dorsally located regions of the PFC takes place over the course of 
development (Catts et al., 2013). Thus, different brain regions may become differentially involved 
in cognitive operations over the course of development. As the PFC is developing rather late 
(Fuster, 2001), its influence in cognitive tests may increase as the animal matures. 
While the ECS in distinct brain regions is differentially developing throughout adolescence, the 
functional interactions between these regions most likely underlie the behavioral performance 
observed in the presently employed cognitive tests. Thus, the performance variations observed in 
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the behavioral tests may reflect inter alia the differential maturation of the ECS during 
adolescence in different brain regions. Conversely, adult like behavioral performance levels in 
cognitive tests are reached after developmental alterations in this (and possibly also additional) 
neurotransmitter system(s) have reached mature levels. 
 
Conclusion 
The main finding of the present project was that various behavioral tests of cognition display 
different developmental trajectories in the adolescent rat. This included a non-linear development 
of OBJR memory. After successful discrimination of novel from familiar objects in the OBJR test 
on pd 30 a performance decrease was observed on pd 40, followed by a gradual increase to adult 
levels (until pd 130). The successful performance in an OBJRecency test developed later than 
OBJR memory but remained stable across development. ASR and PPI developed gradually until 
adult levels were reached. Some of these behavioral alterations appear to be linked to the 
developing ECS since the influence of a low dose of the CB1R antagonist/inverse agonist SR 
specifically ameliorated the age-dependent dip in performance of OBJR on pd 40. Additionally, 
increased levels of CB1R in the Hip of adolescent animals were found in western blot analysis. 
Therefore, an enhanced ECS during adolescence may render the animals more sensitive to 
pharmacological agents affecting eCB tone and/or receptors. Furthermore, the development of 
myelination, which is associated with developing cognitive abilities, was shown to increase in a 
brain region-dependent way.  
Neurodevelopmental processes during adolescence including the maturation of neurotransmitter 
systems and changes in gray and white matter take place with varying time-courses and patterns 
in distinct brain regions. The present molecular analyses showed that the CB1R levels and the 
relative myelination in brain regions involved in cognition display non-linear increases (e.g. the 
myelination in the CPu), gradual increases (e.g. the myelination in the Hip, the CB1R levels in the 
mPFC) or decreases (e.g. the CB1R levels in the Hip). These processes most likely underlie and 
contribute to the behavioral performances in the analyzed cognitive tests and may explain the 
variable developmental patterns in different aspects of cognition. However, due to the 
interconnection of brain regions and their functional interaction it is hardly possible to infer from 
the influence of one mechanism to a particular aspect of behavioral output from the present 
findings. While some brain regions develop rather late (e.g. the PFC) others develop earlier (e.g. 
subcortical regions) and this may create an imbalance during adolescence (Casey et al., 2008) 
which may result in the presently observed variable behavioral output in the cognitive tests. 
Altogether, successful mature cognitive performance necessitates a mature and interconnected 
network of brain regions including mature molecular components.  
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4.3 Project III: Long-term Effects of Chronic Pubertal WIN Treatment on 
Cognition 
The present study revealed long-term effects of a chronic pubertal WIN treatment in adult male 
W[rcc] rats on cognitive skills. In an object recognition test both the percentage object 
discrimination and the discrimination index were decreased in WIN treated animals compared to 
vehicle treated controls. No lasting effects were observed for sensorimotor gating abilities or 
startle amplitude as revealed by PPI or ASR tests. In an ASST both WIN and vehicle treated 
animals learned to discriminate different rewarding sets and displayed similar set shifting abilities 
for both intradimensional shifts and an extradimensional shift. However, WIN treated animals 
displayed impaired reversal learning abilities based on the higher number of trials needed to reach 
the criterion during the reversal stage of the test. Western blot analysis for CB1R revealed a 
significantly increased protein level in the mPFC of WIN treated animals in adulthood. No 
differences in protein levels were observed in the CPu, the Hip, or for the degrading enzymes 
FAAH and MAGL in these brain regions. 
 
Object Recognition 
Several studies have shown long-term effects of a chronic pubertal cannabinoid treatment on the 
object recognition test (Schneider and Koch, 2003, O'Shea et al., 2004, O'Shea et al., 2006, 
Schneider and Koch, 2007, Schneider et al., 2008, Abush and Akirav, 2012, Renard et al., 2013). 
Particularly, chronic WIN or CP 55,940 treatments during adolescence have been shown to impair 
object recognition memory in adulthood (O'Shea et al., 2004, Schneider and Koch, 2007, 
Schneider et al., 2008). In the present project both the object discrimination and the discrimination 
index were significantly reduced in animals chronically treated with WIN during puberty and 
tested in adulthood compared to vehicle treated controls. The exploration time during P1 did not 
differ between the groups; therefore differences in exploratory behavior or locomotor activity are 
likely not accountable for the observed recognition memory deficit. 
These results add to the previously mentioned observations and furthermore show that the W[rcc] 
rat line displays similar deficits after chronic pubertal WIN treatment as previously observed in 
W[hsd] animals. Rat line and strain differences for various behavioral paradigms are of great 
interest (see project I (4.1) and Rex et al., 1999, Brand et al., 2012) and only little attention has 
been directed to this topic in studies of long-term cannabinoid treatment. Recently, one study 
investigated the differential effects of chronic CP 55,940 treatment in Wistar and Lister Hooded 
rats during adolescence and adulthood (Renard et al., 2013). They found an impaired OBJR 
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memory for both Wistar and Lister Hooded rats (treated for 3 weeks starting from pd 29) after 
ITIs of 30 and 120 min. Although the present project was not intended to compare the two lines of 
Wistar Han rats directly it is important to validate that similar object recognition deficits persist in 
these two lines after the same chronic pubertal WIN treatment.  
Various studies implicated different brain regions in the successful performance of OBJR memory 
(Dere et al., 2007, Rinaldi et al., 2010, Warburton and Brown, 2010, Barbosa et al., 2013). Lesion 
studies suggest that for OBJR memory that does not involve contextual information like changed 
location of an object or temporal information, the Hip and mPFC are not involved (Warburton and 
Brown, 2010). However, it is difficult to compare the present pharmacological manipulation with 
the extensive damage of a lesion study. Studies of immediate early genes implicate the mPFC and 
the striatum in OBJR memory in rats and mice (Rinaldi et al., 2010, Barbosa et al., 2013) and this 
indicates the involvement of multiple brain regions that are connected during OBJR test 
performance.  
Interestingly, increased levels of the CB1R were found in the mPFC by western blot analysis in 
the present project. This may indicate a possible elevation of the ECS activity or sensitivity as a 
long-term effect of the pubertal WIN treatment in this brain region. The ECS is modulating a 
number of neurotransmitter systems directly and indirectly (see Kano et al., 2009) and may 
therefore influence OBJR memory via one or multiple of these systems. In the cortex, intense 
CB1R staining is found in layers II/III and V/VI (Hill et al., 2007, El Khoury et al., 2012). CB1Rs 
are mainly expressed by GABAergic interneurons and to a lesser extent by pyramidal neurons 
(Marsicano and Lutz, 1999). Studies investigating the localization of CB1Rs in the differential 
cortical layers as well as data from electrophysiology suggest that in layers II/III the receptors are 
mainly expressed by GABAergic interneurons (Katona et al., 1999, Trettel and Levine, 2002, 
Fortin and Levine, 2007) while in layer V they are suggested on glutamatergic terminals (Fortin 
and Levine, 2007). Layer V is the main output layer of the cortex while layers II/III are 
intercortically projecting layers (Fortin and Levine, 2007). Activation of the CB1Rs is supposed 
to elicit opposite effects in cortical network activity: In GABAergic terminals (where GABA 
release is suppressed upon CB1R activation) a disinhibition would result in a net increase of 
glutamate and in the pyramidal neurons CB1R activation would decrease glutamatergic activity 
(Fortin and Levine, 2007, El Khoury et al., 2012). 
Although from the present results it is not possible to further elucidate where exactly the CB1Rs 
have been increased in the mPFC, their increase particularly in this brain area and not in other 
regions may result in an imbalance of network activity between this and connected regions. 
However, these connections are probably involved in successful cognition and therefore altered 
CB1R levels in the mPFC most likely underlie the cognitive deficits observed here. Furthermore, 
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the reduction in neuronal activity in the PFC has been associated with an imbalance of additional 
neurotransmitter systems like the DAergic system and brain regions like the NAc (Del Arco and 
Mora, 2008, El Khoury et al., 2012).  
A hypothetical model has been described for the effects of adolescent cannabinoid exposure 
leading to prefrontal dysfunction (Caballero and Tseng, 2012). According to this model, 
cannabinoid exposure leads to functional maturational deficits of the prefrontal GABAergic 
interneurons that are developmentally regulated (Caballero and Tseng, 2012). This would lead to 
a reduced inhibitory tone of cortical pyramidal cells and consequently to a decreased 
synchronization of the prefrontal network. Additionally, it has been shown that coordinated 
network oscillations between the Hip and the mPFC are disrupted by the cannabinoid agonist CP 
55940 which also decreases accuracy in performance of a working memory test (Kucewicz et al., 
2011). Altogether, the increased levels of CB1Rs in the mPFC of adult animals appear to underlie 
the cognitive deficits observed after pubertal WIN treatment. 
 
Prepulse Inhibition of the Acoustic Startle Reflex 
No differences were observed between WIN and vehicle treated animals for PPI and ASR after 
chronic pubertal WIN treatment. Previously, a PPI deficit after chronic WIN treatment (from 
pd 40 – 65) was observed in the W[hsd] rat line (Schneider and Koch, 2003) or for earlier 
treatment periods (pd 15 - 40; Schneider et al., 2005). However, in addition to another rat line, the 
PPI in those former studies was conducted in a different apparatus (TSE vs. SR-LAB) using lower 
startle impulses (100dB vs. 115dB employed in the present study). Therefore, the lack of effect of 
the pubertal WIN treatment on PPI and ASR amplitude may be attributable to the possible 
differences in the two lines of Wistar Han rats and experimental settings. As previously discussed, 
strain and supplier differences have been found regarding the PPI of the ASR (Rigdon, 1990, 
Swerdlow et al., 2000). Additionally, different rat lines within the same rat strain revealed 
significant differences in basal PPI levels in project I (see 4.1).  
 
Attentional Set Shifting 
In the present project a chronic pubertal WIN treatment induced impairments specifically in the 
reversal stage of an ASST while leaving initial learning of the task as well as intra- and extra-
dimensional shifting abilities intact. Intake of the food reward analyzed in a free intake paradigm 
before the ASST did not differ significantly between vehicle treated and WIN treated animals. 
Therefore, differences in reward perception are unlikely to have influenced the cognitive 
differences observed. 
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Several studies have investigated the effects of cannabinoids on the performance in complex 
cognitive tasks including attentional set shifting and reversal learning (Egerton et al., 2005a, Hill 
et al., 2006, Harte and Dow-Edwards, 2010, Sokolic et al., 2011, Wright et al., 2013). Mainly 
acute effects have been investigated and less attention has been directed to long-term effects of 
chronic treatments. For example, one study found impaired reversal learning and intradimensional 
set shifting abilities in rats after acute administration of 1 mg/kg ∆9-THC (Egerton et al., 2005a). 
Similarly, in rhesus monkeys impaired reversal learning was observed after acute ∆9-THC (0.1 –
 0.5 mg/kg i.m.) administration (Wright et al., 2013). One study investigated the effects of a 
chronic intermittent ∆9-THC treatment in rats (1 mg/kg i.p. once per week for 4 weeks; Allison, 
2004). In this study deficits were observed for IDS, EDS, and the first reversal learning stage. 
However, animals were already tested 30 min after the last injection, which may not be enough 
time to exclude any possible acute effects of the treatment (Allison, 2004). As far as the author 
knows, the present project appears to be the first investigation of long-term effects of a chronic 
pubertal cannabinoid treatment on behavioral flexibility abilities measured in an ASST. The 
results showed that the abilities of adult rats to learn several discriminations (Pre, SD, CD) were 
intact both after chronic pubertal WIN and vehicle treatment. Additionally, transferring an 
acquired rule to a novel situation was also intact as observed in similar IDS performance levels. 
Moreover, shifting the previously learned rule when reward contingencies had changed was also 
similar in both groups as similar EDS performance levels were observed. The higher number of 
trials to criterion during this stage indicates that the EDS was more challenging than the others 
stages (see Barense et al., 2002, Colacicco et al., 2002) since subjects had formed attentional sets 
at this point and rats successfully learned the cognitive task.  
In the reversal stage both groups needed more trials to complete the rule learning than in the 
previous CD stage although, this increase was less pronounced in the vehicle group compared to a 
previous study conducted with identical settings in our lab (Klugmann et al., 2011a). This may be 
due to, for example, differences between batches of animals (see Palm et al., 2011a) since also the 
trials needed to complete the pretraining stage differed between the present project and the 
previous study (Klugmann et al., 2011a). Nevertheless, in the reversal stage WIN treated animals 
displayed significantly more errors compared to vehicle treated animals. This strongly implies a 
lack of ability to inhibit a previously learned response while employing a new rule when reward 
contingencies have been changed (Egerton et al., 2005a, Bissonette et al., 2013). Thus, this 
reversal learning impairment is implicated as a long-term effect of a chronic pubertal WIN 
treatment on complex cognitive abilities. 
Interestingly, similar observations were made in a previous study, after a viral-mediated 
upregulation of the CB1R in the mPFC of adult rats (Klugmann et al., 2011a). In this study both 
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the abilities to learn and to shift attention in IDS and EDS stages remained intact. But animals 
with increased levels of CB1R in the mPFC had difficulties reversing a previously learned rule 
compared to control animals. These behavioral observations resemble those of the present project 
after chronic pubertal WIN treatment. It is therefore highly likely that the pubertal WIN treatment 
may have altered the ECS in adulthood, possibly by increasing CB1R levels as a long-term 
treatment effect, providing similar behavioral outcomes in the reversal learning ability of the 
ASST.  
Although, in lesion studies the OFC was shown to be critical for reversal learning (McAlonan and 
Brown, 2003, Kim and Ragozzino, 2005), other studies have suggested the involvement of 
additional brain areas in reversal learning (Joel et al., 1997, Li and Shao, 1998, Oualian and 
Gisquet-Verrier, 2010, Klugmann et al., 2011a). For example, one study showed that lesions 
restricted to either the PL or the IL region of the mPFC induced reversal learning deficits in a T-
maze task (Li and Shao, 1998). More recently, similar observations were found in the reversal 
stage of a strategy shifting task in IL and/or PL cortices-lesioned rats compared to sham-lesioned 
controls (Oualian and Gisquet-Verrier, 2010). Lesioned animals displayed higher preservative 
errors for rule shifting and reversals. In this study the authors suggested that these brain regions 
are specifically involved in the resolution of a response conflict, i.e. either testing for and 
choosing a previously irrelevant strategy or selecting and maintaining that strategy (rather than 
inhibiting a previously valid response). However, in the ASST employed in this project it is not 
possible to differentiate whether the animals were not able to inhibit a previously learned rule or 
to look for, select, and maintain a novel strategy during the reversal stage of the test. It is possible 
that, during this stage, the combination of both, the inhibition of the previously learned rule and 
the novel strategy selection, is dependent on the integrity of the mPFC (and possibly additional 
brain areas). This appears to be compromised by the chronic pubertal WIN treatment leading to 
the increased number of trials needed to complete the reversal learning stage in the adult animals. 
Because no impairments in IDS and EDS were observed in the present project, the WIN treated 
animals appear to be able to look for, select, and maintain a new strategy in the present paradigm, 
therefore strengthening the possibility of deficits in inhibition of a previously learned rule (or a 
combination of inhibition and novel rule selection). However, one has to consider that, in addition 
to using a strategy set shifting paradigm in a Y-maze (instead of the presently employed digging 
test), in the study by Oualian and Gisquet-Verrier (2010) the ibotenic acid lesions were conducted 
in Sprague-Dawley rats, thus making a direct comparison difficult. 
Further evidence suggesting the involvement of additional brain areas in the ASST performance 
comes from molecular analysis. Acute ∆9-THC treatment was observed to alter immediate early 
gene expression of c-fos and ngfi-b in the dorsolateral striatum and frontal cortical regions 
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(including the PL and the IL frontal cortical regions; Egerton et al., 2005a). Furthermore, 
associations between this altered mRNA expression and reversal learning in the NAc and the 
dorsolateral striatum were found in this study.  
Behavioral evidence for the involvement of cortico-striatal interactions in behavioral flexibility 
was also observed, again in strategy set shifting tests (reviewed by Floresco et al., 2009). 
According to a hypothetical neural circuitry, different components of a network between the PFC, 
the NAc, and the mediodorsal thalamus contribute to behavioral flexibility during strategy set 
shifting (Block et al., 2007, Floresco et al., 2009). Inputs from the PFC to the NAc appear to 
facilitate the maintenance of a novel behavioral strategy whereas DAergic inputs to the PFC are 
involved in disengaging from a previously employed strategy. Thus, disconnections between the 
PFC and the NAc induced an increase in preservative errors which, according to the authors, may 
be “attributed to disruptions of the transfer of updated information from the PFC regarding the 
success or failure of current strategies to the NAc for maintenance of a novel discrimination 
strategy“ (Block et al., 2007).  
This is comparable to the present observations of a deficit in reversal learning in the ASST where 
animals appear to have difficulties in disengaging from a previously rewarded strategy, while 
maintaining a new strategy. Therefore, the functional network between the PFC and the NAc 
appears to be required for successful completion of the test. 
Complementary, alterations of neurotransmitter systems (e.g. the DA system) in these areas may 
cause deficits in one or more aspects of the test. DAergic transmission in the NAc is increased by 
natural rewards and the mesocorticolimbic pathway is important in acquiring behavior reinforced 
by natural rewards (Spanagel and Weiss, 1999). An involvement of the ECS in indirectly 
modulating the DA system has previously been observed (reviewed by van der Stelt and Di 
Marzo, 2003). Additionally, previous studies found that repeated administration of ∆9-THC or 
WIN decreased DA turnover in the rat PFC which persisted up to two weeks following treatment 
cessation (Jentsch et al., 1998, Verrico et al., 2003) and this may underlie the impaired reversal 
learning abilities. A reduction in DA transporter levels in the striatum was found in one study 
after a methamphetamine treatment which also induced reversal learning impairments (Izquierdo 
et al., 2010). However, modulation of the DA system by the ECS was not measured in the present 
project and a possible involvement in the behavioral observations is therefore highly theoretical.  
Overall, the present project revealed that a chronic pubertal WIN treatment impaired reversal 
learning of animals tested in an ASST in adulthood therefore, implicating long-term cognitive 
effects of this treatment. This chronic pubertal WIN treatment has been suggested as an animal 
model for aspects of schizophrenia (Leweke and Schneider, 2011) and patients suffering from this 
disorder displayed more preservative errors and responses in the Wisconsin Card Sorting test (an 
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analogous test of the presently employed ASST; Van der Does and Van den Bosch, 1992, Everett 
et al., 2001, Hartman et al., 2003). Additionally, heavy marijuana use in humans is associated with 
deficits in behavioral flexibility measured in the Wisconsin Card Sorting Test (Bolla et al., 2002, 
Lane et al., 2007). Moreover, particularly prefrontal regions (the dorsolateral PFC and the anterior 
cingulate cortex) have been shown to display higher CB1R levels in schizophrenic patients (Dean 
et al., 2001, Zavitsanou et al., 2004) and similarly, higher CB1R levels may be the long-term 
effect of the presently administered pubertal WIN treatment. Altogether, these observations are in 
line with the present results and suggest long-term effects on behavioral flexibility skills 
(particularly reversal learning) after an interference with the developing ECS. 
 
Western Blots of Cannabinoid Receptor 1, Fatty Acid Amino Hydrolase and 
Monacylglycerol Lipase 
Western blot analysis for CB1R, FAAH, and MAGL were conducted in adulthood (> pd 100) 
after a chronic pubertal WIN treatment and brain regions implicated in cognitive skills (mPFC, 
CPu, Hip) were investigated. In the mPFC a significant increase of CB1R was found in WIN 
treated animals compared to vehicle treated controls. No differences of CB1R expression levels 
were measured in the CPu, the Hip, or for the eCB degrading enzymes FAAH and MAGL in any 
of the three brain regions investigated. 
Effects of repeated cannabinoid administration on CB1R expression have been investigated in 
several studies (Romero et al., 1998, Sim-Selley and Martin, 2002, Breivogel et al., 2003, Sim-
Selley et al., 2006). These studies mainly found a CB1R downregulation or desensitization after 
injection (or cannulation as in the study of Breivogel et al., 2003) of ∆9-THC or WIN in adult rats 
or mice. However, these studies employed adult animals and focused on time points soon after 
treatment. For example, 24h after the last injection of a ∆9-THC treatment (lasting 1, 3, 7, or 14 
days; Romero et al., 1998), 1, 3, 7, and 14 days after the final injection of a treatment of ∆9-THC 
or WIN (lasting 15 days; Sim-Selley and Martin, 2002, Sim-Selley et al., 2006), and 25h after a 
∆
9
-THC infusion treatment (lasting 4 days; Breivogel et al., 2003). Thus, it appears that a short-
term consequence of repeated cannabinoid treatment in adulthood is a downregulation of the 
CB1R. However, several studies also implicated that this short-term effect is only transient (Sim-
Selley et al., 2006, Hirvonen et al., 2012). In one study, in which mice received either incremental 
doses of ∆9-THC or WIN for 15 days, receptor levels returned to untreated levels in the striatum 
and globus pallidus after 7 days and in the Hip after 14 days of treatment cessation (Sim-Selley et 
al., 2006). Additionally, a PET study found a reversible and regionally dependent downregulation 
of the CB1R in human chronic cannabis smokers (approx. 28 – 32 years old Hirvonen et al., 
4. Discussion 
 109 
2012). After about 4 weeks of continuously monitored abstinence these levels returned to control 
levels further indicating that this downregulation appears to be a transient effect.  
Several other studies have investigated the effects of a chronic adolescent cannabinoid treatment 
on the CB1R levels in rodents (Rubino et al., 2008, Dalton and Zavitsanou, 2010, Chadwick et al., 
2011, Winsauer et al., 2011, Behan et al., 2012, Winsauer et al., 2012). However, similarly to the 
studies mentioned above, samples were often taken 24h after the last injection, revealing CB1R 
downregulation as a short-term effect of a chronic cannabinoid agonist, e.g. 25, 50, or 100 µg/kg 
HU210 i.p. for 4 or 14 days (Dalton and Zavitsanou, 2010) or a ∆9-THC treatment in adolescence 
with escalating doses of 2.5 – 10 mg/kg i.p. from pd 35 – 45; (Rubino et al., 2008). The latter 
study also investigated long-term effects of a chronic ∆9-THC treatment in samples taken between 
pd 75 and pd 80. Decreased CB1R levels were observed only in the amygdala of male rats. 
Differences between this and the present study are the drug used, dosage, and treatment time as 
well as strain differences. Another study found no effect in the PFC and Hip of adult male mice 
(sample preparation on pd 150 – 160) after an adolescent ∆9-THC treatment (8 mg/kg s.c. from pd 
32 - 52; Behan et al., 2012). Other studies found further contradicting results after adolescent ∆9-
THC treatment (5.6 mg/kg i.p. from pd 35 – 75) of female Long-Evans rats (Winsauer et al., 
2011, Winsauer et al., 2012). In their first study these authors found an increase of CB1R in 
adulthood (measured approx. on pd 200) in the Hip (Winsauer et al., 2011) whereas, in a later 
study, no alterations were found in the Hip although reduced levels were measured in the striatum 
(where no alterations had been observed previously after ∆9-THC treatment; Winsauer et al., 
2012). However, in their second study the western blot analysis appears to have been conducted a 
bit earlier (around pd 180) than in the first one. Several other differences to the present results 
further complicate direct comparison. Although they checked for estrus stage to control for 
possible effects of circulating endogenous hormones, these studies investigated females. 
Moreover, in addition to treatment differences (drug and doses employed, age of administration, 
and rat strain), the control animals were sham-operated and injected again with ∆9-THC during a 
progressive ratio learning task after pd 76. Thus the current literature investigating the effects of 
cannabinoid administration during adolescence on CB1R expression is somewhat limited and 
controversial. The present results of an increased CB1R expression in the mPFC in adulthood 
after more than 35 days of a drug-free period suggests a long-term effect of the chronic pubertal 
WIN treatment. This effect may be a developmental compensation for disturbances of the ECS 
during this critical period of neurodevelopment. Interestingly, a recent study investigating effects 
of a repeated stress paradigm on CB1R levels observed region- and age-dependent effects in 
adolescent and adult rats (Lee and Hill, 2013). In this study CB1R levels in the PFC were 
increased 24h after stress both in adolescents and in adult animals. Moreover, after a recovery 
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period of 40 days, CB1R levels in the PFC of the animals after stress treatment in adulthood 
returned to normal levels whereas a sustained downregulation in the PFC of animals after stress 
treatment in adolescence was observed. This effect was attributed to the prolonged development 
of the PFC which could have been disturbed by the treatment specifically in the adolescent time 
period. This study shows that limited treatments during adolescence can cause long-term effects 
on CB1R levels that are different from the effects of the same treatment in adulthood.  
This would be in line with a possible explanation of the present results. Accordingly, the presently 
employed pubertal WIN treatment increases the CB1R levels specifically in the mPFC due to its 
prolonged development and may also account for the region-specifically observed effect here 
compared to the CPu and the Hip where no alterations were detected. Additionally, this increase 
may only be found at a particular time window of cannabinoid administration during adolescence 
due to the enhanced vulnerability at this time period of continuing developmental processes and 
constitute a compensatory mechanism for disturbing the developing ECS. Investigating the time-
course of these long-term CB1R alterations more thoroughly by including more time points may 
show similar patterns in other brain areas. Regionally dependent alterations of the CB1R are in 
accordance with results of a previous time-course study, however, this study did not investigate 
long-term effect (as mentioned above; Romero et al., 1998). Altogether, the long-term effects of a 
chronic pubertal WIN treatment are increased CB1R levels in the mPFC of adult rats which may 
be a compensatory mechanism for the disturbances of the ECS during development. 
 
Conclusion 
The present project revealed long-term deficits of a chronic pubertal WIN treatment on cognitive 
abilities in adult animals. Decreased OBJR memory performance has been observed before in the 
W[hsd] rat line (Schneider and Koch, 2007, Schneider et al., 2008) and could here be confirmed 
for the W[rcc] rat line. No effects could be found for sensorimotor gating abilities and startle 
amplitude in the PPI of the ASR. In an ASST specifically the reversal learning ability was 
impaired while other learning abilities remained intact, thus indicating deficits particularly in the 
complex behavioral flexibility domain of reversing a previously learned rule. This is in 
accordance with previously found similar behavioral observations in the ASST after viral-
mediated upregulation of the CB1R (Klugmann et al., 2011a). In this previous study a long-lasting 
upregulation of the CB1R was specifically found in the mPFC (Klugmann et al., 2011a). 
Similarly, molecular analysis revealed increased levels of CB1R in the mPFC in the current 
project. Thus, the long-term effects of the pubertal WIN treatment resulted in a distinct elevation 
of the CB1Rs in the mPFC of adult animals possibly increasing the ECS activity or sensitivity in 
this region. This most likely underlies the deficits in OBJR memory and reversal learning abilities 
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in the ASST since the ECS is modulating neurotransmitter systems involved in cognition (Lopez-
Moreno et al., 2008, Kano et al., 2009, El Khoury et al., 2012). Furthermore, the mPFC is 
connected to multiple brain regions that most likely act in a coordinated way during various 
cognitive tests and imbalance in signaling between these regions is associated with cognitive 
deficits (Kucewicz et al., 2011, El Khoury et al., 2012). 
Overall, the long-term molecular alterations in the mPFC after chronic pubertal WIN treatment 
may demonstrate a compensatory mechanism for disturbances of the ECS during the vulnerable 
developmental period of adolescence which are probably region specific in their manifestation 
(Schneider, 2008). 
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4.4 Project IV: Long-term Effects of Chronic Pubertal MPH Treatment on 
Cognition 
In this project the long-term effects of a chronic MPH treatment with 2 mg/kg during puberty 
(pd 40 – 55) were investigated in adulthood (> pd 80) 25 days after treatment cessation in male 
Wistar rats. Tests for locomotor activity and anxiety related behavior did not show any behavioral 
differences between MPH and saline treated animals. There were no differences found either in 
the intake of liquids of differing palatability or in cognitive tests between MPH and saline treated 
animals. 
 
Open Field 
MPH increases locomotor activity upon acute administration (e.g. Yang et al., 2011, Jones and 
Dafny, 2013). However, the effect of chronic administration has been less well investigated. One 
study showed that MPH (2 mg/kg i.p. for 28 days starting either at pd 25 or pd 60) was the major 
modulator (in addition to light cycle) in locomotor behavior (Gomes et al., 2009). However, in 
their experimental design animals were tested 2 h after the last injection not ruling out any 
possible acute effects of the MPH treatment. In this project, no effect of 2 mg/kg MPH during 
adolescence was found in adult animals. Similar to the present results, one study showed that 
Wistar rats treated with 1, 2, or 10 mg/kg MPH i.p. for 28 days (pd 25 – 53) showed no increased 
locomotor activity in adulthood (pd 67) after a 14 days long wash-out period (Valvassori et al., 
2007). 
 
Anxiety-Related Behavior 
Several studies have investigated the possible long-term effects of a chronic MPH treatment but 
the results vary considerably for anxiety related behavior in rats. On the one hand, an increased 
anxiety-like behavior was observed (for a treatment paradigm of 2 mg/kg MPH administered i.p. 
twice daily from pd 20 – 35 and testing 6 or 8 weeks after treatment Bolanos et al., 2003, Bolanos 
et al., 2008, Wiley et al., 2009). On the other hand, an anxiolytic-like effect was observed after a 5 
mg/kg MPH i.p. treatment twice daily from pd 7 – 35 (Gray et al., 2007). But also no effect could 
be observed for 2 mg/kg MPH i.p. from pd 27 – 53 and testing on from pd 92 – 94 (Britton and 
Bethancourt, 2009) or a 21 day long lasting s.c. administration of MPH (2, 4, or 8 mg/kg) via 
osmotic minipumps (Gill et al., 2013). In addition, an EPM test in mice revealed no differences in 
anxiety related behavior after a 7 day long treatment of 2.5, 5, 10, 20, 40, or 80 mg/kg MPH s.c. 
twice daily from pd 26 – 32 (McFadyen et al., 2002).  
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These contradictory results are often attributed to differences in either the employed behavioral 
tests or treatment paradigms. One study even found contradicting results within the same 
treatment conditions (Crawford et al., 2013) where the same dose of MPH (5 mg/kg i.p. from 
pd 11 – 20) showed an increased anxiety-like phenotype in an EPM test whereas a novelty CPP 
suggested a reduced anxiety-like behavior in the same animals. The authors stated that the novelty 
CPP is generally very similar to the EMT test and this usually reveals similar results as the EPM. 
However, as anxiety is a multidimensional emotional behavior, different test paradigms can lead 
to various outcomes (Ramos, 2008).  
In this project no significant difference was found in the anxiety-related behavior between animals 
treated chronically with MPH during puberty and saline control animals neither in the EMT nor 
the EPM test, which is similar to the results found in previous studies (Bethancourt et al., 2009, 
Gill et al., 2013). These studies employed similar doses of MPH and analyzed the behavior of rats 
on the EPM. Particularly Britton and Bethancourt (2009) investigated the behavior of Wistar rats 
after a similar time of treatment (pd 27 – 53) and tested the animals in adulthood (pd 92 – 94 for 
the EPM) which is a similar regimen as in this project. For 2 mg/kg there was no difference in 
behavior which is in line with the present results, apart from a trend for a higher open arm entry 
rate of MPH treated animals observed in the present project. This trend might be explained by a 
higher arousal state of the animals in the novel environment of the EPM. In the EMT Britton and 
Bethancourt (2009) found a decreased time spent in the lit compartment of 2 mg/kg treated 
animals but other measures (latency, risk assessments and transitions) did not differ.  
 
Intake of Liquids of Variable Palatability 
The consumption of SCM was investigated in only one other study (Eckerman et al., 1991). In 
this study a decrease after a 15 min intake paradigm was found after an acute injection of MPH. 
But they employed a repeated drinking paradigm and used eight months old animals. In addition, 
the injected MPH concentrations were much higher than in this project (2.5 – 17.5 mg/kg). The 
consumption of sucrose however, was investigated during a ten days MPH treatment in food 
restricted male rats (Bello and Hajnal, 2006, Gill et al., 2013) and a reduced intake at a dose of 
1.5 mg/kg MPH was observed. Nonetheless, in this paradigm adult rats were used and the intake 
was measured 3 days after treatment onset, therefore probably analyzing also acute effects of 
MPH. 
Other studies showed that chronic administration of MPH (2 mg/kg i.p. twice daily from pd 20 for 
16 days or 15 days respectively) can reduce the preference for a sucrose solution (Bolanos et al., 
2003, Bolanos et al., 2008). In contrast, another study showed that, in a lever press task for 
sucrose pellet intake, chronic MPH treatment increased break points in treated animals compared 
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to controls (Crawford et al., 2007). This task however did not investigate the free choice intake of 
palatable food but used a conditioning paradigm. Similar to the results of the SCM intake in this 
project, one recent study found no differences between MPH treated and control animals for 
sucrose solution intake or preference in a free choice two-bottle paradigm (Crawford et al., 2013).  
There is an ongoing discussion whether the treatment with MPH might increase the risk of drug 
addiction (Lambert and Hartsough, 1998) or rather reduce the risk of substance abuse disorders 
(Biederman et al., 1999). Interestingly, only very few studies have investigated whether the 
treatment of MPH influences ethanol consumption or preference in animal models so far. One 
study found that adolescent MPH treatment (2 mg/kg i.p. twice daily for 16 days from pd 23 – 38) 
increases EtOH consumption only in female and not male SHR rats (Vendruscolo et al., 2008). 
Similar to the present project no difference in EtOH preference was found. However, SHR rats are 
used as an animal model of ADHD which makes the comparison to the Wistar rats in this project 
difficult. Additionally, another study did not find a changed consumption of EtOH in SHR or 
Wistar-Kyoto rat (i.e. the control strain from which SHR were derived) after animals had been 
treated with MPH from pd 21 – 35 and tested after pd 50 (Soeters et al., 2008). In contrast, after 
an acute treatment with MPH in adult mice a decrease in EtOH consumption was found (Griffin et 
al., 2010). However, in addition to the species differences (mice vs. rats) the acute administration 
of MPH makes a comparison of the present project with this study difficult. Altogether there 
appear to be contradicting effects of MPH treatment on EtOH intake and preference as found in 
the literature. In the present project, no differences in the preference of a 6 or a 10 % EtOH 
solution was observed. 
 
Cognitive Tests 
Sensorimotor gating like PPI of the ASR can be modulated by dopaminergic agents (Swerdlow et 
al., 1995). For example the DA agonist apomorphine can disrupt PPI (Mansbach et al., 1988, 
Geyer et al., 1990). A recent study found reduced PPI in ADHD patients (Schulz-Juergensen et 
al., 2014) and this has also been observed previously in ADHD patients with a comorbidity for 
Tourette’s syndrome (Castellanos et al., 1996). However, another study reported no reduced PPI 
in ADHD (Ornitz et al., 1999). MPH as a treatment for ADHD seems to have an effect on PPI if 
the subjects were instructed to focus their attention on the prepulse (Hawk et al., 2003, Ashare et 
al., 2010). Both, the study done by Ashare et al. (2010) and Schulz-Juergensen et al. (2014) 
furthermore found that MPH increased PPI in ADHD patients with a low baseline PPI. Regarding 
the ASR, one study found that MPH restores the normal attenuation and potentiation of startle 
modulation in response to pleasant and unpleasant visual stimuli respectively in ADHD patients 
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(Conzelmann et al., 2011). Before treatment these patients had displayed deficient responses to 
pleasant stimuli. 
Only few rodent studies have investigated the effect of MPH on PPI and ASR so far. Interestingly, 
only acute doses of MPH were analyzed and mainly an increase of startle and an impairment of 
PPI was found for rats (Drolet et al., 2002, Conti et al., 2006, McLaughlin et al., 2011). The doses 
applied were all higher than in the current project (5, 10 and 20 mg/kg) and testing was conducted 
shortly after injection. In contrast, one study found an increased PPI after administration of 
4 mg/kg MPH s.c. (Palsson et al., 2011). It is difficult to compare the impact of the chronic MPH 
treatment in this study to the results of the studies mentioned above. Here no long-term effect of a 
chronic MPH treatment on ASR and PPI was observed in adult rats. From a translational point it 
could also mean that the group of animals tested here was too heterogeneous to show any effects 
of MPH (as in the human studies without the division of high and low baseline PPI). Most human 
studies focus on ADHD patients in contrast to healthy individuals. In addition, effects of MPH in 
humans could only be observed in specific subgroups e.g. individuals with a low baseline PPI or 
those who were instructed to focus their attention to the prepulse. From the present results in adult 
Wistar rats the chronic treatment of a low dose of MPH from pd 40 – 55 does not seem to have a 
long lasting impact on ASR and PPI performance.  
Several studies investigated the effect of MPH treatment on OBJR performance, some of which 
found no effect while others found an impairment in performance (Heyser et al., 2004, LeBlanc-
Duchin and Taukulis, 2007, Bethancourt et al., 2009, Gomes et al., 2009, LeBlanc-Duchin and 
Taukulis, 2009, Pires et al., 2010). High doses generally appear to impair memory for objects 
whereas low doses do not have such an impact (for review see Britton, 2011). For example, one 
study found a disruption of novel object discrimination after a 7 days treatment (from pd 15 – 21 
or pd 28 – 34) of MPH for 5 mg/kg but not for 2 mg/kg in Sprague-Dawley rats (Heyser et al., 
2004). However, this treatment was injected i.p. twice daily and testing occurred 30 min after the 
last injection, not ruling out any possible acute effects of the drug. An impairment of OBJR 
performance was also observed by another study after MPH treatment of rats starting from 
pd 35 – 39 for 21 days (3 or 5 mg/kg administered orally twice daily with drug free days on 
weekends; LeBlanc-Duchin and Taukulis, 2007). In this study the animals were tested 14, 28, and 
42 days after treatment and the impairment persisted up until the last testing point. Interestingly, 
in the same study, animals treated with 2 mg/kg for only 11 days did not show any impairments of 
OBJR memory. This is very similar to the present results, although the ITI was longer (3h 
compared to the 15 min in the present project) and MPH was administered orally. Furthermore, 
similarly to the results of the present study, no impairments of OBJR performance were found by 
another study (Bethancourt et al., 2009) although, rats were treated orally twice daily from 
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pd 27 – 71 with 2 and 5 mg/kg MPH and performance was analyzed during the dark phase of the 
light/dark cycle 18 days after treatment cessation.  
A more recent study in female rats revealed that the chronic effect of MPH (2 mg/kg i.p. from 
pd 25 – 38) in SHR rats improved OBJR performance, but at the same time impaired 
discrimination abilities in control Wistar rats (Pires et al., 2010). Here, animals were tested four 
weeks after the treatment had ended (at 9 – 10 weeks of age). However, in that study only female 
animals were observed.  
The social aspect of MPH effects has received less attention so far. One study observed that MPH 
suppressed social play behavior without abolishing general social interest (Vanderschuren et al., 
2008). In contrast, another study found no effect on social play behavior (Bolanos et al., 2003). 
Both studies did not investigate social memory. One more study also investigated MPH influence 
on social interaction and found no effect (Leblanc-Duchin and Taukulis, 2004). As far as the 
author is aware this is the first time social memory has been investigated after chronic pubertal 
treatment with MPH. Here, no differences between chronically MPH and saline treated animals in 
the ability to recognize a conspecific rat could be observed. Altogether, the current results imply 
that long-term MPH treatment during this specific time period of adolescence does not appear to 
have a specific effect on the abilities of rats to recognize an object or a social partner. 
 
General Conclusion 
The time window of MPH treatment, onset, and duration varies considerably between studies, 
starting as early as pd 7 (Gray et al., 2007) and pd 11 (Crawford et al., 2013) or around and 
shortly after weaning (pd 20: Bolanos et al. (2003), pd 25: Britton et al. (2007), pd 27: Britton and 
Bethancourt (2009)). Treatment duration varies from 7 days (Heyser et al., 2004) to 15/16 days 
(Britton et al. (2007) and Bolanos et al. (2003) respectively) but also longer periods like 4 or 7 
weeks have been employed (Gray et al., 2007, Britton and Bethancourt, 2009). Some studies 
administer the drug twice a day (Bolanos et al., 2003, Britton et al., 2007) , others only once a day 
(Adriani et al., 2006). Moreover, in some studies the weekends are drug-free days (Britton and 
Bethancourt, 2009) whereas others continue treatment on every day (Bolanos et al., 2003).  
In general, most studies investigated treatment during the juvenile period or early adolescence 
whereas prolonged treatment until early adulthood is only rarely investigated.  
However, from a translational perspective and in the context of neuroenhancement the age group 
of MPH users includes high-school students that take MPH to increase their performance in 
school. Furthermore, these adolescents often take MPH while during this age period most of them 
start to drink alcohol. This was why in the current project the time between the approximate onset 
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of puberty (pd 40) up until almost early adulthood (pd 55) in males was of particular interest and 
the influence of MPH on EtOH intake was investigated. 
Additionally, the time of testing often varies and animals are tested shortly after treatment 
cessation (24h: McFadyen et al., 2002) or directly after the last treatment (Gill et al., 2013) when 
acute effects of MPH can not be ruled out. Our testing time had started after the animals reached 
adulthood at > pd 80 after a drug free period of 25 days therefore, any potential acute effects are 
unlikely. However, the time that elapsed after treatment cessation and the start of behavioral 
testing might explain the lack of effects in the current project. It can also imply that the specific 
time window between pd 40 and pd 55 employed here does not yield any lasting effects of the 
drug treatment.  
Also the route of drug administration varies across studies including i.p. injection (e.g. Adriani et 
al., 2006, Crawford et al., 2013) as used in this project or oral administration (e.g. Britton and 
Bethancourt, 2009) but also osmotic minipumps are being employed (e.g. Gill et al., 2013). 
Moreover, different doses of MPH are employed often ranging from 2 – 5 mg/kg.  
Differences in employed strains of rats also make it difficult to compare studies. Often Wistar rats 
are investigated (this project, Adriani et al., 2006, Britton and Bethancourt, 2009) but also 
Sprague Dawley rats are used (Bolanos et al., 2003, Crawford et al., 2013, Gill et al., 2013). The 
importance to mind possible differences between rat strains has been mentioned before (see 
project I; Rex et al., 1999, Brand et al., 2012), even within the same rat strain but in different lines 
or obtained from different suppliers (Langer et al., 2011, Palm et al., 2011b, Goepfrich et al., 
2013).  
Altogether, in the current project a chronic, 2 mg/kg MPH treatment of male Wistar rats from 
pd 40 – 55 injected i.p. once a day and with the beginning of behavioral testing after pd 80, did 
not induce any persistent behavioral effects. Nevertheless, the lack of enduring effects of a MPH 
treatment are no evidence for the safety of prolonged MPH use (Bethancourt et al., 2009). More 
research is needed to determine if there are developmental periods more or less risky to use 
psychostimulant medication. 
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4.5 Conclusion 
In the present thesis various behavioral and molecular characteristics of basal cognitive abilities, 
the influence of the ECS and the development throughout adolescence and in adulthood in male 
Wistar rats were studied.  
First of all, the comparison of three Wistar Han rat lines revealed several differences in cognitive 
abilities and therefore added to the increasing evidence of behavioral differences even within the 
same strain but different lines of rats.  
The second project showed differing trajectories of the development of cognitive abilities 
throughout adolescence that included non-linear, gradual and delayed patterns for various 
cognitive tests. These behavioral findings appear to be connected to underlying molecular changes 
in the ECS and myelination during development. Particularly the deficit in OBJR memory was 
ameliorated by the CB1R antagonist / inverse agonist SR indicating an involvement of the 
developing ECS at the approximate onset of puberty in memory processing. Furthermore, 
differing levels of the CB1R in various brain regions throughout development suggested that these 
molecular processes subserve behavioral performances in different cognitive paradigms. 
Similarly, increasing myelination contributes to increased cognitive performance and was shown 
to develop differentially in various brain regions. This indicates that the differential development 
of brain regions and transmitter systems involved in cognition proceeds in variable ways and most 
likely contributes to the observed behavioral patterns. Because several brain regions are working 
in a coordinated network together during cognitive tasks the variable development of these 
regions may create an imbalance at specific developmental time points and may therefore add to 
the observed behavioral trajectories.  
The third project showed that the interference with the developing ECS can lead to long-term 
impairing effects on cognition. These observations support the animal model of chronic pubertal 
WIN treatment at the specific vulnerable time period of puberty. Furthermore, the here found 
increased CB1R levels in the mPFC, most likely underlie the cognitive deficits observed and may 
demonstrate a compensatory mechanism of the disturbance of the ECS at this vulnerable 
developmental time period.  
The presently employed chronic pubertal MPH treatment did not reveal any long-term effects in 
various behavioral tests, thus indicating that this particular treatment regimen may not have 
impairing effects after a drug-free period in adulthood.  
Altogether, this thesis revealed a differential development of basal cognitive abilities in the male 
Wistar rat, some of which are likely due to underlying alterations in the developing ECS. 
Furthermore, adolescence is very prone to the influence of pharmacological agents interfering 
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with this system. Thus, this vulnerable period of neurodevelopment is a time period where 
manipulations of the ECS can have lasting effects on cognitive abilities into adulthood. 
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5. List of Abbreviations 
(m)PFC (medial) prefrontal cortex 
(m)sec (milli)second 
(RM) ANOVA (repeated measurement) analysis of variance 
2-AG 2-Arachidonoylglycerol 
AC adenylat cyclase 
ACh acetylcholine 
ADHD attention deficit hyperactivity disorder  
AEA anandamide 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ASR  acoustic startle reflex 
ASST attentional set shift test 
BPS balano-preputial separation  
BW body weight 
CA cornu ammonis 
cAMP / ATP cyclic adenosin monophosphate / adenosin triphosphate 
CB1R /CB2R cannabinoid receptor 1 / 2 
CD compound discrimination 
cm centimeter 
COMT catechol-o- methyl transferase 
COX-2 cyclooxygenase 2 
CP casein pellet 
CPu caudate putamen 
D1/2R dopamine receptor 1/2 
DA dopamine 
DAB 2,4 diaminobutyric acid  
DAG diacylglycerol 
dB decibel 
DG dentate gyrus 
DSI / DSE depolarization-induced suppression of inhibition / excitation  
DSM Diagnostic and Statistical Manual of Mental Disorders 
eCB endocannabinoid 
ECS endocannabinoid system 
EDS extradimensional shift 
EDTA ethylenediaminetetraacetic acid 
EMT light/dart emergence test 
EPM elevated plus maze 
ERK extracellular signal-regulated kinase  
EtOH ethanol 
FAAH fatty acid amino hydrolase 
FAK focal adhesion kinase  
FAN factor associated with neutral sphingomyelinase activation 
GABA ɤ-aminobutyric acid 
GPR G-protein coupled receptor 
h hour 
HCl hydrochloride acid 
Hip Hippocampus 
i.p. intraperitoneal 
IDS intradimensional shift 
IEG immediate early gene 
IL infralimbic  
IQ intelligence quotient 
ITI intertrial interval 
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JNK c-jun N-terminal kinase  
K+A A-type potassium channels  
kDA kilodalton 
Kir inwardly rectifying potassium channels  
LOX lipoxygenase 
LTM long-term memory 
LTP long-term potentiation 
lx Lux 
mA milliampere 
MAGL monoaclyglycerol lipase 
MANOVA multivariate analysis of variance 
min minute 
ml milliliter 
MPH methylphenidate 
MRI magnetic resonance imaging 
NAc Nucleus accumbens 
NaCl natrium chloride 
NAPE N-arachidonoyl-phosphatidylethanolamine  
NAT N-Acetyltransferase 
NGS normal goat serum 
NIH National Institute of Health 
NMDA N-Methyl-D-Aspartate 
OBJR object recognition 
OBJRecency object recency 
OD optical density 
OFC orbifrontal cortex 
p38  p38 mitogen-activated protein kinase  
P1 / 2 / 3 presentation 1 / 2 / 3 
PBS (-T) phosphate buffered saline (-Tween) 
PCP phencyclidine 
pd postnatal day 
PE phosphatidylethanolamine 
PFA paraform aldehyde 
PI phophatidylinositol 
PKA / C protein kinase A / C 
PL prelimbic  
PLC / PLD phospholipase C / D 
PnC nucleus reticularis pontis caudalis 
PPI prepulse inhibition 
Pre pretraining 
PVC polyvinylchloride 
PVDF polyvinylidene difluoride 
RDoC Research Domain Criteria 
rep  repetition 
rev reversal 
ROI region of interest 
RT room temperature 
S.E.M. standard error of the mean 
SCM sweetened condensed milk 
SD simple discrimination 
SDS Sodium dodecyl sulfate 
SHR spontaneously hypersensitive rats  
SM sphingomyelin 
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Smase sphingomyelinase 
SOCR social recognition 
SPL sound pressure level 
SR SR 141716A 
STD / LTD short-term depression / long-term depression 
STM short-term memory 
TBS (-T) tris-buffered saline (-Tween) 
TRPV1 transient receptor potential vanilloid 1 
V Volt 
W[hsd] HsdHan:WIST  
W[Jan]  RjHan:WI  
W[rcc] RccHan:WIST  
WCST Wisconsin Card Sorting Test 
WIN WIN 55,212-2 
WM working memory 
∆9-THC ∆9-tetrahydrocannabinol 
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